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ABSTRACT 
 
 
Structural Studies of Mycobacterium tuberculosis KatG, an INH Drug Activator, and 
Brucella abortus VirB11, an ATPase of Type IV Translocation System. (May 2007) 
Hong Yu, B.S., Northeast Agriculture University, China; 
M.S., Kansas State University 
Chair of Advisory Committee:  Dr. James C. Sacchettini 
 
 
Catalase-peroxidase (KatG) of Mycobacterium tuberculosis is a bifunctional heme 
enzyme that has been shown to play an important role in the activation of a first line 
drug, isoniazid (INH), used in the treatment of tuberculosis infection. Mutations in the 
katG gene have been found to be associated with INH resistance. The most commonly 
encountered mutation is the Ser315Thr point mutation. In this dissertation, the x-ray 
crystallographic structures of MtbKatG and the mutant enzyme KatG[S315T] are 
presented to explore the molecular basis of the INH activation and resistance.  The 
structure is dimeric and contains a heme cofactor in each subunit of the dimer.  The most 
important change in KatG[S315T] is due to the presence of the methyl group of the 
threonine 315 side chain, which is located at the narrowest part of the substrate channel. 
The protruding methyl group effectively constricts the accessibility to the heme by 
closing down the dimensions of the channel, constraining the substrate entrance.  
VirB11 of Brucella abortus is a hexameric ATPase that belongs to the type IV 
secretion system.  The crystal structure of BaVirB11 was found to contain six molecules 
per asymmetric unit.  The Walker A (P loop), His box, and Glu box from the C-terminal 
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domain are located at the interface of the N- and C-terminal domain.  A large 
conformational change was found in the linker region when compared with that of 
HP0525 structure, the VirB11 analogous from H. pylori. To elucidate the functional role 
of each domain, seven functional mutations were generated and used for biochemical 
studies.  The GER motif and the linker region were found to be crucial for ATP 
hydrolysis activity of BaVirB11. Mutations in the GER motif (R101Q) and the linker 
region (R120E) of BaVirB11 completely abolish the ATP hydrolysis activity of the 
enzyme. The binding affinities of the two mutants to the ATP; however, are similar to 
that of the wild-type enzyme, indicating that mutation in the GER motif or the linker 
region has no effect on ATP binding.   
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CHAPTER I 
 
INTRODUCTION 
 
Overview 
 
Both Mycobacterium tuberculosis and Brucella abortus are intracellular bacteria that can 
cause infections in mammals.   
Tuberculosis (TB), an infectious disease caused by Mycobacterium tuberculosis, is 
the single leading cause of death worldwide due to the wide spread of multidrug-
resistant strains and increasing infections among AIDS/HIV patients (WHO 2003).  
Isoniazid (INH), a frontline drug used in the treatment of tuberculosis, is a pro-drug that 
requires activation by the M. tuberculosis catalase-peroxidase (KatG) (Zhang et al., 
1992).  Shortly after the introduction of INH, bacteria strains resistant to the drug were 
identified (Middlebrook 1952; Dean 1953). Most INH resistance in clinical isolates has 
been associated with loss or decreased KatG activity due to mutations in the katG gene 
(Slayden and Barry 2000).  The most commonly encountered mutation is the Ser315Thr 
point mutation, which has been found in over 50% of resistant clinical isolates (Slayden 
and Barry 2000).  Understanding the molecular basis of the pro-drug activation and the 
relationship between drug resistance and the structure and function of KatG is essential 
for new drug development.   
_________________ 
This dissertation follows the style and format of the EMBO Journal. 
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Brucellosis is the most frequent human zoonosis of global importance (Young 1983; 
Boschiroli et al., 2001). The disease is characterized by acute fever, night sweats, undue 
fatigue, anorexia, headache, and several neurological disorders. The causative agents of 
brucellosis are intracellular pathogens Brucella spp. The severity of the disease and lack 
of vaccines suitable for use in human has led to the investigation of Brucella as an agent 
for bioterrorism (Culter et al., 2005). Indeed, Brucella has been classified as a class 3 
bioterrorism agent (Robinson-Dunn 2002). Like M. tuberculosis, Brucella spp. are 
Gram-negative bacteria that survive and replicate within host monocytes and 
macrophages, causing chronic granulomatous infections both in animals and humans 
(Smith and Ficht 1990). Brucella abortus is the aetiological agent of bovine brucellosis, 
which induces abortion and sterility in cattle and causes significant economic losses 
(Corbel 1997; Ficht 2003).  A key aspect of the virulence of Brucella species is thought 
to be due to their ability to avoid the killing mechanism within host cells via the type IV 
secretion system (T4SS), encoded by the virB region (O’Callaghan 1999; Comerci et al., 
2001; Baron et al., 2002; Boschiroli et al., 2002a). The bacteria use T4SS to translocate 
DNA and protein effectors across the cell envelope into the host cells. A. tumefaciens, a 
plant pathogenic bacterium, uses T4SS to deliver DNA and proteins into plant cells 
causing the Crown Gall tumour disease.  H. pylori, a causative agent of peptic ulcers, 
translocate a 40 kDa protein CagA into the host cell through T4SS to interfere with the 
signaling pathway of the host cell (Segal 1999).  VirB11 ATPase is an energy-
consuming component of T4SS, presenting a good target for developing new drugs 
against pathogenic bacteria.  Elucidating structural features and molecular determinants 
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that govern the activity of the enzyme may lead to drug discovery. Structural studies are 
important for understanding the molecular basis of drug resistance and ultimately 
inhibitor design.  In this thesis, we describe the structure of KatG[S315T], which 
explains the mechanism of isoniazid resistance.  We also describe the structure of 
VirB11 in Brucella, which is a virulent factor of the pathogenic bacterium. 
Chapter I introduces M. tuberculosis, the front-line drug isoniazid (INH) and the 
catalase-peroxidase (KatG) that is responsible for the pro-drug activation.  It also 
describes brucellosis and the type IV secretion system of Brucella spp.  Chapter II 
describes the X-ray crystallographic methods. Chapter III presents the X-ray crystal 
structures of the Mtb KatG, S315T mutant and the wild-type MtbKatG co-crystallized 
with INH.  Functional and structural studies of VirB11 ATPase from Brucella abortus 
are described in chapter IV. Future studies and perspectives on VirB11 and other 
components of T4SS are proposed in chapter V. 
 
Tuberculosis 
 
History of Tuberculosis 
 
 
Mycobacterium tuberculosis has affected humans for several millennia (Ayvazian 1993) 
and remains a devastating public health threat with an estimated eight million people 
contracting the disease and approximately two million deaths worldwide each year 
(WHO 2003).  In the United States, bacteria of this genus have significantly increased in 
prevalence in the past two decades due to synergistic co-infection among AIDS/HIV 
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patients and the emergence of wide spread multi-drug resistant strains (Musser 1995).  It 
has been estimated that approximately 1 billion people will be newly infected in next 20 
years, over 150 million people will get sick, and 36 million will die of tuberculosis, if 
proper controls are not instituted (WHO 2005). 
Tuberculosis (TB) is an ancient disease that can be traced back to the predynastic era 
(Morse et al., 1964).  Tuberculosis probably occurred as a sporadic disease in early 
history (Bates and Stead 1993).  The epidemic slowly spread as a result of increasing 
population density.  During the so-called “Great White Plague” in the seventeenth 
century, almost all Western Europeans became infected with TB, and about one in four 
deaths were due to tuberculosis (Dubos 1952).  As infected Europeans traveled to and 
colonized distant cities, the epidemic spread worldwide.  By the turn of the 19th 
Century, the estimation of TB death rate was seven million per year and the pulmonary 
TB rate was 50 million per year worldwide (Bates and Stead 1993). 
The invention of antimicrobial chemotherapy in the 20th century was a great 
contribution to modern medicine.  The first vaccine used on humans was introduced by 
French physician Calmette in 1921 and the vaccines have been widely used for 
tuberculosis prevention since World War II (Sakula 1982).  With the development of the 
antibiotic streptomycin by Schatz and Waksman in 1944 (Schatz et al., 2005), treatment 
of tuberculosis became a possibility.  When more effective drugs such as isoniazid 
(INH) and pyrazinamide (PZA) were introduced in the early 1950s, tuberculosis became 
a treatable disease (Temple 1951).   
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From early 1950s to 1980s, TB cases declined significantly with the worldwide 
implementation of disease control and prevention program.  From 1985 through 1990, 
however, the number of reported cases has increased rapidly due to the neglect of TB 
control programs, insurgence of HIV/AIDS, and immigrations (Schweinle 1990).  
Multiple drug resistant strains of tuberculosis (MDR-TB), resistant to both isoniazid and 
rifampin at least, are the emerging public health crisis in many regions of the world. The 
World Health Organization (WHO) declared TB a global health emergency in 1993.  
Since then, new cases have decreased due to the widespread use of directly observed 
therapy, short-courses (DOTs), treatments regiment recommended by the World Health 
Organization. 
 
Microbiology and Pathogenesis of Tuberculosis 
 
Tuberculosis is a complex communicable respiratory infection of human caused by M. 
tuberculosis and less commonly by M. africanum and M. bovis, collectively referred to 
as tubercle bacilli (Coberly et al., 2001).  M. tuberculosis has been classified in the 
genus of Mycobacterium, which belongs to the family of Mycobacteriaceae of the order 
of Actinomycetales (Osoba 2003).  A virulent strains of M. tuberculosis that infects 
humans is H37RV (Daniel et al., 1997).   
Mycobacteria are acid-fast, non-spore forming, non-motile, and non-encapsulated 
bacilli.  They are slender, slightly curved, obligate aerobes averaging 4x 0.3mm in size.  
The distinct feature of Mycobacteria is their unique and complex cell walls rich in lipid 
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complexes.  The lipid content of the cell wall is remarkably high (60% as contrasted to 
20% in Gram negative organisms, and 1-4% in Gram positives) (Coberly 2001).   
The lipid wall of mycobacteria is responsible for difficulty in staining, acid-fastness, 
and the relative resistance to host phagocytic defenses. 
The pulmonary tuberculosis is usually caused by the inhalation of tubercle bacilli in 
cough spray (Rieder et al., 1989). The majority of inhaled bacilli are destroyed by 
pulmonary alveolar macrophages.  However, bacilli that escaped macrophage killing 
start to multiply within the macrophages and establish primary infection (Alland et al., 
1994).  T cells respond nonspecifically to the components of the bacilli leading to 
secretion of the gamma-interferon, which causes macrophage aggregation and activation, 
enabling more aggressive phagocyte killing (Ellner 1997).  If these early, nonspecific 
reactions do not wipe out the infection, bacilli are transported to the lymph nodes at the 
hilum of the lung, resulting in the formation of granuloma.  
 
Treatments of Tuberculosis 
 
 
The abnormal thickness of the lipid bilayer, along with its slow-growing nature and the 
co-existing of semi-dormant and dormant forms, complicate tuberculosis chemotherapy, 
often requiring months of treatment. 
Drugs used in the chemotherapy of tuberculosis are divided into two categories: 
the first line and the second line agents. The first line agents (Figure 1) including 
isoniazid (INH), rifampin, pyrazinamide (PZA), Ethambutol (EMB) and streptomycin, 
are the most commonly used drugs against M. tuberculosis with a low incidence of  
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  A).  Isoniazid     B).  Rifampin 
 
   
C).  Pyrazinamide    D).  Streptomycin 
 
 
    E).  Ethambutol 
 
 
Figure 1.  Chemical structures of the first line antituberculosis drugs. 
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toxicity.  The second line drugs are used when resistance or unacceptable toxicity 
precludes the use of first line agents.  They are generally less effective and more toxic.  
The second line drugs include kanamycin, amikacin, capreomycin, cycloserine (CS), 
ethionamide (ETH), para-aminosalicylic acid (PAS), and fluoroquinolones (FQ).  
The American Thoracic Society (ATS) and the Centers for Disease Control (CDC) 
have collaborated to develop joint guidelines for the diagnosis, treatment, prevention, 
and control of tuberculosis.  The guideline was published in 1994 for treating 
tuberculosis in settings where mycobacteria cultures, drug susceptibility testing, 
radiographic facilities, and second-line drugs are routinely available (ATS/CDC 1994).  
There are four recommended regimens for treating patients with tuberculosis caused by 
drug-susceptible organisms (Table 1).  Each regimen has an initial phase of 2 months 
followed by a choice of several options for the continuation phase of 4 to 6 months.   
 
Drug Resistant Tuberculosis  
  
Drug resistance as a limiting factor for a successful TB treatment was recognized 
immediately following the introduction of the first antibiotic streptomycin in 1946 
(Youmans and Feldman 1946).  Subsequent studies proved that the increase in drug 
resistance following mono-therapy was due to the selection of the drug-resistant mutants 
(Temple 1951) (Dean and Hinshelwood 1953).  In many parts of the world such as 
Africa and Asia, drug resistant tuberculosis is an increasing problem. The World Health 
Organization estimated that up to 50 million persons worldwide may be infected with 
drug resistant TB strains.  
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Table 1. Four recommended regimens (WHO) for treating patients with 
tuberculosis caused by drug-susceptible organisms  
 
   
 
 
INH (Figure 1A) is the mostly common used drug for treating tuberculosis. 
Following its introduction in 1952, bacteria strains that were resistant to INH were 
detected (McDemott 1958).  Mutations leading to INH resistance have been identified in  
different genes including katG, inhA and ahpC (Sherman et al., 1996).  A variety of 
point mutations in two genes have been identified that account for most of clinical INH 
resistance characterized to date:  the katG gene, which encodes a catalase-peroxidase 
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(KatG) (Stoeckle et al.,1993), and the inhA gene, which encodes a fatty-acyl carrier 
protein enoyl reductase (Banerjee et al., 1994).  Mutations in these genes account for 60-
70% (katG) and 10-15% (inhA) of INH-resistant tuberculosis and vary considerably with 
location (Sherman et al., 1996).  
MDR-TB is a form of tuberculosis that is resistant to two or more of the primary 
drugs used for the treatment of tuberculosis. The first report of MDR-TB outbreak at a 
London hospital HIV Unit occurred in August 1995, and the second in June 1996 
(Breathnach et al., 1998).  By the year of 2001, there were about 50 million people 
infected with MDR-TB (Espinal et al., 2001). 
Treatment for MDR-TB involves drug therapy over many months or years.  Despite 
the longer course of treatment, the cure rate decreases from over 90 percent for 
nonresistant strains of TB to 50 percent or less for MDR-TB (Espinal et al., 2001).  In 
2003, the CDC in Atlanta USA reported that 7.7% of tuberculosis cases in the U.S. were 
resistant to isoniazid and 1.3% resistant to both isoniazid and rifampin.  About 300,000 
new cases of MDR-TB are diagnosed around the world each year and 79% of the MDR-
TB cases show resistance to three or more drugs (ATS/CDC 2003).  MDR-TB has been 
a particular concern among HIV-infected persons.  Patients with HIV/AIDS are at a 
greater risk of developing TB.  The spread of antibiotic-resistant strains presents a 
serious threat to current tuberculosis control programs throughout the world.    
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Isoniazid, a First Line Anti-tuberculosis Drug 
 
Isoniazid (INH) has been the most widely used of all antituberculosis drugs for the past 
several decades.  INH was first synthesized by Meyer and Malley in 1912 (Meyer  
1912).  However, its antituberculous effect was not recognized until 1942 (Chorine 
1945).  Three drug companies, Hoffman LaRoche, E.R. Squibb & Sons, and Bayer, 
developed INH simultaneously in 1952 by reshuffling chemical groups in 
thiosemicarbazone (Bernstein et al., 1952); (Fox 1952); (Offe et al., 1952).  Since its 
discovery, INH has been a mainstay TB drug and is the cornerstone of all effective 
regimens for TB treatment and prevention.  The emergence and outbreak of MDR-TB 
has renewed the interest in understanding the mechanisms of drug activation and 
resistance in M. tuberculosis (Bloom and Murry 1992).  
The structure of INH consists of a pyridine ring and a hydrazide group (Figure 2).  
Both the pyridine and hydrazide moieties are essential for the high level of activity of 
INH against M. tuberculosis (Bernstein et al., 1952).  M. tuberculosis is highly 
susceptible to INH with MIC values in the range of 0.01 to 0.25 ug/ml.  However, INH is 
active against growing tubercle bacilli but not resting bacilli (Zhang 2005).  M. bovis is 
slightly less susceptible to INH than to M. tuberculosis.  M. smegmatis and M. avium are 
relatively insensitive to INH treatment with MIC of 10-100 ug/ml.  Other bacterial 
species outside the mycobacterial genera are highly resistant to INH (MIC greater than 
600 ug/ml) (Pansy et al., 1952).  The reason for these differences is that M. tuberculosis 
contains only KatG that has both peroxidase and catalase activities, whereas other 
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bacterial species contain one more catalase in addition to a peroxidase-catalase protein 
(Shoeb 1985).  The activities of KatG are responsible for INH activation, whereas the 
activity of a catalase is not. The mechanism by which catalase confers protection against 
INH is not known.  A plausible explanation is that catalase scavenges H2O2 and inhibits 
H2O2-dependent peroxidase-mediated oxidation of INH (Shoeb 1985). 
               
Figure 2.  INH activation pathway.  The figure was draw to show the isonictinic acyl 
radical and the INH-NAD adduct. 
 
 
INH Activation and the Drug Targets 
 
INH is a pro-drug that requires activation by M. tuberculosis KatG.  However, the 
mechanism of activation has not been precisely elucidated.  It is not known where the 
substrate-binding site is located in M. tuberculosis KatG, and how the electrons are 
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transferred between the enzyme and the substrate. It has been shown that initiation of 
isoniazid oxidation starts with the resting enzyme, oxygen, and the reductant 
(Chouchane et al., 2000).  Oxidation of INH may also be mediated nonenzymatically by 
Mn(III) (Magliozzo and Marcinkeviciene 1997).  Activation of INH, by either KatG or 
Mn+3, leads to an acyl radical species that can attack the 4th position of the nictonamide 
group of NAD(H) to yield a covalent isonicotinoyl-NAD adduct (Figure 2) (Rozwarski 
et al., 1998).  Despite numerous and intensive studies, knowledge of the mechanism of 
INH activation is limited (Ghiladi et al., 2005).  The consensus opinion is that MtbKatG 
oxidizes INH to an isonicotinic acyl radical, which then couples to NAD+ to form an 
isonicotinoyl-NAD adduct (Figure 2). 
The primary target of INH inhibition is thought to be the mycolic acid synthesis 
pathways. INH treatment can cause the loss of acid-fastness in mycobacteria 
(Middlebrook 1952).  InhA is a key enzyme involved in the biosynthesis of mycolic 
acids, which are specific components of the mycobacterial cell wall (Marrakchi et al., 
2000).  It was first identified as the drug target of INH using genetic experiments 
(Banerjee et al., 1994) (Dessen et al., 1995).  Mutations in the InhA gene in INH-
resistant clinical strains were identified and a point mutant (S94A) was shown to confer 
resistance to INH in M. smegmatis and in M. bovis (Banerjee et al., 1994).  Mutations in 
InhA that have been identified in INH resistant strains of Mycobacteria were found to be 
localized to the binding site of the isonicotinoyl-NAD adduct and were shown to result 
in a decreased affinity of the InhA enzyme for NADH (Basso et al., 1998).  Much 
progress has been made in regard to the INH inhibition of the InhA enzyme by means of 
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biochemical and crystallographic studies (Johnsson et al., 1998); (Rozwarski et al., 
1998); (Quemard et al., 1995).  INH has been shown to inhibit the catalytic activity of 
InhA in vitro (Johnsson et al., 1995), and that isonicotinoyl-NAD is a slow, tight-binding 
competitive inhibitor of InhA (Rozwarski et al., 1998); (Rawat et al., 2003).  The co-
crystal structure revealed  that the isonicotinoyl-NAD adduct binds irreversibly to a 
cysteine residue near the active site of InhA, blocking NADH-binding sites (Rozwarski 
et al., 1998).  Inactivation of InhA alone was shown to be sufficient for inhibition of 
mycolic acid biosynthesis (Kremer 2003).    
 
M. tuberculosis Catalase-Peroxidase (KatG) 
 
All living organisms, except anaerobic bacteria, require protection against the damaging 
effects of reactive oxygen species.  The M. tuberculosis KatG is a component of the 
oxidative defense system of the bacteria and functions primarily as a catalase to remove 
hydrogen peroxide.  Such catalase activity is regarded as one of the virulence factors for 
M. tuberculosis (Middlebrook 1954), because this reaction detoxifies reactive oxygen 
species generated by macrophages and facilitates the bacterial survival.   Strains of M. 
tuberculosis lacking the katG gene are heavily attenuated in animal models (Pym et al., 
2002).  On the other hand, M. tuberculosis KatG functions as a peroxidase, oxidizing INH 
to its active form.  KatG is thought to be the only enzyme in M. tuberculosis that is 
capable of generating isoniazid susceptibility (Zhang et al., 1992).  It has been shown that 
most INH resistance in clinical isolates results from blocking prodrug activation through 
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mutation in the katG gene that alters or diminishes catalase-peroxidase activity (Musser 
1995).     
In the following section, the peroxidase family will be introduced and the catalase and 
peroxidase properties of KatG will be summarized. Reaction mechanisms of KatG and 
class I peroxidases will be compared and the structural studies of class I peroxidases will 
be reviewed.  
 
Classification of Peroxidases   
 
Based on the sequence similarity, KatGs have been classified into the class I peroxidase 
superfamily (Welinder 1992b). 
Peroxidases are ubiquitous oxidative heme-containing enzymes that utilize hydrogen 
peroxide to oxidize a wide variety of organic and inorganic compounds.  They have been 
implicated in diverse biological processes that include cell wall synthesis and 
degradation, stress response, signaling during oxidative stress, and removal of 
xenobiotics (Rodriguez-Lopez 2001). The plant peroxidase superfamily includes 
peroxidases of prokaryotic origin, secreted fungal and secreted plant peroxidases.   
The plant peroxidase superfamily is further classified into three families, class I, 
class II, and class III (Dunford 1999).  Class I peroxidases consist of peroxidases of 
prokaryotic origin, including plant peroxidases, e.g. horseradish peroxidase (HRP), 
ascorbate peroxidase (APX), fungal peroxidases, e.g. cytochrome c peroxidase (CCP), 
and bacterial catalase-peroxidases (KatGs).  Class I peroxidases contain no 
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carbohydrate, no cysteine bridge ions, and no signal peptide for secretion.  Class II 
peroxidases include the secretory fungal peroxidases such as lignin peroxidase (LiP), 
manganese peroxidase (MnP) (Sundaramoorthy 1994), and Arthromyces ramosus 
peroxidase (ARP). Class II peroxidases contain an amino terminal signal peptide 
sequence for the secretion through the endoplasmic reticulum (Welinder 1992a).  Class 
III peroxidases are the secretory plant peroxidases that are targeted for the secretory 
pathways (Welinder 1992b).  All members of the three classes catalyze the reduction of 
hydrogen peroxide.  
The sequence alignment for the class I peroxidase superfamily is shown in Figure 2. 
There are three additional insertions in the N-terminal domain of KatG which other class 
I peroxidases do not possess (Figure 3).  The short insertion occurs between Trp 36 and 
Ala 60 in MtbKatG, named loop LL1.  The large insertion LL2 occurs from Pro 194 to 
Asn 231 in MtbKatG and it is unique to all KatGs.  Another conserved insertion among 
KatGs occurs from Pro 280 to Ile 313 in MtbKatG, named loop LL3.  Structural 
consequences of the insertions in KatGs will be addressed in a later chapter.   
KatGs are homodimeric proteins with monomers being twice as large as other 
members of class I peroxidase e.g. CCP or APX, which is ascribed to gene duplication 
(Welinder 1992a). Their N-terminal domain binds a heme and shows high sequence 
homology to yeast cytochrome c peroxidase (Duroux and Welinder 2003).  The C-
terminal domain has lost its heme and has a much lower homology to cytochrome c 
peroxidase.  In contrast to other members of the class I family, KatGs exhibit a high  
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Figure 3. Sequence alignments of class I peroxidases.  The figure was generated using 
the Clustalw multiple sequence alignment program in Biology Workbench.  CCP: 
cytochrome c peroxidase; HP: horseradish peroxidase; APX: ascorbate peroxidase; 
KatG_TB: M. tuberculosis KatG.  LL1: loop 1; LL2: loop 2; LL3: loop 3 in MtbKatG. 
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catalase activity comparable to monofunctional catalase, despite having low sequence 
similarity with typical monofunctional catalase (Murthy et al., 1981).    
 
 
Reaction Mechanisms of Class I Peroxidases 
 
 
Class I peroxidases, in general, show very broad substrate specificity and produce highly 
reactive products. The biological functions and the specific substrates in this peroxidase 
group have been difficult to verify and are not yet fully resolved.  The generally 
accepted mechanism of the enzyme reaction is a three-step catalytic cycle in the classical 
peroxidation reaction as shown in Figure 4.  The initial step in the catalytic cycle is the 
heterolysis of the oxygen-oxygen bond of hydrogen peroxide (1).  Hydrogen peroxide 
binds to the heme in the Fe(III) state to form the two-electron oxidized enzyme 
intermediate, compound I, which contains an oxyferryl iron center and a second 
oxidizing equivalent stored as a radical Fe(IV)=OR* (Hiner et al., 2002).  The reaction 
causes the release of one water molecule.  In the second step (3), compound I reacts with 
a reducing agent, typically a phenol derivative, to form compound II, in which the 
oxygen-oxygen bond of hydrogen peroxide is cleaved, and a phenolic radical is 
discharged leaving only the oxyferryl iron.  Another water molecule is released during 
this reaction.  In the third reaction step (4), the compound II is reduced back to the ferric 
state of the resting enzyme by a second reducing phenol derivative.  In the peroxidase 
cycle, two reducing agents are converted to reactive phenolic radicals.  
The catalase-peroxidase catalytic cycles both begin with the oxidation of the ferric 
heme by two electrons of a hydrogen peroxide to form oxyferryl porphyrin-protein 
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intermediate compound I (reaction 1 as showed in figure 4).  The catalase cycle is 
completed by the reduction of compound I to the ferric resting enzyme by a second 
hydrogen peroxide molecule (reaction 2).  In the peroxidase cycle, compound I is 
reduced in the two sequential one-electron steps by an exogenous reducing agent as in 
other peroxidases (reaction 3&4).  In presence of excess hydrogen peroxide, compound 
II is oxidized into compound III (reaction 5), an oxyperoxidase at an oxidation state IV 
(Chouchane et al., 2000);  (Jakopitsch et al., 2005). 
         
Figure 4.  Proposed reaction pathways of catalase-peroxidase of M. tuberculosis.  The 
peroxidase cycle includes reaction 1, 3, 4 and reaction 5 if there is excess hydrogen 
peroxide presence.  The catalase cycle includes reaction 1 and 2.  AH2 represents a 
phenol derivative as a reducing agent in the peroxidase cycle. The dot represents a 
compound in its radical form. R represents protein residues.  
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Properties of MtbKatG  
 
M. tuberculosis KatG is an 80 kDa bifunctional enzyme exhibiting a high catalase 
activity and a peroxidase activity with broad specificity (Heyme et al., 1993) (Welinder 
1992a) (Zhang et al., 1992).  It is capable of using a single active site to catalyze both the 
catalase and peroxidase reactions and thereby remove hydrogen peroxides from the 
biological system efficiently.  It is believed that the catalase function of KatG is essential 
for the protection of the bacteria against oxygen free radicals within the macrophage 
(Manca et al., 1999).   
KatGs differ from classic catalases in many respects.  They have little sequence 
homology with typical catalases.  In contrast to classic catalases which show a broad pH 
activity (range from pH 5.5 to 10.0), KatGs show maximum activity in a narrow pH 
range (6.0-6.5) and are not inhibited by typical catalase inhibitors (Nadler 1986).  The 
catalase activity of KatG is greatly reduced by dialysis against low concentration 
hydrogen peroxide, while dialysis against hydrogen peroxide had no effect on the classic 
catalase (Nadler 1986).  A covalent bond between the active site tryptophan, tyrosine, 
and methionine residues was found to present in the H. marisomortui KatG, 
Synechocystis KatG, B. pseudomallei KatG, and M. tuberculosis KatG (Yamada et al., 
2002; Jakopitsch et al., 2003a).  Thus, the Trp-Tyr-Met adduct may be a common feature 
to all catalase-peroxidase.  The integrity of the covalent adduct correlates to catalase 
activity but not the peroxidase activity of KatGs (Jakopitsch et al., 2003a).  Studies had 
been shown that upon exchange of the active site tryptophan, the catalase activity was 
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dramatically diminished in E. coli (Hillar et al., 2000) or even lost in the Synechocystis 
(Regelsberger et al., 2000) and the bifunctional enzyme was converted to a 
monofunctional peroxidase (Jakopitsch et al., 2003a).   
On the other hand, KatG possesses significant peroxidase activity with several 
reducing substrates such as o-Dianisidine, a typical substrate for class I peroxidase, p-
Phenylendiamine, pyrogallol, NADH, and INH (Johnsson and Schultz 1994). The 
function of KatG as a peroxidase is believed to play a critical role in activation of INH 
(Zhang et al., 1992); (Zhang et al., 1993); (Rouse et al., 1995); (Wengenack et al., 1997); 
(Saint-Joanis et al., 1999).  However, INH is not a natural substrate of KatG. The 
endogenous substrate of KatG has not yet been identified.  The activation of INH by 
KatG produces an isonicotinic acyl radical, which can covalently attach to NAD+ to 
form an isonicotinic acyl-NAD (INH-NAD) adduct (Figure 2).  The ultimate target of 
the INH-NAD adduct is InhA.  Binding of the INH-NAD adduct to InhA blocks enoyl-
acyl ACP reduction and thereby results in inhibition of mycolic acid biosynthesis, which 
is a key component of the mycobacterial cell wall (Marrakchi et al., 2000). 
It is interesting to note that other bacterial species outside the mycobacterial genera 
are highly resistant to INH, though they contain a katG gene with high homology to 
MtbKatG.  Figure 5 shows sequence alignments of KatG amino acids from several 
bacterial species.  MtbKatG shares 65% identity to BpKatG, 55% identity to HmKatG, 
and 50% identity to E. coli HRPI.  M. smegmatis, which is in the mycobacterial genera, 
is insensitive to INH treatment though it contains a katG gene with 85% similarity to M. 
tuberculosis.
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Figure 5.  Sequence alignments of KatGs from several bacterial species. The figure was 
generated using the Clustalw multiple sequence alignment program in Biology 
Workbench.  MtKatG: M. tuberculosis KatG; KsmKatG: M. smegmatis KatG; BpKatG: B. 
pseudomalli KatG; SyKatG: Synechococcus PCC 7942; HmKatG: H. marsimortui KatG. 
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Structural Studies of Class I Peroxidases 
 
The first X-ray structure solved for the peroxidase superfamily is that of the cytochrome 
c peroxidase (CCP) (Finzel et al., 1984).  Since that time, great efforts have been made 
to probe the mechanism of the enzyme reaction and the characteristics of the 
intermediates, both structurally and biochemically.  In the past two decades, there has 
been a rapid growth in crystallographic structural information on the peroxidase 
families.  Structures have been obtained including horseradish peroxidase (HRP) 
(Gajhede et al., 1997), ascorbate peroxidases (APX) (Patterson and Poulos 1995); (Sharp 
et al., 2003) and the KatGs of several bacteria species (Yamada et al., 2002); (Carpena et 
al., 2003); (Bertrand et al., 2004). 
The overall folding of the class I peroxidases are similar.  Structural comparison 
among class I peroxidases is shown in Figure 6.  The structures of the class I peroxidases 
contain mostly α-helices.  The structure of the two domains in KatGs, the N-terminal 
domain and the C-terminal domain, is organized similar to those of HRP and APX.  A 
heme-binding consensus sequence is present in the N-terminal domain of the KatGs 
where the active site is located.  The C-terminal domain has no heme-binding motif and 
its function is elusive.  The rms differences for atoms in the heme-binding moiety and 
eight conserved residues in the active site are 0.27 Å between CCP and HmKatG, and 
0.29 Å between APX and HmKatG (Yamada et al., 2002).   
The native enzymes contain a heme, a ferric-protoporphyrin IX, with four pyrrole 
nitrogen bound to Fe(III).  A ferric-protoporphyrin IX contains eight side chains, four 
 24
  
  
 
Figure 6.  Ribbon diagrams of peroxidases from class I peroxidase super-family. HRP: 
horseradish peroxidase; CCP: cytochrome c peroxidase; APX: ascorbate peroxidase; 
BpKatG: Burkholderia pseudomalli KatG. The figure is constructed using PyMol 
(DeLano 2002).   
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methyl groups, two vinyl groups, and two propionate groups.  In peroxidases, the heme 
is attached to the enzyme through a covalent linkage, in which the side chain of a 
histidine is attached to the fifth coordination position of Fe(III).  The propionate side 
chains form hydrogen bonds with neighboring residues, and the binding of the heme to 
the protein is stabilized by the van der Waals contact between the organic porphyrin and 
the hydrophobic amino acid residues (Dunford 1999).  
To better understand the enzyme reaction mechanism, it is very important to 
determine the binding site of reducing substrates on peroxidases.  However, only a few 
X-ray crystallographic studies have been made on peroxidases which complexes with 
aromatic compounds.  Crystal structures of aromatic substrate complexes with class I 
peroxidases have not yet been reported.  The well-studied cases are the ARP and 
horseradish peroxidase isoenzyme C (HRPC), which belong to the class II and class III 
peroxidases, respectively.  The crystal structure of ARP in complex with 
Benzohydroxamic acid (BHA) was obtained, showing that BHA binds to ARP in the 
distal heme pocket (Figure 7B) (Itakura et al., 1997).  The benzene ring is located at the 
entrance of the heme cavity and parallel to the heme plane.  All three functional groups 
of BHA are involved in hydrogen bonds with the distal amino acid residues histidine, 
arginine and proline (Itakura et al., 1997).  Structures of HRPC-BHA complex and 
HRPC-CN Ferulic (FA) complex revealed a similar aromatic binding site as that found 
in ARP-BHA complex (Figure 7A) (Henriksen et al., 1999); (Laberge et al., 2001).  
BHA is a reducing substrate of ARP, a class II peroxidase, but not a good substrate of 
KatG.  However, the structure of BHA is similar to that of INH containing a benzene 
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ring and an amine hydroxyl group (Figure 7C).  It has been speculated that INH binds 
near the δ-meso edge of the heme in a similar position to BHA in the ARP-BHA and 
HRPC-BHA crystal structures (Bertrand et al., 2004). 
  
 
 
    
Figure 7.  Substrate binding site in HRPC-BHA and ARP-BHA structure complexes. 
(A): HRPC-BHA; (B): ARP-BHA; (C): Structure of Benzohydroxamic acid (BHA). The 
figure is constructed using PyMol. HRPC:  horseradish peroxidase isoenzyme C; ARP: 
Arthromyces ramosus peroxidase; BHA: Benzohydroxamic acid, colored red.  
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Brucellosis and Brucella abortus 
  
Brucellosis 
 
Brucellosis, like tuberculosis, is a chronic granulomatous infection caused by 
intracellular bacteria Brucella sap and requires combined prolonged antibiotic treatment.  
It is the most frequent human zoonosis, a human infection of animal origin (Young 
1983).  The most incidences have been reported from the Middle East and India (Ficht 
2003).  Transmission of brucellosis to humans occurs through the consumption of 
infected animal-milk products, direct contact with infected animal parts and the 
inhalation of Brucella aerosolized particles.  Bacteria that have entered the human body 
and have been taken up by local tissue lymphocytes are transferred through regional 
lymph nodes into the circulation system and spread throughout the body (Harmon et al., 
1988).   
The disease is characterized by acute fever, undue fatigue, anorexia, weight loss, 
headache, and arthralgia.  The most common complication caused by brucellosis in 
human is osteoarticular disease including peripheral arthritis, sacroiliitis, endocarditis, 
and spondylitis and several neurological disorders (Young 1983).  Brucellosis has been 
proposed as a cause of reactive arthritis as well (Ariza et al., 1993).  In most host 
species, the disease primarily affects the reproductive system, resulting in the loss of 
productivity in animals.  Brucellosis presents a substantial risk of testicular inflammation 
in men and spontaneous abortion in pregnant women (Khan et al., 2001; Navarro-
Martinez et al., 2001).  
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Treatment of human brucellosis involves a combination of antibiotics that can 
penetrate macrophages and act in the acidic intracellular environment.  The treatment 
recommended by the WHO for acute brucellosis in adults is rifampin and doxycycline 
daily for a minimum of six weeks (WHO 1986).  There is no human brucellosis vaccine 
available.  Brucellosis vaccines for animal use are live attenuated vaccines, which show 
a residual virulence and cause disease in human (Banai et al., 2002).   
 
Brucella spp. 
 
Members of the bacterial genus Brucella are Gram-negative facultative 
extracellular/intracellular bacteria that cause infections in a broad range of mammals 
(Acha and Szylres 1980; Corbel 1997).  Brucella belongs to the α 2 subdivision of the 
proteobacteria, along with Ochrobactrum, Rhizobium, Rhodobacter, Bartonella, and 
Agrobacterium (Moreno et al., 1990).  Based on their host preference, the Brucella 
genus have been classified into six nomenclature species:  B. abortus (cattle), B canis 
(dogs), B. melitensis (sheep, goats), B. neotomae (desert wood rat), B. ovis (sheep), and 
B. suis (swine, reindeer) (Corbel 1984).  All Brucella species seem to have arisen from a 
common ancestor (Moreno and Moriyon 2002).  B. melitensis , B. abortus and B. suis 
can cause brucellosis in humans, leading to chronic disease such as orchitis, spondylitis, 
arthritis and Mediterranean fever (Ariza et al., 1995).  B. abortus causes bovine 
brucellosis, a major disease in cattle, leading to abortion during the last trimester of 
gestation.   
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Brucella  pathogenesis 
 
Brucella, a facultative extracellular/intracellular pathogen that survives and replicates 
inside both phagocytic and nonphagocytic host cells, is able to penetrate target cells by 
inducing a local rearrangement of the host-cell plasma membrane around the invading 
bacteria (Pizarro-Cerda et al., 1999).  Upon cell contact, the bacteria are internalized via 
complement and Fc receptors in the macrophages and monocytes through activation of 
small GTPases of the Rho subfamily (Harmon et al., 1988; Guzman-Verri et al., 2001; 
Chaves-Olarte et al., 2002).  Treatment with nocodazole or cytochalasin D impairs the 
internalization of the bacteria, suggesting that both microtubules and the actin 
cytoskeleton are necessary for entry (Pizarro-Cerda et al., 1999; Guzman-Verri et al., 
2001). Once brucellae invade mucosa, phagocytes ingest the bacterium and the majority 
of brucellae are rapidly eliminated by phagolysosome fusion. Of those surviving, some 
are relocated to early phagosomes where they avoid fusion with late endosomes and 
lysosomes (Arenas et al., 2000).  It was suggested that Brucella is ingested through a 
discrete recruitment of actin filaments in HeLa cells (Gorvel and Moreno 2002).  Most 
of the ingested Brucellae are relocated to the endoplasmic reticulum by the 
autophagocytic route in HeLa cells, whereas only a few bacteria are directed to 
phagosome (Comerci et al., 2001).   
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Virulence Factors in Brucella  
 
In contrast to other pathogenic bacteria, the classical virulence factors such as exotoxins, 
cytolysins, capsules, fimbria, flagella, plasmids and the cellular receptors that are 
involved in attachment and entry of the bacteria into host cells are not known in 
Brucella.  It has been demonstrated that there are specific molecules participating in 
Brucella binding to host cells.  Brucella binds to the cellular spikes in cells treated with 
Clostridium difficile TcdB toxin, suggesting the participation of adhesion plaques 
(Guzman-Verri et al., 2001).   
The ligand(s) implicated in the internalization process must be widespread since B. 
abortus is able to invade a broad range of mammalian cell lines (Detilleux et al., 1990; 
Pizarro-Cerda et al., 1998).  Lipoplysaccharide (LPS), a major component of the outer 
membrane of gram-negative bacteria, has been implicated in the bacterial virulence 
(Freer et al., 1996).  The entrance of Brucella by non-professional-phagocytes is also 
suppressed by inhibitors of energy metabolism such as iodoacetate and dinitrophenol, 
inhibitors of receptor-mediated endocytosis and cyclic-AMP (Gorvel and Moreno 2002).  
Invasion of Brucella into epithelial cells was inhibited by clostridial toxins, a GTPase 
inhibitor (Ferreira et al., 2002).  
Genomic approaches used in the infected macrophage studies identified some genes 
implicated in the virulence of Brucella (O’Callaghan et al., 1999; Sieira et al., 2004).  
The first identified virulence determinant in Brucella was the virB operon, which codes 
a type IV secretion system that is responsible for the injection of effectors into the 
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cytoplasm of infected cells (O’Callaghan et al., 1999; Delrue et al., 2001; Boschiroli et 
al., 2002a:  Boschiroli et al., 2002b; DelVecchio 2002). 
It has been demonstrated that internalization (cell entry) and intracellular trafficking 
are two independent events during B. abortus infection in non-professional phagocytes 
(Pizarro-Cerda et al., 1998).  The recent discovery of a type IV secretion system in 
gram-negative bacteria has been described to control the intracellular trafficking of 
Brucella but not the internalization to host cells (Comerci et al., 2001; Delrue et al., 
2001).  In infected hosts, Brucella reside in the endoplasmic reticulum and survive 
intracellularly under the control of the VirB type IV secretion system within 
macrophages (Celli and Gorvel 2004).  However, the molecular mechanisms that 
regulate those processes are still poorly understood.  It has been speculated that the type 
IV secretion system may export bacterial effectors. These effectors are able to modulate 
the biogenesis pathway of the Brucella-containing vacuole (BCV), allowing the BCV to 
mature into a replication-permissive organelle (Celli and Gorvel 2004).  Vacuoles 
containing virB mutants are deficient in full maturation and are unable to sustain fusion-
proficient interactions with the ER (Comerci et al., 2001; Celli and Gorvel 2004).  
 
Type IV Secretion System (T4SS) 
 
The T4SS is medically important, due to virulence-gene spread, genome plasticity and 
the alteration of host cellular processes during infection (Ochman et al., 2000; Ding et 
al., 2003). The T4SS secretion machinery plays essential roles in many pathogenic 
bacteria such as Legionella (Nagai and Roy 2001; Nagai et al., 2002), Bordetella 
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(Covacci and Rappuoli 1993; Weiss et al., 1993), Helicobacter (Segal et al., 1999; 
Comerci et al., 2001) and Brucella (Baron et al., 2002; Boschiroli et al., 2002a). In the 
past decade, the type IV family has expanded considerably, and many new VirB/D4 
systems were discovered through genetic screens or genome sequencing. 
 
Secretion Systems in Gram-negative Bacteria 
 
At least five major independent mechanisms of protein secretion exist in the gram-
negative bacterial species, namely type I, II, III, IV and V (Stathopoulos et al., 2000).  
The type I secretion system (TOSS) or ABC (ATP-binding cassette) secretion 
systems are involved in multidrug efflux and toxin export (Andersen 2001). ABC 
transporters are classified as importers and exporters depending on the direction of the 
substrate translocation. The type I export apparatus consists of two hydrophobic 
membrane spanning domains (MSDs), which allow the translocation of the substrate 
through the membrane, and two cytoplasmic nucleotide binding domains (NBDs), which 
bind to ATP and couple ATP hydrolysis to drive the transport process (Braibant et al.,  
2000).   
The type II secretion system (T2SS) is defined as the main terminal branch (MTB) of 
the Sec-dependent General Secretion pathway (GSP) (Filloux et al., 1998). All proteins 
secreted via a type II secretion pathway are synthesized with an N-terminal signal 
peptide.  This pathway is responsible for secretion of extracellular proteins and toxins by 
a wide variety of gram-negative bacteria. 
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The type III secretion system (T3SS) was first identified in pathogenic Yersinia spp. 
for Yop proteins secretion and lately has been found in several mammalian and plant 
pathogens (Hardt and Galan 1997; Mecsas et al., 1998; He et al., 2004; Tampakaki et al.,  
2004). The type III secretion system translocate effector molecules across the inner and 
outer membranes in a Sec-independent fashion (Blocker et al., 2001). Type III secretion 
is activated by bacterial contact with host cells and is capable of translocating effectors 
through a large secretion apparatus into the cytosol of target eukaryotic cells (Hueck 
1998).  
A macromolecular translocation system ancestrally related to the conjugal transfer 
system is referred as type IV secretion system (T4SS) (Christie and Vogel 2000).  Many 
pathogenic bacteria use T4SS to translocate proteins and DNA-protein complexes to 
prokaryotic and eukaryotic cells   (Christie and Vogel 2000; Hofreuter et al., 2000; 
Cascales and Christie 2004; Sexton et al., 2004). Members of this family include those 
involved in bacterial conjugation, pathogenic transfer of DNA, and the secretion of 
protein virulence factors.  Most of the type IV effector translocation systems inject their 
substrates directly into the eukaryotic cytosol. This type of translocation is a dominant 
virulence mechanism of the phytopathogen Agrobacterium tumefaciens, and of several 
medically important pathogens, including H. pylori, Brucella spp. and Bartonella spp. 
(Figure 8). 
Type V secretion systems include the autotransporter system (type Va or AT-1), the 
two-partner secretion pathway (type Vb), and the recently described type Vc system 
(also termed AT-2) (Sopasakis et al., 2004). Proteins secreted via these pathways have  
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Figure 8.  Examples of medically important pathogens that use Type IV secretion 
systems (T4SS) to translocate effector molecules and virulent factors into host cells. 
 
 
similarities in their primary structures as well as striking similarities in their modes of 
biogenesis.   
 
Classification of T4SS 
 
 
The T4SS have been classified into three subfamilies based on function: (1) conjugation 
systems mediating DNA transfer to recipient cells by cell-to-cell contact; (2) the effector 
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translocation system that transfers effector molecules to eukaryotic target cells; and (3) 
‘DNA uptake or release’ systems mediating the exchange of DNA with the extracellular 
milieu (Cascales and Christie 2004).  Most conjugation and effector translocation 
systems transfer DNA, DNA-protein complexes, or protein substrates by a cell-contact-
dependent mechanism.  The ‘DNA uptake or release’ system delivers DNA substrates to 
extracellular milieu, as in the F plasmid conjugation system of Neisseria gonorrboeae, 
or acquires DNA substrates from the extracellular environment as that of the DNA 
uptake mediated by Helicobacter pylori competence system (Hofreuter et al., 2000; 
Hofreuter et al., 2001; Hofreuter et al., 2003).    
Besides the classification schemes based on function, the T4SS have been grouped as 
type IVA, type IVB, and ‘other’ (Christie and Vogel 2000).  The conjugation system 
comprises the largest type IVA subgroup, sharing common ancestries with the A. 
tumefaciens VirB/D4.  Several medically important pathogens including 
Helicobacter pylori, Bordetella pertussis, Brucella spp., and Bartonella spp (Ding  et al., 
2003), are classified into the type IVA.  The type IVB is represented by the plasmid 
ColIb-P9 Tra and the Dot-Icm of Legionella pneumophila. 
 
Subunits of the Multiprotein Complexes in T4SS 
 
Bacterial type IV secretion systems are multiprotein complexes composed of up to 11 
proteins named VirB1 to VirB11 (Figure 9).  Protein complexes of T4SS can be grouped 
into three major groups based on their function: the pilus at the bacterial surface (VirB2 
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and VirB5); a pore that spans the membrane (VirB3, VirB6, VirB7, VirB8, VirB9, and 
VirB10); and two ATPases (VirB4 and VirB11). The transporter forms a secretion 
channel and often a pilus structure that spans from the inner membrane of the bacterium 
through the outer membrane and into the extracellular space (Christie 2004). The pilus is 
composed of the major subunit VirB2 and the minor subunit VirB5.  Other VirB proteins 
are believed to form the remainder of the transport apparatus to connect the pilus to the 
outer membrane and may form a continuous bridge from the outer membrane to the 
inner membrane of the bacterium (Christie and Cascales 2005). 
VirB1 is a periplasmic protein that is processed to a secreted C-terminal fragment.  It 
commonly associates with macromolecular surface structures as pili and flagella in the 
T2SS, T3SS and T4SS (Christie and Cascales 2005). VirB1 was identified as a putative 
lytic transglycosylase.  Such lysozyme-like activity has been proposed to be important 
for hydrolysis of peptidoglycan and the proper formation of a channel that is filled by the 
other VirB proteins (Mushegian et al., 1996).  In Brucella abortus, VirB1 is dispensable 
for T4SS function (den Hartigh et al., 2004).   
VirB2 is the major subunit of the pili and an essential component of the secretion 
channel (Berger and Christie 1994).  It locates to both membranes and the periplasm.  
VirB2 contains an unusually long signal peptide (~5 kDa).  Cleavage of the signal 
peptide results in a small, hydrophobic polypeptide containing conserved multiple Gly 
residues dispersed along the polypeptide.  This mature VirB2 of A. tumefaciens 
undergoes a unique cyclization reaction through formation of a covalent bond between 
the N-terminal Asp and C-terminal Glu residues (Sagulenko et al., 2001).  The cyclized 
 37
pilins serve as the building blocks for pilus polymerization and stabilize the pilus 
structure in A. tumefaciens (Haase and Lanka 1997; Lai and Kado 1998).  However, it 
was reported that VirB2 from E. coli do not undergo cyclization (Lai and Kado 1998; 
Lai 2002). There is no ultra structural information for any T4SS pilin subunit yet. 
VirB3 is an essential virulence protein (Berger and Christie 1994), which localizes 
predominantly to the outer membrane.  VirB3 has a short polypeptide chain with one or 
two TMS near the N- terminal (Jones, Shirasu et al. 1994).  Studies have shown that the 
VirB3 subunits assemble as a functional complex with the VirB4 ATPase at the inner 
membrane (Christie and Cascales 2005).   
 
Figure 9.  Subunits of the multiprotein complexes in T4SS. OM: outer membrane; P: 
periplasma; IM: inner membrane.  The figure is constructed base on the protein-protein 
interactions detected by the yeast two hybrid systems (Christie 2004). 
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VirB4 and VirB11 are inner membrane-associated proteins, and VirD4 is a 
cytoplasmic protein, all of which possess ATPase activity (Krause et al., 2000). VirB4 
and VirB11 contain a  consensus Walker A box, the nucleotide-binding domain that is 
critical for transport (Atmakuri et al., 2004). These two proteins may provide the energy 
for the biogenesis of the transporter or perhaps for the transport process itself through 
the hydrolysis of ATP.  VirB4 is the largest T4SS component (~90 kDa for a monomer 
molecule) and is essential for virulence (Dang et al., 1999).  It is also highly conserved 
among T4SS components, i.e. 31% identity between A. tumefaciens and B. suis.  It 
localizes at the base of a trans-envelope in the inner face of the cytoplasmic membrane.  
Its short N-terminal domain is exposed to the periplasm and interacts with VirB8 of the 
VirB5-VirB8 complex.  Stabilized and properly oriented VirB5 forms complex with 
VirB2, a key complex in the pilus formation (Yuan et al., 2005), suggesting that VirB4 
plays an important role in VirB2-VirB5 pilus formation.  It has been shown that the 
interaction between VirB3 and VirB4 is required for complex localization in the outer 
membrane (Jones et al., 1994).  VirB4 was also suggested to interact with other T4SS 
components such as VirB1, VirB8, VirB10, and VirB11 (Krall et al., 2002).  VirB11 was 
identified as an essential component of T4SS and is the virulence factor of many 
pathogenic bacteria (O’Callaghan et al., 1999; Schmiederer and Anderson 2000; Baron 
et al., 2002; Cascales and Christie 2004; Christie 2004; Remaut and Waksman 2004; 
Sexton et al., 2004).  It presents a good drug target for developing antimicrobial drugs 
because of its essential function in T4SS. 
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VirB5 subunits are exported to periplasm and localize extracellularly as components 
of the pili (Schmidt-Eisenlohr et al., 1999; Christie and Cascales 2005).  VirB5 was 
shown to cofractionate with VirB2 indicating that VirB5 may be directly involved in 
pilus assembly (Schmidt-Eisenlohr et al., 1999).  It has been proposed that VirB5 might 
function as a periplasmic chaperone to deliver pilin from the inner membrane reservoir 
to the outer membrane by a route independent of the virB-encoded mating channel (Lai 
et al., 2000).   
VirB6 is a highly hydrophobic inner membrane protein with a periplasmic N-
terminus, five TMS, and a cytoplasmic C-terminus (Jakubowski et al., 2003; 2004).  It 
plays an important role in the  assembly of a stable secretory apparatus in T4SS (Berger 
and Christie 1994; Hapfelmeier 2000; Jakubowski et al., 2003) and participates 
directedly in substrate trafficking (Jakubowski et al., 2004).  The large central 
periplasmic loop P2 of VirB6 was found to be responsible for DNA substrate 
translocation in A. tumefaciens.  It has been proposed that loop P2 might adopt a specific 
secondary structure that is required for the substrate interaction (Jakubowski et al., 
2004).  The N-terminal and C-terminal regions were found to be essential for substrate 
transfer to the periplasmic and outer membrane-associated VirB2 and VirB9 
(Jakubowski et al., 2004).  
VirB7 subunits are small lipoproteins found in only a subset of the T4SS systems, 
although there are other type of lipoprotein common to T2SS and T3SS (Sagulenko et 
al., 2001).  VirB7 of A. tumefaciens localizes extracellularly at the outer membrane and 
assembles as a homodimer through the formation of a disulfide bridge and then interacts 
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with VirB9 to stabilize several other VirB proteins (Baron et al., 1997; Sagulenko et al., 
2001).  N-terminal Cys15 of VirB7 plays an important role in lipid modification which is 
essential for pilus formation (Sagulenko et al., 2001).  VirB7 from H. pylori HP0532 
also localizes extracellularly, involving in the formation of a large sheathed filament in 
the Cag T4SS (Tanaka et al., 2003).  Studies showed that extracellular VirB7 
homodimer tightly associated with the T-pilus in A. tumefaciens and could be co-purified 
with VirB2 (Sagulenko et al., 2001).   
VirB8 is found in the inner membrane of most type IVA systems.  VirB8 was shown 
to interact with VirB1, the putative transglycosylase (Ward et al., 2002).  A three-
dimensional structure of a periplasmic fragment of B. suis VirB8 was solved (Terradot et 
al., 2005).  The structure contains a large extended β-sheet and five α-helices organized 
in a globular fold.  VirB8 might contribute to the T4SS apparatus biogenesis by first 
recruiting the transglycosylase to punch holes in the peptidoglycan, and then recruiting 
the structural components of VirB9 and VirB10 to the site for assembly (Jakubowski et 
al., 2005). 
VirB9 possess a cleavable signal peptide and is exported across the inner membrane 
to the outer membrane. The subunits are mostly hydrophobic and are located in the 
periplasm and outer membrane, forming a portion of the secretion channel that extends 
from the inner membrane to the outer membrane (Jakubowski et al., 2005).  VirB9 of A. 
tumefaciens is composed of three functional domains, a highly conserved periplasmic N-
terminal domain, a less conserved central domain, and a well conserved C-terminal 
domain.  The N-terminal domain is required for both channel activity and pilus 
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biogenesis.  The C-terminal domain possesses several TMS and may associate with the 
outer membrane.  The C-terminal domain of the VirB9 forms a disulfide bridge with the 
VirB7 to form a heterodimer that stabilizes the VirB9 structure (Jakubowski et al., 
2005).  It has been shown that the VirB7-VirB9 heterodimer interacts with the inner 
membrane protein VirB10 to form a VirB7-VirB9-VirB10 complex (Cascales and 
Christie 2004; Jakubowski 2005).  However, the interaction between VirB9 and VirB10 
seems to be dynamic and driven by a conformational change in VirB10.   
VirB10 is an inner membrane protein associated with proteins located in the 
periplasm.  It possesses a proline-rich region, which is predicted to form an extended 
structure in the periplasm (Thorstenson et al., 1993).  VirB10 also possess protein-
protein interaction motifs, such as coiled-coils near the TMS and highly conserved 
hydrophobic residues near the C-terminal domain.  It has been proposed that VirB10 
interacts with other inner membrane proteins such as VirB8 and VirB4 (Das et al., 2000; 
Christie and Cascales 2005).  VirB10 also interacts with the outer-membrane-associated 
VirB7-VirB9 dimer (Beaupre et al., 1997; Christie 2005).  The crystal structure solved 
for a periplasmic fragment of H. pylori reveals an elongated α-helical projection from a 
β-barrel (Terradot et al., 2004).   
The Brucella virB operon contains one additional gene, virB12, which has been 
shown to be essential for virulence (Boschiroli et al., 2002b).  VirB12 contains a 
lipoprotein consensus sequence and a predicted signal peptide.  No homolog has been 
found in other classic T4SS (Boschiroli et al., 2002b).   The function of this protein in 
either transport or virulence is unknown. 
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Biogenesis of the T4SS 
 
A general T4SS assembly pathway was proposed and refined (Christie 2001) based on 
biochemical studies in A. tumefaciens VirB/D4 conjugation system.  In the model, it was 
suggested that pilus formation initiates at the inner membrane and proceeds outward 
through the periplasm to the outer membrane.  An alternative model suggests that the 
pilus subunits are translocated from the periplasm to outer membrane through a 
chaperone before the pilus complex formation (Christie et al., 2005).    
Recently, a four-stage biogenesis pathway was proposed for the VirB/D4 T4SS: 
Stage I, core complex formation; Stage II, pilus-associated protein recruitment; Stage III, 
recruitment of VirB11 ATPase; and stage IV, the pathway bifurcation (Christie et al., 
2005).   
Stage I involves the formation of the core complex.  The core complex containing 
VirB4, VirB7, VirB8, VirB9, and VirB10 subunits assembles across the cell envelope 
(Christie et al., 2005).  It has been shown that the core subunits can be cofractionated as 
a large complex (> 500kDa) in the gel filtration columns (Krall et al., 2002).  VirB7 and 
VirB9 are small outer membrane lipid protein participating in T-pilus assembly in A. 
tumefaciens.  First, VirB7 assembles as a disulfide-cross-linked homodimer and then 
interacts with VirB9 to form VirB7-VirB9 hetero-multimers.  Second, both the VirB7 
homodimer localized at the outer membrane and the VirB7-VirB9 hetero-multimers 
interact with the bitopic inner membrane proteins VirB8 and VirB10 through contact 
with the VirB9 subunits (Anderson et al., 1996; Baron et al., 1997; Sagulenko et al., 
2001).   
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Stage II involves the recruitment of pilus-associated proteins.  The core complex 
recruits subunits VirB2, VirB3, and VirB5 for pilus assembly (Christie 2005).  Recently, 
a network of stabilizing interactions for formation of a VirB2-VirB5 complex was 
identified (Yuan et al., 2005).  VirB4 is the largest component of T4SS and forms a 
homomultimeric complex which is essential for virulence (Watarai et al., 2001).  VirB4 
was shown to interact with VirB1, VirB8, VirB10, and VirB11 (Ward 2002).  VirB4 has 
been found to bind to the periplasmic domain of VirB8 and is required for the assembly 
of pilus-associated proteins with VirB3, VirB6, and VirB8 (Yuan et al., 2005).  VirB4 
binds to VirB8 and stabilizes VirB3 and VirB8.  The stabilized VirB8 interacts with 
VirB5 in the periplasm.  Stabilization of VirB5 and VirB3 through interaction with 
VirB6 enables VirB5 to complex with VirB2 and thereby impact pilus biogenesis 
(Hapfelmeier et al., 2000; Yuan et al., 2005). 
Stage III is associated with the recruitment of VirB11 ATPase.  VirB11 was shown 
to be essential for secretion channel formation and pilus production (Lai et al., 2000).  
VirB11 ATPase localizes at the cytoplasmic face of the inner membrane and supplies 
energy from ATP hydrolysis to drive organelle assembly and substrate translocation at 
the cell envelope (Rashkova et al., 2000).  The cytosolic VirB11 homohexamer undergo 
ATP-dependent conformational changes that likely affect protein-protein interaction and 
the formation of the pilus subunits.  It was proposed that VirB11 are recruited to the core 
structure, where they stimulate the formation of a transenvelope composed of an inner 
membrane platform that across the periplasm, and an outer membrane complex (Christie 
et al., 2005). 
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Stage IV is the pathway of the bifurcation.  Stage IV is a bifurcation process in 
which the assembly pathway produces a pilus or a secretion channel (Christie 2005).  It 
has been proposed that VirB2, pilin monomers, are added to the base of the nascent 
polymer of the stage III structure (Christie et al., 2005).  The energy-consuming 
subunits, VirB4 and VirB11, would drive conformational changes required for channel 
gating.  This process is most likely driven by energy supplied through VirB11 because 
the Walker A mutant of VirB11 shows disruption of pilus biogenesis in B. suis (Yuan et 
al.,  2005).  Other factors may also be required for channel activity, such as the substrate 
binding to the receptor (Christie et al., 2005).  
 
Models of the Translocation Pathway in T4SS 
 
Three working models have been proposed to describe the possible machine architectures 
and translocation pathway (Christie et al., 2005): (1) a one-step model using a 
transenvelope channel, (2) a two-step ‘ping-pong’ model for transferring substrates across 
the inner membrane to the outer membrane, (3) the ‘shoot and pump’ model, in which the 
substrates are recruited and translocated across the inner membrane through a protein 
export apparatus.   
The first model involves recruitment of secretion substrates and transfers them 
through an inner membrane channel (Christie et al., 2005).  It has been suggested that the 
energetic subunits, VirB4 and VirB11, would energize conformational changes required 
for channel gating (Middleton et al., 2005).   
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The ‘ping-pong’ model was proposed such that the T-DNA was recruited by VirD4 
and transferred to the VirB11 chaperone (ping) where it was refolded and retro 
transferred back to VirD4 (pong) by VirB11 (Atmakuri et al., 2004).  Next, VirD4 uses 
ATP energy to translocate the DNA-protein substrate across the inner membrane through 
interaction with VirB6 and VirB8 (Atmakuri et al., 2004). 
The ‘shoot and pump’ model was initially proposed by Llosa to describe bacterial 
conjugation, suggested that two inner membrane translocases are involved in the 
translocation (Llosa et al., 2002).  It postulated that VirD4 recruits the T-DNA to the 
secretion apparatus and then transfers only the relaxase component to VirB11, which 
unfolds the relaxase through a chaperone activity to deliver the relaxase across the inner 
membrane (shoot) through interaction with other VirB proteins (Atmakuri et al., 2004).  
Simultaneously, VirD4 uses ATP energy to drive the T-strand across the membrane 
(pump), releasing the particle to the secretion channel (Llosa et al., 2002; Atmakuri et 
al., 2004).  Brucella spp lacks the VirD4 homolog, so the energy sources most likely are 
from either VirB4 or VirB11. Of these models, the ‘shoot and pump’ model is especially 
appealing.  This model accommodates all experimental findings to date (Christie and 
Cascales 2005) .  
 
Effectors Translocation by the T4SS  
 
Although members of the type IV family share structural homologies, they display 
diversity in the nature of the substrates that they transport. A. tumefaciens, a plant 
pathogen causing tumorous growth in plant tissue, uses the type IV secretion system to 
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transfer T-DNA and several effector proteins to plant cells (Christie 2004).  Helicobacter 
pylori, a causative agent of gastric pathologies such as peptic ulcer disease and gastric 
adenocarcinoma uses a related system to deliver the 145kDa CagA protein to 
mammalian cells.  CagA is the only virulence protein shown thus far to be translocated 
by the H. pylori CagA T4SS.  The translocated CagA undergoes tyrosine 
phosphorylation to form a cylindrical structure and seems to induce cytoskeletal 
rearrangements in the host cell (Segal et al., 1999).  Bordetella pertussis, the causative 
agent of whooping cough, exports the six-subunit pertussis toxin (PT) across the 
bacterial outer membrane to the extracellular milieu and establishes contact with the 
mammalian cell (Baron et al., 2002).  So far, it is not known how the T4SS in Brucella 
spp. recruit and translocate their effector molecules across the inner membrane.   
The bacterial effectors of the secretion system of Brucella have not been identified 
yet.   However, some surface exposed and secreted proteins were screened from B. 
abortus by an N-terminal protein-capturing system using the CAT fusion scan 
(Marchesini et al., 2004).  Some fusions displayed notably reduced secretion levels in a 
virB mutant background, suggesting the requirement of a complete VirB apparatus for 
the secretion.  Secretion of the fusion BvrR, a transcriptional regulator protein that is 
essential for B. abortus virulence (Sola-Landa et al., 1998), was found to be associated 
with intact VirB expression.  Secretion of the N-terminal fragment of BvrR fused to 
CAT was diminished in virB1 and virB10 mutants (Marchesini et al., 2004).  The B. 
abortus BvrS/BvrR system has been shown to play a role in the homeostasis of the 
bacterial membrane (Lopez-Goni et al., 2002).   It has been proposed that modification 
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of LPS is responsible for the damages of the outer membrane in BviS/BviR mutants, 
causing severe attenuation in B. abortus mutant strains (Lopez-Goni et al., 2002; 
Manterola et al., 2005).   
The flagellar hook protein (FlgE), an extracellular component of flagella, has been 
described as being secreted to the culture media of several bacteria species such as 
Salmonella typhimurim (Komoriya et al., 1999), Bordetella bronchiseptica (Tu et al., 
2001), and H. pylori (Bumann et al., 2002).  Secretion of CAT-fused FlgE is notably 
reduced in the virB1, virB10, and virB11 mutant background, respectively (Marchesini 
et al., 2004).  It has been shown that the Brucella T4SS and flagellar apparatus are 
tightly regulated along the growth curve in growth media (Sieira et al., 2000).  The 
expression and assembly of the flagella or pili of T4SS are both energy dispersive 
processes that require intricate regulation controls to allow their expression and 
assembling at the very precise steps of the infection (Muir and Gober 2002).  A quorum 
sensing-related transcription regulator (vjbR) was proposed to regulate the expression of 
both virB operon and flagellar genes either during vegetative growth or during 
intracellular infection (Delrue et al., 2005). 
Most of the type IV effector translocation systems inject their substrates directly into 
the eukaryotic cytosol.  The A. tumefaciens T-DNA conjugation system and the H. pylori 
CagA translocation system are thought to export substrates in one step across the 
membrane directly to the eukaryotic cytosol. This type of translocation is now 
recognized as a dominant virulence mechanism of the phytopathogen A. tumefaciens, 
and of several medically important pathogens, including H. pylori, L. pneumophila, 
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Brucella spp. and Bartonella spp.   A subfamily of the Ptl system of B. pertussis exports 
its protein substrate, pertussis toxin, independently of host-cell contact. The Bordetella 
pertussis, the causative agent of whooping cough, is thought to export pertussis toxin in 
two steps across the cell envelope to the extracellular milieu. Secreted holotoxin then 
binds to the mammalian cell membrane (Christie 2001). 
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CHAPTER II 
 STRUCTURE DETERMINATION BY X-RAY 
CRYSTALLOGRAPHY 
Introduction  
 
Macromolecules are the major constituents of living cells.  Proteins are the largest group 
of macromolecules and perhaps the most versatile of all biomolecules. Some proteins 
function as enzymes and others serve as structural elements, signal receptors, or 
transporters.  Knowledge of the detailed three-dimensional structures of proteins and 
other macromolecules is vital to the understanding of cellular process and the functional 
roles of proteins/enzymes.  X-ray crystallography techniques are widely used for the 
structural determination of macromolecules at atomic resolution.  During the past 
decades, macromolecular X-ray crystallography has undergone dramatic development.  
Rapid progress in molecular biology, improved crystallization screens, more powerful 
synchrotron sources for data collection, high-speed computers and advances in computer 
software and programs have dramatically enhanced the efficiency of crystallographic 
structural determination and produced an exponential growth of the number of X-ray 
crystal structures solved. Of those 36,121 structures deposited in the Protein Data Bank 
(PDB) (by April 18, 2006), over 30,583 structures were solved by the X-ray 
crystallographic method. Continued advances in computing methods and technologies 
usher in the age of high-throughput structure determination.  
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Protein Crystals  
 
A protein crystal is the result of the three-dimensional periodic packing of homogeneous 
protein molecules surrounded by solvent.  The three-dimensional components of a 
crystal can be described as a repetition of identical unit cells (Rhodes 1993). In 
general, the unit cell is characterized by six parameters, three axial lengths a, b, c and 
three interaxial angles α, β, γ .  These six parameters are called unit cell parameters, 
which define a unit cell in the crystal lattice (Figure 10a). The vector in a direction is 
called the x-axis of the lattice; the y-axis is in b direction and the z-axis is in the c 
direction.  The x-, y- and z-axes together form a coordinate system.  Location of atoms 
within a unit cell can be described by their Cartesian coordinates x, y, z.  The diffraction 
of x-rays by a crystal can be regarded as reflection against planes in the lattice. Many 
sets of these planes can be drawn through the lattice points.  The planes in the same set 
are parallel and have the same perpendicular distance d.  A set of lattice planes is 
determined by three indices h, k, l (also referred to as Miller indices).  The planes cut the 
x-axis in a/h, y in b/k, and z in c/l sections (Figure 10b).  The Miller indices h, k, l are 
integers that serve as the bases for the data processing. 
The minimum free energy of packing and regular repeats in a crystal lattice results in 
a symmetric relationship between the molecules (Drenth 1999). There are seven three-
dimensional coordinate systems that are used in describing crystals, including triclinic, 
monoclinic, orthorhombic, tetragonal, hexagonal and cubic. The triclinic crystals have 
the lowest symmetry and the cubic crystals have the highest symmetry.  There are 230 
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(a) One unit cell in the crystal lattice 
 
              
(b) Lattice plane in a two-dimensional lattice, h=2, k=2. 
 
Figure 10.  Crystal unit cell and the lattice plane. 
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different ways to combine the allowed symmetry operations in a crystal, leading to 230 
space groups (Deranth 1999).  
Protein crystals form and grow in a supersaturated solution (Drenth 1999). In 
principle, there are four important determinants in protein crystallization. First is the 
purity of the protein. The purity requirement for protein crystallography is much more 
stringent in most cases. The more pure the protein is, the better the chance of crystal 
formation and growth.  Second, a suitable solvent from which a protein can precipitate in 
crystalline form is selected.  A solvent is usually a water-buffer solution. Third, the 
protein in solvent is brought to super saturation in which small nuclei form. Spontaneous 
nuclei formation is best achieved at a high degree of super saturation.  However, to 
achieve crystal growth, super saturation should be kept at a low enough level to avoid 
formation of too many nuclei and too many small crystals (Drenth 1999).  Fourth, 
crystals must grow to suitable size.  In reality, protein crystallization is mainly a trial-
and-error procedure. 
There are various methods of growing protein crystals, all designed to increase the 
protein concentration in the solution slowly by slow evaporation, slow diffusion, or slow 
cooling. The most common method is vapor diffusion, including hanging drop diffusion 
and sitting drop diffusion. This method allows a saturated or nearly saturated solution to 
stand under conditions where the solvent evaporates slowly. The hanging drop method 
starts with a drop of protein mixed with precipitant suspended over a reservoir 
containing buffer and precipitant. The most commonly used precipitants are salt, high 
molecular weight polymers and organic solvent. When water diffuses from the drop to 
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the solution, the proteins in the drop reach a supersaturated condition for optimal crystal 
growth. The Microbatch method is another popular method to grow protein crystals. A 
drop of protein solution is put in inert oil and left to grow when the protein reaches its 
super saturation over time. 
Once a crystallization condition has been identified, optimization may be needed in 
order to improve the size and quality of the protein crystal. Optimization is carried out 
by systematically changing the concentrations of the precipitants. Additives such as 
metals, small molecules and detergents may also be tested along with the optimized 
precipitants. In certain cases, pH screening can be used to optimize the protein crystals.   
 
X-ray Diffraction 
 
The diffraction of X-rays by crystals was first discovered by Max-von in 1912, leading 
to one of the most fascinating development in life science. X-ray diffraction occurs as 
waves interact with a regular structure whose repeat distance is about the same as the 
wavelength of X-ray (Drenth 1999).  When certain geometric requirements are met, X-
rays scattered from a crystal can constructively interfere, producing a diffracted beam 
(Drenth 1999). In 1912, W. L. Bragg recognized a predictable relationship among 
several factors. 
 2d sin θ=nλ 
where λ is the wavelength of the x-rays, d is the distance between successive lattice 
planes, n is an integer, and θ is the angle between the incident beam and lattice plane.  
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When Bragg’s Law is satisfied, constructive interference occurs, producing the 
respective reflections in the form of spots recorded on the image plate or CCD (charge 
coupled device area detectors) (Figure 11).  
In x-ray crystallography, integrated intensities of the reflections are used to 
reconstruct the electron density map within the unit cell in the crystal by Fourier 
transformation with appropriate phase assignment. To achieve high accuracy in the 
reconstruction, a high degree of completeness as well as redundancy in diffraction data 
is necessary, meaning that all possible reflections are measured multiple times to reduce 
systematic and statistical error. The most efficient way to do this is by using an area 
detector that can collect diffraction data in a large solid angle.  
 
 
 
Figure 11.  A single X-ray diffraction image generated from a protein crystal.   
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Two main pieces of hardware are required for the collection of X-ray diffraction 
data: an X-ray source and an X-ray detector.  An X-ray generator in a home laboratory 
uses a rotating anode copper sealed in a tube.  Cu produces K α radiation at about λ = 
1.541 Å.  Synchrotrons are devices for creating circulating charged particles at nearly the 
speed of light.  They generate high intensity radiation 10 to 1000 times stronger than that 
of a conventional X-ray tube.  Synchrotron radiation allows the measurement of the 
weak diffracting amplitudes of protein crystals and for measurements at various λ.  
Radiation damage to protein crystals caused by synchrotron exposure can be minimized 
by flash cooling the crystal to cryogenic temperatures.   
Charged Coupled Devices (CCD) and Image Plate (IP) detectors are the best-known 
2D detectors that have high quantum efficiency, high saturation, and high stability 
(Drenth 1999). Image plates are coated with a thin layer of inorganic storage phosphor 
on their surface.  X-ray photons excite electrons in the material to higher energy levels 
causing fluorescent light illumination.  The light emitted is proportional to the number of 
photons from X-ray diffraction exposed to the particular area of the image plate.  CCD is 
an electronic device that detects X-ray photons on a two-dimensional surface and 
processes the signal immediately after the detection.  It provides the capability for faster, 
more accurate, automated data collection for use in macromolecular crystallography. It 
has enhanced efficiency for measuring diffraction patterns from crystals of 
macromolecules, especially at high resolution, when the X-ray intensities are weak 
(Walter et al., 1995).  The output of the data collection consists of raw intensity data for 
each frame along with detector parameters. 
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Data Processing 
 
The ultimate goal of an X-ray diffraction experiment is to determine the 3-D structure of 
a protein molecule. The first step in data processing is to determine the unit cell 
parameters and space group symmetry of the crystal.  It is crucial to define the space 
group of a crystal of unknown structure correctly because the subsequent calculations 
are based on the relationships implied by the space group symmetry.   
There are several major steps involved in data analysis and data reduction from a 
single crystal.  The first step is to visualize and preliminarily analyze the original 
unprocessed data, such as the shape of the diffraction spots, ice-rings, and twining.  
Second, the diffraction pattern of a crystal has to be indexed before the refinement of the 
crystal and detector parameters.   The intensity of each reflection in a single fame (or a 
few frames) has to be identified by its h, k, and l, based on the cell parameters. Next, all 
diffraction maxima are integrated, scaled, refined and statistically analyzed.  The 
HKL2000 (Otwinowski and Minor 1997), Mosflm, and CrystalClear are the most 
popular programs that are used for the data processing. The HKL2000 suite program 
contains XDISPLAY for image display and measurement, DENZO for auto-indexing, 
refinement and integration, SCALEPACK for data scaling, and HKLINT for the GUI 
interface.  The output of the processing data (scaled data) is a list of all reflections with 
their Miller indices h, k, l and corresponding intensities and systematic errors.  
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Phasing Method ------ Molecular Replacement  
 
The intensity of the diffracted beam (h k l) is proportional to the square of the amplitude 
of the structure factor F (h k l). The structure factor is a function of the electron density 
distribution in the unit cell.  The result of an X-ray structure determination is the electron 
density in the unit cell: 
( ) ∑∑∑ +++=
h k l
hklhkl lzkyhxFV
zyx )(1,, αρ  
In the equation, ρ(x,y,z) is expressed as a Fourier transformation of the structure 
factors F(h k l) . ρ(x,y,z) is the electron density at the point with coordinates (x,y,z) in 
the unit cell, V is the volume of the unit cell, αhkl is the phase angle of the reflection (h, 
k, l). Structure factors are directly related to the intensity I (h,k,l) of the corresponding 
reflection h, k, l:   
I(hkl) = |Fhkl|2 LP A 
where Ihkl is the integrated data in the form of intensities for each of the Bragg 
reflections, F is the structure factor, LP is a combined geometry and polarization factor 
and A is an absorption correction factor. The phase angles αhkl cannot be measured 
directly in the diffraction experiment.  However, the phase information is required for 
solving the crystal structures. Two common methods, molecular replacement (MR) and 
multiple wavelength anomalous dispersion (MAD), have been used frequently to obtain 
the phase information necessary for solving the crystal structures.   
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Molecular replacement can be used to get initial phases if the structure of its 
homologous protein has been solved. In general, two major steps are used in the 
Molecular Replacement are known as the rotation and translation functions.  The 
rotation function allows the correct orientation of the search molecule to produce 
maximal overlap with the target structure by comparing the Patterson self-vectors of the 
known and unknown structures at different orientations of the search model (Drenth 
1999).  The rotation matrix calculated from the rotation search can be applied to the 
coordinates of the search molecule.  The resulting model then can be used for the 
translation function to correctly determine related symmetry elements of the target 
crystal.  
The success of the MR phasing strategy is mainly dependent on the similarity 
between the search model and the structure to be determined. The higher the sequence 
similarity to the search model, the higher the probability that the structure will be solved 
by MR phasing.  In general, a 30% identity to the search model is considered minimal in 
finding the right solution by using MR phasing.  
MOLREP developed by Alexei Vagin is an automated program for molecular 
replacement (Vagin and Teplyakov 1997).  It is especially advantageous for the rotation 
function search when different unit cells are present in the search model and the 
unknown structure.  The orientation and position of the model obtained from the rotation 
and translation search can be refined by the rigid-body refinement already incorporated 
in MOLREP.  The best solution is written out based on the highest correlation 
coefficient. 
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Phaser is a crystallographic program for phasing macromolecular crystal structures 
using maximum likelihood algorithm (Read 2001). The Automated Molecular 
Replacement in Phaser is a very robust program for solving most structures by using 
relatively simple strategies.  
EPMR is another crystallographic molecular replacement program developed by 
Charles Kissinger (Kissinger et al., 1999). The program finds molecular replacement 
solutions by using an evolutionary search algorithm (Kissinger et al., 1999).  Once an 
initial set of random solutions is generated, the correlation coefficient between the 
observed structure factor Fo and the calculated structure factor Fc is calculated for each 
orientation based on the search model. A fraction of the highest scoring orientations are 
used to generate a set of new orientations by applying random alterations to the 
orientation angles and translations. The correlation coefficients of the new solutions are 
calculated and the search runs to the next cycle. At the end of this evolutionary 
optimization, a local rigid-body refinement is performed and the best solution is written 
out.    
 
Phasing Method -----Multiple Wavelength Anomalous Dispersion (MAD) Phasing 
 
 
The anomalous scattering method has been widely used for solving protein structures.  
The anomalous scattering by an atom is due to the fact that its electrons cannot be 
regarded as completely free electrons (Hendrickson 1991).  If heavy atoms are present in 
a protein structure, the consequence of their anomalous scattering results in the 
 60
differences in intensities measurements between a reflection h k l and its Bijvoet pair ⎯h 
⎯k ⎯l.  The heavier the atom, the stronger the effect of the anomalous scattering 
becomes.  Wide varieties of elements have been used as anomalous scatter makers.  
Selenium is the most often used marker atom for MAD phasing because of the 
successful production of selenomethionyl (SeMet) proteins (Hendrickson et al., 1990).  
The advantage of MAD phasing is that it exploits additional anomalous redundancy not 
only by using anomalous (Friedel- or Bijvoet-) differences within each data set, but also 
by employing dispersive anomalous differences between data sets recorded under 
different wavelengths (Hendrickson 1991). 
Anomalous scattering or dispersion occurs when the wavelength of the incident X-
rays is near that of an absorption edge of the heavy metal.  The X-ray absorption edge-
scan for the anomalous marker atom (Se in this case) defines optimal wavelengths in the 
MAD experiments.  For a MAD experiment with a single absorption edge, three 
wavelengths can be chosen, a peak point at the wavelength with maximal f”, an 
inflection point with maximal f’, and a remote point that is away from the absorption 
edge.    
The X-ray scattering power will depend on the number of electrons in the particular 
atom. The X-ray scattering power of an atom decreases with an increasing scattering 
angle and is higher for heavier atoms.   Its anomalous scattering can be written as 
fanom = f + Δf + if ” 
Δf is the change in the electron scattering factor along the horizontal axis in the 
Argand diagram and if ” along the vertical axis.  
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The structure factors FPH (h k l) and FPH (⎯h ⎯k ⎯l) for the heavy atom derivative of a 
protein are different and have a different phase angle due to their anomalous scattering.   
Δ⎜F⎜anom = {⎜FPH (h k l) ⎜- ⎜ FPH (⎯h ⎯k ⎯l) ⎜} f’/2f” 
Δ⎜F⎜anom is the difference between the amplitudes of the structure factor for the 
reflections hkl and ⎯h ⎯k ⎯l (Bijvoet or Friedel pairs), scaled up with the factor f’/2f”. 
The changes in the intensities of reflections caused by the anomalous scattering are 
very small.  Differences of a few percent can be observed between |F(hkl)| and its 
Friedel opposite |F(-hkl)| at the same wavelength (Bijvoet differences) and the same 
|F(hkl)| at different wavelengths (Dispersive differences). To obtain a usable anomalous 
signal, the data must be measured with a significantly better (lower) noise level, which 
can be determined by deriving the Bijvoet ratios from measured centric reflections. By 
comparing the Bijvoet differences and the Dispersive differences, initial phase 
information can be obtained for solving the structure of the protein crystal. 
SHELXD (Schneider and Sheldrick 2002) and HYSS (Gross-Kunstleve and Adams 
2003) direct methods can be used for solving heavy atom substructures.  
The quality of the scaled data need be evaluated using XTRIAGE (Zwart 2005) 
before the SHELXD or AutoSHARP phasing. The analysis includes unit cell parameter, 
systematic absences and the determination of the space group and the maximum 
resolution for which significant anomalous signal is present.  XPREP or HYSS can 
generate an input file (.ins) and an hkl file to be used in SHELXD later. 
SHARP/AutoSHARP and SOLVE/Phaser are automated programs for solving 
macromolecular structures based on reduced, merged and scaled data from SAD, 
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SIR(AS), MIR(AS) and MAD experiments (Online www.globalphasing.com/SHARP). 
The program calculates phase probability distributions for all reflections in the dataset 
and can detect disordered sites using likelihood-based residual maps.   
 
Model Building and Refinement 
 
Once a structure solution has been obtained either through molecular replacement or 
MAD phasing, the electron density map can be calculated. The final step of model 
building and refinement can proceed based on the calculated map. 
The initial calculated electron density map from either MR or MAD is either biased or 
incorrect.  Errors have been introduced during data collection, data processing and 
phasing. Refinement allows us to obtain the calculated structure factor (Fc) and compare 
it with the observed structure factor (Fo) from the X-ray experiment.  The quality of the 
structure model is indicated by a residual factor (R-factor) of which is based on following 
equation: 
 R-factor=Σ| |Fo|-|Fc| / Σ |Fo|  
The higher the similarity between the observed and calculated structure factors, the 
lower the value of the R-factor and the better the quality of the model. One of the aims of 
model building and refinement is to bring the R-factor to its lowest value. 
During model building, the structure model is manipulated using graphic interfaces to 
adjust the atomic positions based on the electron density maps. 
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XtalView is a complete package for building the molecular model (McRee 1999). It 
has a simple but comprehensive windows based interface.  Xtalview contains XtalMgr, 
the central control program that launches all other applications and organizes the files, 
and the Xfit user interface, a model-building and map viewing program.  Manual fitting 
programs such as Xtalview also allows for changes to the structure that are outside the 
radius of computational convergence.  For example, the rotamer search can fit side chains 
into the electron densities.  Once the correct rotamer is chosen, the refinement program in 
Xtalview can re-adjust the local main chain conformation correctly. 
Xtalview also allows individual change of amino acid residues into correct sequence 
and refines locally using geometric and real space refinement based on the electron 
density map.   
The resulting model is subjected to computational refinements to localize atoms to the 
most probable positions by applying constraints and restraints to some parameters.  For 
example, stereochemical restraints are incorporated in most refinement programs. Bond 
lengths, bond angles, torsion angles and other chemical properties used in restrained 
refinement are referred as stereochemical restraints.  Constraints include anisotropic 
thermal parameters used in the refinement (Winn et al., 2003). 
REFMAC5 is based on the maximum likelihood refinement formalism to minimize 
the coordinate parameter differences (Murshudov et al., 1997).  The likelihood function 
for macromolecular structures including prior phase information and experimental 
standard uncertainties or possibilities is implemented. The overall parameters of 
likelihood and the atomic parameters are refined sequentially in the program.  The 
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indicators of a successful refinement include the value of figure of merit (FOM), R factor 
and R free, and the correlation between maps generated from the model and the final map 
derived from refined structural coordination.   
The maps derived from MR phases can be significantly biased because the reflection 
phase angles (αhkl) are not directly measured. The SHAKE&WARP is a program that 
combines multiple bias-reduction methods into a single web service. The strategies 
include omitting parts of the model, the perturbation of the model coordinates, and, most 
importantly, the averaging of six maps which resulted from differently perturbed starting 
models (Perrakis et al., 2001).  The improved unbiased map can be used to further refine 
and improve the model.   
The quality of the refined structure can be further checked with program PROCHECK 
(Laskowski et al., 1993).  PROCHECK is a validation program used to assess the 
geometry of the residues in a given protein structure compared with stereochemical 
parameters derived from well-refined, high-resolution structures. The checks also make 
use of "ideal" bond lengths and bond angles derived from small molecule structures in the 
Cambridge Structural Database, CSD.   
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CHAPTER III 
STRUCTURAL STUDIES OF MtbKatG, KatG[S315T] 
MUTANT, AND MtbKatG COMPLEXED WITH KCN AND 
INH* 
 
Introduction 
 
M. tuberculosis KatG is an 80 kDa bifunctional enzyme exhibiting a predominant 
catalase activity and also a substantial peroxidase activity with broad specificity (Heyme 
et al., 1993) (Welinder 1992a) (Zhang et al., 1992).  It uses a single active site to 
catalyze both catalase and peroxidase reactions and to remove hydrogen peroxides from 
the biological system efficiently to protect bacterial cells from damage due to reactive 
peroxide(s) generated by host macrophages (Manca et al., 1999).  The peroxidase 
function of KatG is believed to play a critical role in the activation of INH (Zhang and 
Young 1993).  Most INH resistance in clinical isolates results from mutations in the 
katG gene (Saint-Joanis et al., 1999), leading to the elimination or reduction of catalase 
or peroxidase activity (Heym et al., 1995; Musser 1995; Rouse et al., 1995; Rouse et al., 
1996), resulting in lack of  IHN  activation.    Transformation  of  M. smegmatis  and  M. 
______________ 
*Part of the data reported in this chapter is reproduced in part with permission from 
“Hydrogen peroxide-mediated isoniazid activation catalyzed by Mycobacterium 
tuberculosis catalase-peroxidase (KatG) and its S315T mutant." (2006) Zhao X, Yu H, 
Yu S, Wang F, Sacchettini JC, Magliozzo RS, Biochemistry 45(13): 4131-40. Copyright 
2006 American Chemical Society. 
 66
   
tuberculosis with wild-type katG gene restored INH susceptibility to resistant isolates 
(Zhang et al., 1993), confirming that the product of KatG enzyme participated in INH 
action.  
Some mutations in KatG associated with INH resistance result in a significant 
decrease in its catalase or peroxidase activity, while others show no significant change in 
enzyme activity (Saint-Joanis et al., 1999) (Jakopitsch et al., 2003b).  The most common 
mutation accounting for over 50% of INH-resistance in clinical isolates is the S315T 
substitution (van Soolingen et al., 2000) (Saint-Joanis et al., 1999).  The S315T mutant 
produces only moderately reduced catalase or peroxidase specific activity in vitro (2-fold 
and 4-fold, respectively), which does not explain 200-fold increase in MIC for strains 
carrying this mutation (Heyme et al., 1993).  Furthermore, M. tuberculosis strains 
carrying the S315T mutation maintain normal virulence (Alexander et al., 2002), a 
finding that emphasizes the difficulty in dealing with INH-resistant infections. In contrast 
to those reports in which the mutant did not behave differently from wild type enzyme, it 
has been demonstrated that KatG can efficiently catalyze INH-NAD adduct formation in 
the presence of very dilute hydrogen peroxide while the S315T mutant enzyme shows 
poor function under similar conditions (Zhao et al., 2006). These observations raise 
interesting questions about the structural and functional origins of resistance in the 
mutants.   Studies show that purified KatG[S315T] point to a 200-fold reduction in 
affinity for INH in the resting enzyme and poor turnover of the drug with compound I in 
the mutant (Kapetanaki et al., 2003).   
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Despite the importance of M. tuberculosis KatG in the physiology of mycobacteria, 
and its importance in INH action, the detailed mechanisms by which Mycobacterium 
tuberculosis KatG catalyzes hydrogen peroxide and activates INH have not been 
precisely elucidated.  The identity of the active forms of INH that is responsible for 
bacterial killing is not fully known. The substrate-binding site located in Mycobacterium 
tuberculosis KatG has not been identified.  It is not known how the electrons transfer 
between the enzyme and the substrate.  In order to better understand the structure and 
function of KatG, and to begin to define the structural origins of INH resistance due to 
mutations in the katG gene, the x-ray crystallographic structures of the wild-type and 
S315T mutant of KatG from M. tuberculosis were pursued, along with substrate soaked 
or co-crystallized with the wild-type enzyme.    
 
Materials and Methods 
 
Crystallization 
 
The M. tuberculosis KatG and the KatG[S315T] mutant used in these studies were 
prepared from overexpression in E. coli strain UM262 (katG minus) supplied by our 
collaborator Dr. Magliozzo at the Department of Chemistry, Brooklyn College and The 
Graduate Center of the City University of New York, Brooklyn, New York.  The 
bacteria were grown in presence of δ-aminolevulinic acid, the heme biosynthetic 
precursor.  The purified enzyme was dialyzed with 25mM Tris-HCl, pH7.5, 100mM 
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NaCl and concentrated to 16-24 mg/ml.  All protein samples used for crystallization 
trials were less than one week old. 
General reagents were obtained from Sigma.  Polyethylene glycol (PEG) 4000 was 
from Fluka. Crystal Screen I&II and MemFac and PEG/Ion crystal screen kits were from 
Hampton Research. HYDRA 96 high-throughput robotic system was from Robbins 
Scientific. 
The sitting-drop vapor diffusion method was performed by using a HYDRA 96 well 
high-throughput robotic system.  Equal volumes of protein solution were mixed with 
reservoir solution containing ionic solvent with varied pH, precipitant, and additive.  1 ul 
of protein sample and 1 ul of crystallization buffer were injected into each well of the 96-
well INTELLI-plate.  The plates were incubated at 16 oC.  Micro crystal clusters of M. 
tuberculosis KatG were initially obtained in 100mM sodium acetate pH4.6, 12% 
PEG4000 at protein concentration of 11 mg/ml one week after the initial crystal screen.  
Optimization grids of varied concentrations of precipitant (PEG 4000, 5-24%), sodium 
acetate (50-200mM at pH4.6), and protein concentration (11-24mg/ml) were screened to 
improve the size and quality of the crystals by the sitting-drop vapor diffusion method 
using 24-well plates.  Each well of the 24-well plate contains a mixture of 4ul protein 
solution and 4uL crystallization buffer in a small well and 500uL solution in the 
reservoir. Thin plate-like crystals were obtained from the well containing 6% PEG4000, 
100mM NaAcetate, pH4.6 and 16mg/ml of protein.  Additional detergent screens were 
performed by using detergent screen kits from Hampton Research. 1 ul of each detergent 
screen solution from the kit was added into each well of the 24-well plate containing 10 
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ul mixture of the protein and crystallization buffer in each well.  MtbKatG crystals were 
improved to a bigger size and better diffraction in the presence of 6% PEG 4000, 100mM 
NaAcetate, pH 4.6, and 0.17mM n-Dodecyl-β-D-maltoside (Figure 12).  The crystals 
were flash frozen at 120K after quick transfer into paratone-N, a cryoprotectant. MtbKatG 
mutant S315T crystals were grown under the same condition as for the native enzyme. 
 
 
Figure 12.  Single plate-like crystals of MtbKatG.  
 
The structure of wild-type MtbKatG soaked in INH was investigated in order to 
elucidate the mechanism of INH activation.  Both short soaked (5 min in 10mM INH) 
and long soaked (4 hours in 10mM INH) crystals were analyzed. INH-soaked with KatG 
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crystals were prepared by adding 1 μL of 100mM INH to 10 μl of a droplet containing 
crystals in mother liquor.  The crystals were allowed to soak with INH for 5 minutes to 4 
hours before quickly frozen in liquid nitrogen.   
Since attempts to soak the substrate into the crystal failed to produce INH bond 
structure, co-crystallization trials were set up.  However, the oxidation of INH by 
MtbKatG is an ongoing process and its product, the isonicotinic radical is unstable. 
Cyanide binds to heme protein and often be used to probe the accessibility to the heme 
active site (Jakopitsch et al., 2005).  It could be used to compete with INH for its binding 
site and slow down the INH oxidization.  1mM KCN was added to the co-crystallization 
solution.  Both KCN and INH plus KCN co-crystals were investigated.  10 mM INH was 
added to 24 mg/ml (0.3mM) of KatG with or without KCN present.  The mixture was 
incubated for 30 minutes on ice and then crystallized in the same condition as that of the 
wild-type enzyme. 
 
Data Collection and Structure Determination  
 
X-ray diffraction studies were conducted using an R-axis IV ImagePlate at the Center for 
Structural Biology, Albert B. Alkek Institute of Biosciences and Technology (IBT), 
Houston, Texas and a MacScience DIP2030b image plate detector coupled with a 
Rigaku X-ray generator at the department of Biochemistry & Biophysics at Texas A&M 
University.  For high-resolution data collection, the Advanced Photo Synchrotron (APS) 
and the Advanced Light source (ALS) were utilized. 
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Integration and scaling of the X-ray data was performed using the HKL2000 
containing XdisplayF/DENZO/Scalepack software packages (Otwinowski and Minor 
1997). The crystal structure of Mtb KatG was solved by molecular replacement using the 
program MOLREP (Vagin 1997)  in the CCP4 package (Collaborative Computational 
Project 1994).  Burkholderia pseudomalli KatG (BpKatG) (1MWV) (Carpena et al., 
2003) was used as the search model. 
 
Model Building and Refinement  
 
The resulting model from MOLREP was initially refined to 2.7 Å resolution with strict 
non-crystallographic restraints using the REFMAC5 program in the CCP4 suit 
(Collaborative Computational Project 1994), followed by model building using TEXTAL 
(Ioerger et al., 2003). The model was refined using the Simulated Annealing in CNS 
(Brunger et al., 1998) with further building and refinement in Xtalview (McRee 1999). 
The phases of wild-type MtbKatG were improved and extended to a resolution of 2.0 
Å with the program SHAKE&WARP (Reddy et al., 2003).  The resulting map shows 
clear continuity over the complete length of Mtb KatG from Met26 to Arg740 with the 
exception of a break in density in one subunit (chain B) in the region of Ala506 to 
Ala507.  All refined residues from both chains fall into the energetically favorable 
regions of the Ramachandran plot by using program PROCHECK (Laskowski et al., 
1993) (Figure 13).  
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Figure 13.  Ramachandran plot of MtbKatG.  The figure was generated using program 
PROCHECK. 
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Results and Discussion 
 
Overall Structure of MtbKatG 
 
The crystals of wild-type KatG belong to space group p42212 with cell dimensions 
a=b=150 Å, c=154 Å, α=β=γ= 90° (Table 2). The structure was refined to a 
crystallographic R and Rfree factors of 18.5% and 22.8%, respectively, with good 
geometry at a resolution of 2.0 Å (Figure 13). 
The MtbKatG enzyme exists as a dimer in the asymmetric unit, containing 1418 
amino acids, two heme b prosthetic groups (iron protoporphyrin IX) and 938 ordered 
water molecules.  The asymmetric unit contains two protein molecules denoted as 
subunits A and B (Figure 14).  The two subunits of the dimer are related by a non-
crystallographic 2-fold symmetry.  The dimer is roughly ellipsoidal with approximate 
dimensions of 100 Å x 70 Å x 50 Å.  The dimer interface buries a total of 4380 Å2 
accessible surface area per subunit, corresponding to approximately 15% of the total 
surface of a single subunit, indicating the extensive contact between the two subunits.  
Three cis proline residues (proline 131, 219, and 501) were found in both subunits. The 
residue arginine 418 was found to have alternate side-chain conformations in one 
subunit.  The structure of each subunit contains 22 alpha helices folded into two separate 
domains, an N-terminal domain (residues Met 26 to Val 423) and a C-terminal domain 
(from Ala 424 to Arg740). Using the same naming scheme of HmKatG (Yamada et al., 
2002) and the yeast cytochrome c peroxidase (CCP) (Finzel et al., 1984), ten helices 
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Table 2. Data collection and structure refinement statistics for wild-type MtbKatG 
 
a Numbers in parentheses represent values in the highest resolution shell. 
b Rsym Rsym = ∑h∑i⏐I(h,i) - <I(h) ⏐/ ∑h∑i I(h,i) where I(h,i) is the intensity value of I(h) 
for all i measurements. 
c Rcryst = ∑⏐⏐Fo - Fc ⏐⏐/  ∑ ⏐Fo⏐, where ⏐Fo⏐ and ⏐Fc ⏐ are the observed and 
calculated structure factor amplitudes respectively. 
dRfree  is the same as Rcryst but calculated with 5% subset of all reflections that was 
never used in any refinement. 
 
 
 A. Data collection statistics  
    Wavelength 0.9 
    Unit cell parameters  
     a  150.1 
     b 150.1 
     c 153.7 
     Space group P42212 
     Resolution limits 2.0 
     Unique reflections 105049 
     Completeness 99.0 (96.7)a  
     Rsym b (%) 8.3 (35.1) 
     I/sigma 26.2 (4.5) 
B. Refinement statistics  
     Resolution range 20.0-2.0 
     Working set reflections  
     Test set size 5% 
     R cryst c (%) 19.8 
     R free d (%) 22.9 
     Protein-non-H atoms 12063 
     Number of water molecule 938 
     Rmsd of bond distances (A) 0.01 
     Rmsd of bond angles (deg) 1.05 
     Average B value 23.93 
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Figure 14.  Overall structure of MtbKatG: Two monomers are labeled gold and purple. 
Loop LL2 is green and loop LL3 is blue.  Heme b is colored red. The figure is 
constructed using MolScript (Kraulis 1991).  
 
 
from each domain were assigned (Figure 15).    Two extra helices (5-7 residues long) 
were also found in the N-terminal domain of each subunit and designated as helices A1 
and C1.  A functional heme group is buried inside a pocket located in between the 
helices B and the helices F in the N-terminal domain of each subunit. The side of the 
heme that faces the molecular surface is called proximal side and the side that faces the 
 76
heme from the second subunit is named the distal side.  The heme pocket has a 
dimension of 8x6x4 Å 3 and its distal side connects to the molecular surface through a 
long substrate access channel (see below).  
In addition to harboring a functional heme group, the N-terminal domain also plays a 
role in protein dimerization (Wilming 2001). It has been demonstrated by the yeast two-
hybrid system that the first 99 amino acids of the N-terminal domain are responsible for 
the dimerization of the Mtb KatG.  From the crystal structure of MtbKatG, it has been 
clearly shown that two N-terminal arms of the dimer are oriented anti-parallel to each 
other with close contacts between residue Asn41 from subunit A and residue Lys 27 
from subunit B and vice versa.  The N-terminal arm of subunit A (residue Met26 to 
Asn41) runs into the C-terminal domain of subunit B and likewise, the N-terminal arm 
of subunit B turns into the C-terminal domain of subunit A, forming a domain-domain 
swapped structure (Figure 14). Aside from the contribution to dimer formation, no 
functional role has been assigned to this domain yet.   
The catalase-peroxidases differ from the other Class I peroxidase enzymes in that 
they have three loop insertions defined as LL1, LL2, and LL3 in the structure of HmCP 
(Yamada et al., 2002).  Similar loops were found in MtbKatG as well (Figure.14).  Loop 
LL2 from Pro 194 to Asn 231 is located on the molecular surface with its near C-
terminal end close to the distal heme pocket.  Tyr 229 is located near the end of this 
KatG specific loop, providing the central side chain in the unique three amino acid 
adduct Trp-Tyr-Met found on the distal side of the active site of KatGs (see below).  
Mutation of residue Tyr 229 to Phe results in loss of catalase function (but enhanced 
 77
peroxidase activity) in the KatG enzyme (Jakopitsch  et al. 2003a), suggesting that the 
loop is a key structural element that transforms a mono-functional peroxidase into a dual 
function enzyme.   Loop LL2 also contains residues that are involved in formation of the 
substrate entrance channel leading to the distal heme pocket including Asp 194, Gln 233, 
Leu 205, Asn 231 and Gly 226 at the molecular surface.  Arg 119 is located at the 
surface of the entrance opposite to Asp 194 and thus gives a low positive charge to the 
other side of the channel.  The second large loop (LL3) from Pro 280 to Ile 313 is unique 
to KatGs as well. Thr 314 and Ser 315, which are adjacent to the loop, are located at the 
narrowest point of the substrate entrance channel (see below).  Therefore, these loop 
insertions in the catalase-peroxidases provide structural features absent from CCP 
(Finzel BC 1984) in the Class I peroxidase family and have a major impact on the 
function of the KatGs.  
 
Figure 15.  Ribbon diagram of one subunit in the MtbKatG dimer:  11 α-helices in each 
domain are labeled according to the naming scheme for CCP and HmCP.  The heme b is 
colored red.  The figure is generated using SPOCK (Christopher 1997). 
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Heme Cofactor 
 
 
Each subunit of the KatG dimer contains a single molecule of the iron protoporphyrin IX 
cofactor buried in a deep pocket of the N-terminal domain.  The protoporphyrin ring is 
moderately distorted into a saddle shape with pyrrole rings II and IV tilted to ward the 
proximal side and pyrrole rings I and III tilted toward the distal side of the heme (Figure 
16).  There is a small displacement of the iron towards the proximal His, about 0.2 Å out 
of the mean pyrrole nitrogen plane. 
The heme iron is six coordinated. The fifth and sixth coordination positions are 
occupied by the side chain of His 270 from proximal side (2.2 Å) and a water molecule 
W261 of the distal side (2.9 Å) (Figure 16).   The structure solved for KatG is consistent 
with the 6-coordinate iron in both subunits, despite the long water-iron bond length (2.9 
Å), when compared with 2.5 - 2.7 Å in other peroxidases such as in LiP (2.7 Å) and 
BpKatG (2.5Å).  The water molecule (W261) at the distal heme site may be considered 
poised in a position such that both 5 and 6-coordinate forms are accessible to the enzyme 
in the solution.  It has been demonstrated that the heme iron in MtbKatG can be 
interchanged between the 5th and 6th-coordinate as a function of the conditions used for 
purification, storage, the pH, and the presence of INH (Kapetanaki et al., 2003).   
 79
  
 
Figure 16.  The heme active site of MtbKatG. Both distal and proximal active site 
residues are shown.  The ordered water molecules at the distal heme site were colored 
red.  Interactions are indicated by dashed lines.  The figure was made using program 
PyMol (Delano 2002). 
 
 
Proximal Heme Binding Site 
 
The proximal side of the heme-binding pocket is lined by mostly hydrophobic residues 
from both helices F and J (Leu265, Phe252, Ile248, Ile266, His270, Thr275, Trp321, 
Asp381, Phe408, and Trp412).  α-helix F runs nearly parallel to the heme plane with its 
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closest contact to the heme plane at a distance of 2.2 Å in between the side chain of 
His270 and the heme iron (Figure 16).  The proximal side of the heme binding site 
contains the catalytically important amino acid triad His270-Asp381-Trp 321 (Figure 16), 
typical of peroxidases in the Class I peroxidase family.  The imidazole side-chain of 
His270 is perpendicular to the heme plane, with the nitrogen of the side chain forming an 
electrostatic interaction with the heme iron (2.2 Å). The indole ring of Trp 321 is parallel 
to the imidazole ring of His 270 at distance of about 3.5 Å.  The oxygen atoms of the 
carboxyl group of the Asp 381 side chain are hydrogen bonded to Nδ of His 270 (at 
distance of 2.8Å) and the indole nitrogen of Trp 321 (at distance of 2.6Å) so that protons 
can be shared within the triad of His-Asp-Trp.  The presence of the hydrogen bonding at 
the proximal histidyl imidazole Nδ is a conserved feature in the peroxidase family that 
contributes to the functional properties of the heme peroxidase enzyme (Finzel 1984).  
 
Distal Heme Binding Site 
 
On the distal side of the heme, the catalytically important residues Trp 107, His 108 and 
Arg104 are conserved in the class I peroxidase family as well.  Figure 16 shows the 
disposition of these residues in the distal active site.  
The indole ring of Trp107 lies parallel to the heme plane at distance of 3.5 Å lying 
over pyrrole ring II on the distal side of the heme (Figure 16).  The imidazole ring of 
His108 is located perpendicular to the heme plane and about 5.6 Å to the heme iron, a 
distance consistent with the lack of evidence for a low spin heme iron in MtbKatG 
 81
(Chouchane et al., 2000).  The center structural water molecule, W261, is in between the 
heme iron (2.9 Å) and His108 (2.7 Å) on the distal side of the heme (Figure 16).   
The imidazole ring of His108 is stabilized by two possible hydrogen bonds formed 
between N δ1 of His108 and O δ1 of Asn138 (2.7 Å) and the main chain oxygen atom of 
Asp137 (2.9 Å) (Figure 17a).  The conserved distal histidine, which facilitates the 
deprotonation of H2O2 and assists in the heterolytic cleavage of the O-O bond, is thought 
to be the essential feature of the heme peroxidase (Poulos et al., 1980).  Mutation of the 
distal histidine or arginine interferes with formation of Compound I, while mutation of 
the tryptophan residue results in lost of catalase activity, with retention or even 
enhancement of peroxidase activity (Hillar 2000) (Regelsberger et al., 2000).  The 
MtbKatG structure presented here does not indicate a major deviation in the mechanism 
for Compound I formation between CCP and KatGs when considering the conserved 
residues on both the distal and proximal sides.   
The extensive hydrogen-bond network formed around the side chain of the Arg104 
may also play an important role with respect to the heme binding and reactivity towards 
hydrogen peroxide.  The backbone carbonyl oxygen of Ala139 is within hydrogen 
bonding distance to both N η1 (2.9 Å) and N η2 (3.0 Å) of the Arg104 (Figure 17b).  The 
disruption of these hydrogen bonds may account for the decreased INH activation (80%) 
in Ala139Pro mutant (DeVito and Morris 2003).  The N η2 of the Arg104 can also 
hydrogen bond to the main chain oxygen atom of Asp137 at 2.9 Å.  Asp137 is located at 
the narrow neck of the substrate entry channel (see below).  The N η1 of the Arg104 is 
hydrogen bond to a solvent molecule (W39) (3.0 Å).  This solvent molecule is located 
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(a). Hydrogen-bond network around distal His108 
         
(b). Hydrogen-bond network around distal Arg104 
 
 
Figure 17. Hydrogen-bond networks at the distal site of MtbKatG.  The figure is 
constructed using PyMol.  The hydrogen bonding interactions are indicated by the blue 
dashed lines.  The ordered water molecules were shown in red balls. 
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between the two propionate groups and forms hydrogen bonds with O 1δ of the propionate 
of pyrrole ring III (2.7 Å) and O 2α of the propionate at the pyrrole ring IV (2.7Å) (Figure 
16). 
A water molecule (W20) is hydrogen-bond to the Nε2 of the imidazole of His 108, the 
Nε of Arg104 side chain and the third water molecule (2.5 Å) in the distal heme pocket, 
but is farther away from the center water molecule W261 (3.3 Å) (Figure 16). The 
coordination of the water molecules (W20 and W445) may represent a hydrogen peroxide 
binding site in the wild-type KatG.  Both Arg104 and His108 are required for the 
peroxidase activity of MtbKatG.  Mutation of Arg104 or His108 results in a loss of 
peroxidase activity (Saint-Joanis et al., 1999).  
 
The Active Site Adduct 
 
The unique three amino acid adduct Trp-Tyr-Met is found in the MtbKatG structure 
(Figure 18a).  The adduct formed among side chains of the Trp107, Tyr229 and Met255 
is located in the vicinity of the distal heme binding site (Figure 18b).  The Tyr229 from 
the end of the KatG specific loop LL1 is the central residue of the adduct suggesting its 
role in this dual function enzyme.  The bond length between Cε1 of Tyr 229 and Cη2 of 
Trp 107 is 1.69 Å, which is the same as in HmCP (1.68 Å) and BpKatG (1.69Å). The 
bond distance between Sδ of Met 255 and Cε2 of Tyr 229 is 1.78Å, similar to the reported 
values of HmCP (1.72Å) and Bp KatG (1.78Å).  While the indole and phenol rings  
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(a) The electron density map of the adduct 
 
(b) The Trp-Tyr-Met adduct at the active site. 
 
Figure 18 The Trp-Tyr-Met adduct.  (a). The unbiased electron density map was 
calculated using SHAK&WARP, the bias removal server (Reddy et al., 2003).  The map 
of the adduct was contoured at one sigma and the figure was constructed using Xtalview; 
(b).  The Trp-Tyr-Met adduct and the distal active site residues were shown.  The heme 
is colored red. The double conformations of the Arg418 side chains were also indicated 
in the figure.  The figure was made in PyMol (DeLano 2002). 
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themselves are planar, the adduct is puckered with its shallow bottom close to pyrrole 
ring II of the distal heme.  This adduct is located in a very hydrophobic environment 
with no possible access to solvent molecules except W261, the central water molecule to 
the indole nitrogen of the Trp107 in the distal heme pocket.   This unusual distal side 
adduct was first identified in the crystal structure of HmCP (Yamada et al., 2002) and 
was more recently confirmed in the structure of BpKatG (Carpena et al., 2003). The 
existence of the adduct in Synechocystis KatG was also found in solution by mass 
spectrometry of tryptic digests (Jakopitsch et al., 2003a), demonstrating that the adduct 
is not an artifact and is a common feature of the catalase-peroxidases.  Indeed, studies 
confirmed that the adduct is required for catalase but not the peroxidase activity 
(Jakopitsch et al., 2003b).  
The double conformation of the side chain of Arg418 is located near the Trp-Tyr-
Met adduct in between helices B and J in the N-terminal domain of each subunit (Figure 
18b).  In one conformation (50%), A guanidino group of Arg418 points toward Tyr229 
and forms a hydrogen bond with O η of Tyr229 (3.1Å), which is longer when compared 
to that of the BpKatG (2.9 Å) and HmCP (2.8 Å).  The N η 2 of Arg418 also forms a 
hydrogen bond to the amide nitrogen atom of Met255 at a distance of 2.6 Å (Figure 
18b).  The interactions that stabilize the covalent bonds in the adduct are conserved 
features in KatGs when compared with two other published KatG structures.  When 
Arg418 is in the alternative orientation, in its side chain points toward a large solvent 
channel (see below) and one water molecule replaces the Arg side chain and is hydrogen 
bonded to the hydroxyl of the Try229. 
 86
 
Substrate Access Channels to the Active Site 
 
The molecular surface of Mtb KatG reveals at least two heme access channels in each 
subunit of the dimer. The first channel is a substrate entrance channel, analogous to the 
channel previously identified in HmPC (Yamada et al., 2002) and Bp KatG (Carpena et 
al., 2003). This major channel provides access to the distal side of the deeply buried 
heme cofactor (about 20 Å from the molecular surface) (Figure 19). This channel differs 
from that of the monofunctional catalases (beef liver catalase and HPII from E coli) or 
peroxidases (CCP and ARP). In catalases, the heme is buried more deep with longer 
substrate access routes (30-55 Å) (Reid et al., 1981).  In contrast, the access channel in 
peroxidases is shorter (~10 Å) and is also less constricted (Finzel et al., 1984).  The 
major access channel in MtbKatG closes down from around 14 Å across at the surface of 
the molecule, to about 6 Å at its narrowest point near Ser315 where there is a bend into 
the distal side pocket. This channel is lined with mostly hydrophobic residues and a 
number of polar residues.  The residues around the channel near the heme pocket are Thr 
314, Ser 315, Asp 137, Leu 227, and Pro 232.  The narrowest part of the channel is 
delimited by Ser 315 and the carboxyl group of Asp 137, which is about 10 Å from the 
heme iron.  This narrow neck in the channel creates a steric barrier for access to the 
heme active site.   
 87
 
 
Figure 19. The access channels to the distal active site. Both major and minor substrate 
channels are colored gold.  The picture was constructed using SPOCK with key active 
site residues and the heme being highlighted.  
 
 
 
The second smaller channel found in each subunit of the dimer in Mtb KatG was not 
identified in the earlier KatG enzyme structures. The smaller portal lies approximately in 
the plane of the heme and comes close to the propionate group at pyrrole ring III (Figure 
19). This portal is about 10 Å long and is formed by residues Gly99, Pro100, and 
Leu101 from one side and Asp94 and Phe368 from the other side.  The portion of the 
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channel that leads to the molecular surface appears to be interrupted by the side chain of 
the distal Asp94 and Phe368, indicating that very small movements in the side chain 
may be able to open up or close down the small channel.  
Both channels contain a large number of ordered water molecules. The existence of 
the two channels and the continuum of the water molecules in the channels suggest a 
model in which separate routes may be available for hydrogen peroxide (substrate) 
access and water and oxygen (products) release during the product turnover. It is 
reasonable to propose that the small portal facilitates release of the water or oxygen that 
was generated from hydrogen peroxide reduction without competition from incoming 
peroxide molecules.  
A large U-shaped channel similar to the one in BpKatG is found to exist in MtbKatG 
as well (Figure 20a).  The interesting feature of the channel is that it connects to the 
molecular surface through two funnels; one side may serve as entry and the other as exit.  
Arg418 is located at the bottom of this U-shaped channel (Figure 20).  The Trp-Tyr-Met 
adduct is located right beside Arg418.  The guanidino group of Arg418 has alternate 
conformations.  In one conformation (50%), the side chain of Arg418 is directed toward 
the central residue Tyr229 of the adduct.  In the conformation in which the side chain of 
the Arg418 is pointed toward the molecular surface, the channel is blocked or 
interrupted (Figure 20b).  This channel may provide a direct access to the adduct through 
the side chain of Arg418.  It has been suggested that this very well defined cavity might 
serve as a second substrate binding site in KatGs (Mo et al., 2004).  It is possible that the 
tyrosine hydroxyl is deprotonated and forms a salt-bridge to the positively charged 
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Arg418 side chain, but it becomes neutral when the Arg side chain takes another 
conformation.  The sulfate of Met255 in the adduct most likely carries a positive charge 
and would provide a driving force to draw electrons from the cationic groups.  It has 
been proposed that the first hydrogen peroxide reacts with the KatG at the initial 
substrate-binding site (close to His108 and Arg104) to form compound I (Mo et al., 
2004).  The second hydrogen peroxide, which is located at the bottom of the U-shaped 
channel and hydrogen bonds to Try229 when the Arg418 side chain is in the orientation 
towards the channel, could serve as a reducing agent to oxidize compound I back to the 
resting enzyme through its interaction with the cationic cluster (Mo et al.,  2004).  
 
(a) U-channel    (b) U-channel interruption by Arg418 side chain 
 
 
 
 
 
Figure 20.  The U-shaped channel and the features of the alternate conformations of 
Arg418 side chain. 
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Overall Structure of MtbKatG[S315T] Mutant 
 
 
The overall structure of MtbKatG[S315T] mutant is the same as the wild-type enzyme. 
The rms deviation for 715 Cα atoms from each subunit, after superimposition of the two 
structures, is 0.29 Å. The first 25 residues from both subunits remain disordered and are 
not included in the refined structure. Crystallographic R and Rfree factors and other 
refinement statistics are similar to that in the wild-type Mtb KatG (Table 3). The quality 
of the model was verified by PROCHECK (Figure 21).  
The electron density of the methyl group of the threonine 315 side chain is clearly 
seen even with Ser315 as the search model (Figure 22).  The arrangement of catalytically 
important residues on both proximal and distal sides at the heme in KatG [S315T] is 
essentially the same as in the wild type enzyme.  The distal side adduct of Trp-Tyr-Met 
side chains was found in both subunits in the mutant structure.  This observation along 
with the very close alignment of all other heme pocket residues in the mutant compared 
to the wtKatG is consistent with the relatively unaltered catalase and peroxidase 
activities of the purified mutant enzyme.   
 
The Heme Cofactor in MtbKatG[S315T] 
 
The heme iron is five coordinated in MtbKatG[S315T] compared to a six 
coordinated heme from the wild-type enzyme.  The ordered water molecule W261 
occupying the sixth coordination position in the wild-type KatG disappeared from the 
mutant structure, leaving the heme iron five coordinated. Five data sets were collected  
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Table 3. Data collection and structure refinement statistics for MtbKatG [S315T]  
   
A. Data collection statistics  
    Wavelength 0.98 
    Unit cell parameters  
     a  149.8 
     b 149.8 
     c 154.5 
     Space group P42212 
     Resolution limits 2.1 
     Unique reflections 76312 
     Completeness 78.5 (64.0)a  
     Rsym b (%) 11.8 (23.8) 
     I/sigma 9.4 (2.1) 
B. Refinement statistics  
     Resolution range 20.0-2.1 
     Test set size 5% 
     R cryst c (%) 23.0 
     R free d (%) 27.6 
     Protein-non-H atoms 11749 
     Number of water molecule 596 
     Rmsd of bond distances (A) 0.01 
     Rmsd of bond angles (deg) 1.39 
     Average B value 20.28 
  
a Numbers in parentheses represent values in the highest resolution shell. 
b Rsym Rsym = ∑h∑i⏐I(h,i) - <I(h) ⏐/ ∑h∑i I(h,i) where I(h,i) is the intensity value of I(h) for all i 
measurements. 
c Rcryst = ∑⏐⏐Fo - Fc ⏐⏐/  ∑ ⏐Fo⏐, where ⏐Fo⏐ and ⏐Fc ⏐ are the observed and calculated 
structure factor amplitudes respectively. 
dRfree  is the same as Rcryst but calculated with 5% subset of all reflections that was never used in 
any refinement. 
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Figure 21.  Ramachandran plot of the MtbKatG [S315T] generated in PROCHECK. 
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Figure 22.  Electron density map showing the methyl group of the threonine 315 side 
chain in KatG[S315T].  The 2Fo-Fc electron density map was obtained by using wtKatG 
(Ser315) as the refinement model. 
 
 
and processed to good qualities for both MtbKatG and MtbKatG[S315T] (Table 4). The 
missing water coordination consistently shows in all of the MtbKatG[S315T] structures 
refined to date. There is clear electron density at the distal heme assigned as W261 and 
the water molecule has a refined B factor of 29.1 A2 (mean B factor for all atoms in the 
structure is 23.9 A2 for wt KatG) (Figure 23a). In contrast, there is no corresponding 
electron density in the mutant structure (Figure 23b).  This coordination shift could be 
significant because the oxidation state or the redox potential of the heme differs in 
different coordination and may affect enzyme reactivity (Proshlyakov et al., 2000).  
Although not the focus of our study, EPR and resonance Raman spectroscopy was used to 
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analyze the electronic absorption spectrum to get some basic insight into the coordination 
environment and spin-state of the heme (Chouchane et al., 2003).  It has been 
demonstrated that the heme iron in the wild-type KatG contains abundant 6-c heme iron, 
while the S315T mutant remains predominantly 5-coordinate (Kapetanaki 2003).  They 
proposed that the S315T mutation weakens the hydrogen bond between His276 and the 
heme 7-propionate group and might result in an increase in nonplanar heme deformation, 
which leads to formation of the 5-coordination heme state (Kapetanaki et al., 2003). 
 
Table 4. Multiple data collections and refinements for MtbKatG and MtbKatG[S315T] 
 Beam 
line 
Wave- 
Length 
Resolution
Ao 
Completeness
% 
R-factor
% 
R-free
% 
Rmsd 
Ao 
Rmsd 
Angles 
B-factor
A2 
wtKatG APSa 
14ID 
0.98 2.0 99 19.8 22.9 0.01 1.26 23.9 
wtKatG APS 
14BM 
1.0 2.4 99 21.2 24.5 0.01 1.34 25.9 
wtKatG DIPb 1.5 2.7 97 23.8 26.7 0.02 1.43 30.1 
S315T IBTc 1.5 2.6 98 22.6 27.4 0.01 1.31 31.0 
S315T ALSd 0.90 2.1 79 23.0 27.6 0.01 1.39 20.3 
 
a Data collected from the Advanced Photo Synchrotron (APS) at Argonne National Laboratory, Chicago. 
b Data collected using a MacScience DIP2030b image plate detector coupled with a Rigaku X-ray 
generator at Texas A&M University. 
c Data collected using an R-axis IV ImagePlate at the Center for Structural Biology, Albert B. Alkek 
Institute of Biosciences and Technology (IBT). 
d Data collected from the Advanced Light Source (ALS) at University of California, Berkeley. 
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(a) wtKatG 
  
(b) KatG[S315T] 
 
Figure 23.  Distal heme environment comparison between MtbKatG and KatG[S315T] 
mutant: (a) The 2Fo-Fc electron density map of wtKatG at 2 sigma contours with the 
model of the heme and distal side residues Arg104, Trp107 and His108 along with the 
water molecules superimposed. Hydrogen bonds are indicated by the broken lines. (b) 
The 2Fo-Fc electron density map of KatG[S315T] at 2 sigma with the model of the heme 
and distal side residues Arg104, Trp107 and His108 along with the water molecule 
superimposed. 
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Substrate Access Channels in MtbKatG[S315T] 
 
The most important change in MtbKatG[S315T] is due to the presence of the methyl 
group of the side chain of threonine 315, which effectively limits the accessibility to the 
heme by constricting the dimensions of the narrowest part of the channel from 6 Å in the 
wtKatG to 4.7 Å in the mutant (Figure 24).  It has been proposed that hydrogen peroxide 
passing through the access channel in the native KatG promotes the formation of a 
continuous flow of solvent and peroxide (Jones 2001). The steric constraints introduced 
by the KatG[S315T] mutant may hinder the continuous flow in the substrate access 
channel (Zhao et al., 2006).  
 The side chain of Arg418, which is located on the bottom of the U channel, has 
alternate conformations in wtKatG.  However, this dual conformation seems to be not as 
well defined in the mutant structure. Refinement gives low occupancy (30%) for the 
conformation pointed towards Tyr229, the central residue of the Trp-Tyr-Met adduct and 
shows well defined electron density for the conformation with the side chain directed 
toward the molecular surface, consequently breaking the U-shaped channel.  A similar 
channel was also found in BpKatG structure, suggesting a possible binding site for a 
substrate (Carpena et al., 2003).  Unfortunately, the identity of the in vivo substrate 
remains unknown for both BpKatG and MtbKatG. 
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Figure 24.  Structural comparisons of MtbKatG and KatG[S315T] mutant at the distal 
side of the substrate access channel. The figure was constructed using graphic program 
SPOCK with superimposed wt and mutant KatG PDB. Molecular surfaces were 
calculated and displayed in yellow for wt KatG and blue for the mutant S315T.  The 
substrate access channel to the distal side of the heme was displayed within 12 Å 
distances to the heme by clicking through molecule surface in the SPOCK program. 
Asp137 and Thr315 residues of the mutant are colored by atom type. The heme is 
colored red in the mutant. The corresponding residues from MtbKatG are colored 
yellow.  The ribbon diagram of the mutant was shown in blue and superimposed with 
that of MtbKatG in yellow. 
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It has been shown that mutation S315T produces only moderately reduced catalase (2-
fold) and peroxidase specific activity (4-fold) in vitro. However, the MIC is increased 
about 200-fold for the S315T mutant strain compare to the wild-type enzyme (Heyme et 
al., 1993).  In general, the catalase activity is measured spectrophotometrically by 
following the decrease in H2O2 concentration at 240nm (Saint-Joanis et al., 999) and the 
peroxidase activity can be determined spectrophotometrically by measuring the oxidation 
rate of o-dianisidine, a peroxidase substrate, to o-dianisidine quinonedimine at 460nm in 
presence of t-butyl hydroperoxide (Saint-Joanis et al., 1999; Zhao et al., 2006).  
Reduction can also be monitored qualitatively by means of the NBT (NitroBlue 
Tetrazolium) reduction assay (Hillar 1995). The radical formation in presence of INH can 
be detected by using NTB, which shows blue color when reduced by phenolic radicals 
(Wengenack et al., 2004). The isonicotinic acyl radical is unstable, the final product of 
the INH oxidation is proposed to be isonicotinic acid.  Studies showed that the wild-type 
enzyme was more efficient than the S315T mutant at converting INH into isonicotinic 
acid (Wengenack et al., 1997; 2004).  The structures of the wild-type KatG and S315T 
mutant solved here suggest  that the replacement of threonine for serine produces steric 
effects that interfere with interaction between the enzyme and INH but do not interfere  
with  formation of Compound I from small peroxide molecule such as H2O2.  The drug 
binding within the heme pocket is a likely requirement for INH activation (Zhao et al., 
2006). 
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Structural Modeling of Clinically Significant Mutants 
 
INH resistance in M. tuberculosis clinical isolates has been associated with either the 
complete loss of the katG gene or deletions, insertions, and/or point mutations within the 
gene. The various clinically significant mutations in MtbKatG are listed in Table 5.   
There are basically four types of mutations. The first category includes the 
KatG[S315T] which is located at the bottom of the narrow neck of the major substrate 
access channel (Figure 24).  The KatG[S315T] mutant shows a minor change in catalase 
and peroxidase activity but a significant effect on INH activation (Saint-Joanis et al., 
1999) due to the presence of the methyl group of the Thr 315 side chain, which 
effectively limits accessibility to the active site.  
The second group of mutants includes the mutations that are located at the distal 
heme side, including R104L, H108Q, N138S and A139V (Figure 25a).  This type of 
mutation shows significantly reduced catalase activity due to the interruption of the 
hydrogen bonding networks that are crucial for  catalase activity (Ghiladi et al., 2005).  
Both arginine 104 and histidine 108 residues were shown to play essential roles in 
compound I and compound II formation (Dunford 1999).  The mutation of arginine 104 
and histidine 108 has been shown to be associated with disruption in Met-Tyr-Trp 
adduct formation, although the presence or absence of the adduct dose not appear to 
correlate with INH resistance (Ghiladi et al., 2005). 
The third category includes the mutants located at the proximal side of the heme 
(Figure 25b). The proximal mutants show significantly decreased catalase and 
peroxidase activity (Rouse et al. 1995; Rouse 1996).  
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The fourth type of mutation is the R418G mutation that is located in the U-shaped 
channel (Figure 20).  This type of mutation shows abolished catalase activity but 
retained peroxidase activity (Mo 2004).  The guanidino group of Arg418 forms a 
hydrogen bond with O η of Tyr229, the central residue of the Met-Tyr-Trp adduct.  The 
N η 2 of Arg418 also forms a hydrogen bond to the amide nitrogen atom of Met255. 
Mutation of this residue may lead to disruption of the hydrogen-bond networks that are 
required for the formation of the adduct as well as for the catalase activity of the 
enzyme.  
The remainder of the mutations appear to be located either on the surface of the 
protein or at the dimer interface, where they may play a role in the electron-transfer 
pathway, or in governing enzyme dimerization (Ghiladi et al., 2005). Comparison of 
catalase and peroxidase activity along with their INH sensitivity does not demonstrate an 
apparent correlation between catalase activity and INH resistance in this type of 
mutation. 
   
Structural Analysis of Substrate Soaked and Co-crystallized MtbKatG Crystals 
 
Table 6 lists the data sets that have been collected and processed for various substrates 
soaked or co-crystallized with MtbKatG crystals.   
The structure of the wild-type MtbKatG crystal soaked with INH was investigated in 
order to elucidate the mechanism of INH activation.  Crystals that were soaked for both 
short (5 min) and long (4 hr) durations with 10mM INH were analyzed. No significant 
change was observed in either structure.  Although there were new electron densities
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Table 5.  INH sensitivity and catalase-peroxidase activity of MtbKatG mutants  
 
Classification Mutation Catalase 
activity 
106 xM-1*S-1 
Peroxidase 
activity 
104xM-1*S-1 
INH 
sensitivity a 
References 
  
wtb KatG 
 
0.7 
 
1.2 
 
0.05 ug/ml 
 
Saint-Joanis, 
1999 
S315T 0.3 0.5 5 ug/ml  Saint-Joanis, 
1999 
 Substrate 
 channel  
     
 
R104L 0.2 0.1 >500ug/ml Rouse, 1996 
 
H108Q ND 0.1 >500ug/ml Rouse, 1996 
 
N138S ND 0.1  >500ug/ml Rouse, 1996 
 
A139V 0.6 0.4 0.1 ug/ml Pym, 2002 
 
 
Distal  
heme side 
 
     
H270Q ND 0.1 >500ug/ml Rouse, 1996 
 
W321G ND 0.09d  >500ug/ml Mo, 2004 
 
 
Proximal heme 
side  
D381G ND ND >500ug/ml Rouse, 1996 
U channel R418G ND 0.6 d e Mo, 2004 
 
 S140N 1.5 1.6 0.5 ug/ml Rouse, 1996 
 
 T275P ND 0.3 >500ug/ml Rouse, 1996 
     
L148R 0.2 0.1 >500ug/ml Rouse, 1996 
 
R463L 0.6 0.9 1.0 ug/ml Saint-Joanis, 
1999 
  
others 
R463G 1.3 0.9 0.5 ug/ml Rouse, 1996 
 
a Data from (Rouse 1996; Pym 2002)  
b wt, wild type. 
 c ND, not detected. 
 d data were converted for comparison. 
 e It did show INH resistance, however, the exact number was missed in the 
reference.  
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Table 6. Data collections and structure refinements for substrates soaked or co-
crystallized MtbKatG 
 
 Beam 
line 
Wave- 
length 
Resolution 
Å 
Completeness
% 
R-factor
% 
R-free 
% 
Rmsd 
Å 
Rmsd 
Angles 
B-factor 
A 2 
 
wtKatG 
+ INH 
DIPa 1.5 2.7 99 24.9 28.7 0.01 1.26 33 
S315T 
+INH 
IBTb 1.5 2.8 100 19.8 24.6 0.01 1.40 35 
wtKatG 
+ KCN 
ALSc 0.9 2.0 97.8 27.4 31.7 0.08 1.59 30 
wtKatG 
+KCN 
+INH 
DIP 1.5 2.6 88.9 19.2 26.3 0.01 1.10 45 
wtKatG 
+KCN 
+INH 
IBT 1.5 2.7 99.5 18.5 23.1 0.01 1.26 23 
wtKatG 
+KCN 
+INH 
co-crystl 
DIP 1.5 2.9 88.6 20.1 27.3 0.01 1.12 41.5 
wtKatG 
+INH 
IBT 1.5 2.6 99.5 22.4 28.9 0.01 1.14 21 
wtKatG 
+BHA 
DIP 1.5 2.7 98.6 19.2 25.6 0.01 1.33 29 
wtKatG 
+NADH 
DIP 1.5 2.9 98.9 18.9 30.1 0.04 2.27 31 
wtKatG 
+NAD+ 
IBT 1.5 2.3 92 37.4 41.7 0.04 2.75 27 
wtKatG 
+NADH 
co-crystal 
DIP 1.5 2.7 88.5 21.2 26.3 0.01 1.10 38 
 
 
a Data collected using a MacScience DIP2030b image plate detector coupled with a Rigaku X-ray generator 
at Texas A&M University. 
b Data collected using an R-axis IV ImagePlate at the Center for Structural Biology, Albert B. Alkek 
Institute of Biosciences and Technology (IBT). 
c Data collected from the Advanced Light Source (ALS) at University of California, Berkeley. 
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  (a). distal site mutations 
 
 
  (b). proximal site mutations 
 
 
Figure 25.  Structure modeling of clinically significant mutants.  The figures were made 
using SPOCK. 
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found in both structures of INH soaked and co-crystallized crystals, the relative 
weaknesses of the density and its extent suggest either low occupancy or, possibly, 
multiple binding sites. We were unable to identify densities that could be confidently 
assigned to the drug molecule.   
The oxidation of INH by MtbKatG is an ongoing process and its product, the 
isonicotinic radical is not stable. This may contribute to the unsuccessful detection of a 
KatG-INH complex.  Cyanide binds to the heme protein and is often used to probe the 
accessibility to the heme active site (Jakopitsch et al., 2005).  It could be used to compete 
with INH for its binding site and slow down the rate of INH oxidization (Battistuzzi et al., 
2005). 1 mM KCN was added to 0.3mM wtKatG enzyme and incubated on ice for 5 
minutes before adding 10mM INH for the co-crystallization.  The mixture was incubated 
for 30 minutes on ice and then crystallized in the same condition as that for the wild-type 
enzyme. Both KCN and INH plus KCN co-crystals were investigated.   
X-ray diffraction data for the MtbKatG co-crystallized with KCN-INH were collected 
using an in-house MacScience DIP2030b image plate detector coupled with a Rigaku X-
ray generator at a resolution of 2.9 Å. A total of 120 frames were collected using one 
degree oscillation per frame under cryogenic conditions.   
The overall structure of MtbKatG-KCN-INH is the same as that of the wild-type 
enzyme. The rms deviation with respect to the wtKatG is 0.25 Å for 715 Cα atoms from 
each subunit. The refined model of MtbKatG-KCN-INH has a crystallographic R and 
Rfree factors of 20.1% and 27.3%. Other data collection and refinement statistics are 
similar to that in wt KatG (Table 7). The quality of the model was verified by 
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PROCHECK for the MtbKatG-KCN-INH structure. An analysis of the main-chain 
geometry with a Ramachandran plot showed that all residues in both subunits fall within 
the energetically allowed region (Figure 26). There were no major conformational 
changes between structures of the wtKatG and the MtbKatG-KCN-INH based on the 
analysis of the superimposed structures, especially at the distal heme binding pocket 
(Figure 27).  The only exception was that the imidazole side-chain of His108 rotated 
about 15 degrees when compared with the MtbKatG structure (Figure 27).  
A region of undefined electron density was initially located in close proximity to the 
Pyrrole I of the distal heme after molecular replacement with the wtKatG and several 
refinements in CCP4.  An unbiased electron density map was obtained using 
SHAKE&WARP.  The resulting map showed an electron density that could contain an 
aromatic compound.  The INH structure was fit and refined into the density (Figure 28). 
The pyridine ring of INH was parallel to the heme plane at distance of 3.6 Å. The 
distance between the carbonyl oxygen of INH and the heme iron is 3.7 Å. The 
surrounding region of the potential INH binding site was mainly composed of 
hydrophobic and aromatic residues including Ile228, Phe252, Try229, Trp107 and the 
heme. The pyridine ring of INH was also parallel to the indole ring of Trp107 at a 
distance of 3.2 Å. The carbonyl oxygen of INH was shown to form a hydrogen-bond to 
the Nε1 of the indole of Trp107 (Figure 28). The pyridinyl nitrogen atom of INH was 
shown to form a hydrogen bond with the nitrogen atom of Tyr229 (Figure 28), the center 
residue of the Trp-Tyr-Met adduct. The carboxyl group of Asp 137 forms a hydrogen 
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Table 7. Data collection and structure refinement statistics for wt MtbKatG-KCN-INH 
 
 A. Data collection statistics  
    Wavelength 1.541 
    Unit cell parameters  
     a  150.4 
     b 150.4 
     c 154.5 
     Space group P42212 
     Resolution limits 2.9 
     Unique reflections 35205 
     Completeness 88.7 (62.4)a  
     Rsym b (%) 23.5 (68.1) 
     I/sigma 4.4 (1.2) 
B. Refinement statistics  
     Resolution range 30.0-2.9 
     Working set reflections  
     Test set size 5% 
     R cryst c (%) 20.1 
     R free d (%) 27.3 
     Protein-non-H atoms 11771 
     Number of water molecule 633 
     Rmsd of bond distances (A) 0.01 
     Rmsd of bond angles (deg) 1.12 
     Average B value 41.5 
  
a Numbers in parentheses represent values in the highest resolution shell. 
b Rsym Rsym = ∑h∑i⏐I(h,i) - <I(h) ⏐/ ∑h∑i I(h,i) where I(h,i) is the intensity value of I(h) for all i 
measurements. 
c Rcryst = ∑⏐⏐Fo - Fc ⏐⏐/  ∑ ⏐Fo⏐, where ⏐Fo⏐ and ⏐Fc ⏐ are the observed and calculated 
structure factor amplitudes respectively. 
dRfree  is the same as Rcryst but calculated with 5% subset of all reflections that was 
never used in any refinement. 
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Figure 26.  Ramachandran plot of MtbKatG-KCN-INH structure. The figure was 
generated using PROCHECK. 
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Figure 27. View of INH binding at the distal heme binding pocket in close 
proximity to the substrate channel. Superimposed MtbKatG and MtbKatG-KCN-
INH residues at the active site were shown to be identical from the two structures 
with an exception of His108, which showed 15 degree rotation in the MtbKatG-
KCN-INH compared to that of the MtbKatG. 
 
 
bond to the nicotinamide-NH2 group of INH. These interactions place INH in a 
remarkably good position for INH activation. Indeed, Asp137 has been proposed to play 
a key role in the binding and activation of INH (Jakopitsch et al., 2003b). A possible 
mechanism for the oxidation of INH might involve protonization or deprotonization by 
the Asp137 side-chain, polarization of the nicotinamide-NH-CO group resulting from 
electrons withdrawal by the Trp-Tyr-Met adduct or the electron-deficient heme, and the 
formation of the pyridine carbonyl and hydrazine radicals.   
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The density of KCN was not identified in the structure.  One reason might be the 
resolution of the structure.  The MtbKatG-INH-KCN data set was collected at home 
source to a resolution of 2.9 Å with average B factor of 41.5 A2.  It is not very reliable to 
define such a small molecule at this resolution. Another possible explanation is that 
KCN might have a low binding affinity to the heme at low pH (personal communication 
with Dr. Magliozzo).  Studies have shown that pH affects the binding affinity of HCN to 
the cytochrome c peroxidase (CCP) (Foshay et al., 2004).  In their studies, they also 
found that mutation of the distal histidine to lysine in CCP also affects the binding 
affinity of HCN to the enzyme. The distal mutant H52K has a higher affinity for HCN 
than does native CCP (Foshay et al., 2004). 
 
 
 
  
 
Figure 28. View of the environment surrounding INH binding site.  The Fourier-
difference map (Fo-Fc) was generated at 1 δ contour level in Xtalview. Interactions of 
INH with its surrounding residues at the heme active site. The green dots indicate the 
possible hydrogen bonding interactions. 
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Summary 
 
In an effort to elucidate the molecular mechanism of INH activation and the relationship 
between drug resistance and the function of catalase-peroxidase, we have solved the X-
ray crystallographic structures of the MtbKatG, S315T mutant, and INH co-crystallized 
MtbKatG. The crystals of MtbKatG belong to space group p42212 with cell dimensions 
a=b=150 Å, c=154 Å, α=β=γ= 90°. The structure of the wild-type enzyme was refined to 
a crystallographic R and Rfree factors of 18.5% and 22.8%, respectively, to a resolution 
of 2.0 Å. The structure of the S315T mutant was refined to a crystallographic R and Rfree 
factors of 23.0% and 27.6%, respectively, to a resolution of 2.1 Å. The overall structure 
of MtbKatG[S315T] mutant is the same as the wild-type enzyme. The arrangement of 
catalytically important residues on both proximal and distal sides of the heme in KatG 
[S315T] is essentially the same as in the wild type enzyme.  The distal side adduct of 
Trp-Tyr-Met side chains was found in both the wild-type and mutant structures.  Our 
results provide a detailed picture on how the S315T mutation affects the function of the 
enzyme. The heme iron in the S315T mutant is 5-coordinate instead of 6-coordinate in 
the wtKatG.  It has been shown that the oxyferrous wtKatG, either as Compound I or 
Compound II, is capable of oxidizing INH, while the  oxyferrous KatG[S315T] is 
incapable (Ghiladi 2004; Ghiladi et al., 2005).  The structures of the wild-type KatG and 
S315T mutant solved here suggest  that the replacement of threonine for serine produces 
steric effects that interfere with interaction between the enzyme and INH but do not 
interfere  with  formation of Compound I from small peroxide molecule such as H2O2.  
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The drug binding within the heme pocket is a likely requirement for INH activation 
(Zhao et al., 2006). 
The structure of the wtKatG co-crystallized with INH was investigated to identify 
the substrate binding site in the enzyme.  The wild-type enzyme was treated with KCN, 
an inhibitor for a heme containing enzyme, before the co-crystallization with INH. The 
overall structure of the wtKatG-INH remained the same as that of the wtKatG.  An INH 
molecule was fitted and refined into a region of electron density located in close 
proximity to the Pyrrole I of the distal heme.  The pyridine ring of INH is located 
parallel to the heme plane.  The carbonyl oxygen of INH forms hydrogen bond with Nε1 
of the indole ring of Trp107 and the pyridinyl nitrogen of INH forms hydrogen bond 
with the nitrogen atom of Tyr229.  Both Trp107 and Tyr229 are involved in the distal 
adduct formation. The nicotinamide-NH2 group of INH forms a hydrogen bond with the 
carboxyl group of Asp137, a key residue that has been proposed to play a role in the 
binding and activation of INH (Jakopitsch et al. 2003b).  Our data revealed an excellent 
position for INH binding and activation through interaction with Asp137 and the distal 
adduct, although the electron density for the INH molecule is weak.  Future work would 
be to determine structures of Compound I, Compound II and Compound III by using the 
KatG[Yy229F] mutant to elucidate the catalytic mechanism of the enzyme. 
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CHAPTER IV 
 
STRUCTURAL AND FUNCTIONAL STUDIES OF VIRB11 FROM 
BRUCELLA ABORTUS 
 
 
Introduction 
 
 
VirB11 is a putative ATPase localized to the cytoplasmic side of the inner membrane 
(Thorstenson et al., 1993).   The function of VirB11 is essential for the virulence of many 
pathogenic bacteria including Helicobacter pylori, which causes gastritis and peptic 
ulcers, Bordetella pertussis, which is responsible for whooping cough, and Brucella spp, 
which causes animal brucellosis (Covacci et al., 1999; O’Callaghan et al., 1999; Delrue et 
al., 2001; Baron et al., 2002; Schulein and Dehio 2002; Cascales and Christie 2004; Celli 
and Gorvel 2004).  It has been proposed that VirB11 either acts as an assembly factor for 
the T4SS or that it is responsible for the translocation of substrate molecules across the 
membrane (Sagulenko et al., 2001). VirB11 is required both for pilus biogenesis and 
substrate secretion.  Studies have shown that certain amino acid substitutions in VirB11 
enables T-DNA transfer without pilus formation suggesting that VirB11 has dual 
functions (Sagulenko et al., 2001). 
It has been suggested that putative ATPases from the type II and type IV secretion 
systems are evolutionarily related based on the identity and similarity scores from the 
sequence comparisons (Segal et al., 1999; Planet et al., 2001).  Sequence alignments of 
VirB11 from several bacteria species are shown in Figure 29.  Four conserved domains 
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Figure 29.  Sequence alignments of VirB11 from several bacterial species. The figure 
was generated using the Clustalw multiple sequence alignment program in Biology 
Workbench. VirB11 [Ba]: VirB11 from Brucella abortus; VirB11 [Bp]: VirB11 from Bordetella 
pertussis; VirB11 [At]: VirB11 from Agrobacterium tumefaciens; VirB11 [Hp]: VirB11 from 
Helicobacter pylori; VirB11 [Bh]: VirB11 from Bartonella henselae; VirB [Re]: VirB11 from Rhizobium 
etli.  
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have been found in all superfamily members, a Walker box A, a Walker box B, an Asp 
(or Glu) box and a His box (Rivas et al., 1997; Planet et al., 2001). Other amino acid 
sequences are also highly conserved, especially in the C-terminal domain. However, the 
linker region between the N-terminal and the C-terminal domain is less conserved 
(Figure 29). The exception is that Arg120, the first residue at the linker, is highly 
conserved.  Other common features of the VirB11-like proteins include the lack of a 
transmembrane domain and amino-terminal export peptide signals.  
VirB11 is thought to interact with other VirB proteins and undergo ATP-dependent 
conformational changes that are required for substrate transfer and pilus formation 
(Krause et al., 2000).  It has been shown that VirB11 interacts with VirB4 directly to 
catalyze the substrate transfer to the VirB6 and VirB8 inner membrane channel in 
Agrobacterium. Studies also have shown that VirB11 interact with VirB1 (Hoppner et 
al., 2005). 
The crystal structures of HP0525, a homolog of VirB11 in H. pylori, in complex with 
ADP or ATPγS, have been solved (Yeo et al., 2000; Savvides et al., 2003). The structure 
reveals that the protein is a homohexamer formed by double-stacked rings.  Each 
monomer of the homohexamer is capable of binding a molecule of ATP at the interface 
between the N-terminal and C-terminal domains (Yeo et al., 2000).  In the hexamer, the 
amino- and carboxyl-terminal domains form two rings, open on one side and closed on 
the other. It has been proposed that HP0525 functions as an inner membrane pore that 
opens and closes in response to ATP binding and hydrolysis (Krause et al., 2000).  The 
structure of apo-HP0525 is significantly different from that of ADP-HP0525 complex, 
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revealing an asymmetric hexameric assembly, suggesting that the hexamers undergo 
dynamic conformational changes with cycles of ATP binding and ADP release 
(Savvides et al., 2003). The structures of ADP and ATPγS complexes are identical with 
rmsd 0.5 Å for 323 Cα atoms, suggesting that nucleotide binding is responsible for ATP-
induced conformational changes, not the product release (Savvides et al., 2003). 
Brucella species are intracellular pathogens that cause long-lasting debilitating 
infections via inhalation of aerosolized particles.  Lack of human brucellosis vaccine and 
the serious consequence of the disease have led to their recent classification as class B 
agents of bioterrorism.  A fully functional T4SS is essential for bacterial survival. The 
spread of antibiotic resistant genes can also be attributed to the T4SS mechanism 
(Cascales and Christie 2003).  VirB11 is one of the essential components of T4SS and 
presents a promising target for novel antimicrobial drug design.  Understanding the 
molecular basis for the VirB11 of B. abortus requires a detailed analysis of the structure 
of VirB11 and its complexes with inhibitors and substrates. The function of VirB11 as 
an ATPase may vary from one organism to another depending on the type of effector 
molecules transported.  In contrast to VirB11 of HP0525, in which the ATPase is 
mediating the 40 kDa CagA protein, the effector molecules that are transferred by 
VirB11 in Brucella abortus have not yet been identified. The primary aim of this study 
is to solve the crystal structure of VirB11 from B. abortus. The molecular features and 
structural determinants that dictate the activity of VirB11 may be elucidated from our 
structural studies and serve as the basis for understanding the mechanism of VirB11 in 
B. abortus virulence factor translocation.   
 116
The crystal structure of VirB11 from H. pylori revealed one ATP binding per 
monomer molecule.  The functional roles of the second ATP binding motif, the Walker 
B motif, and the His box at the C-terminal domain were not clear. In an effort to better 
understand the molecular function of the BaVirB11 and to test which functional groups 
are required for the ATPase activity of BaVirB11, seven mutants were generated based 
on the protein sequence alignment analysis (Table 8). The mutations include a GER 
motif mutation, a linker region mutation, a His box mutation, and a Walker A motif 
mutation.  The presence of the nucleoside triphosphate binding motifs in all VirB11 
proteins from different bacterial species reflects a common requirement for an energy 
source to drive the macromolecular translocation in the T4SS (Krause et al., 2000). 
Mutations of the conserved Walker A motifs were shown to abolish ATP binding and 
ATPase activities of BaVirB11 and block the secretion of the substrates in Brucella spp. 
(Christie 1989; Turner et al., 1993; Stephens et al., 1995).  In our studies, Walker A 
mutant K188Q showed dramatically decreased ATP hydrolysis activity due to the 
decreased ATP binding affinity to the mutant enzyme.  These results along with the 
wild-type enzyme control were used to validate our experimental methods for testing 
other mutants on ATP binding and ATP hydrolysis activities.  A linker region between 
the N-terminal domain and the C-terminal domain was shown to have a rigid-body 
rotation upon ATP binding and hydrolysis (Savvides et al., 2003).  However, it is not 
know if the ATP binding or the ATP hydrolysis is the source for the rigid-body rotation. 
Surprisingly, the linker region mutation showed on effect on ATP binding but 
dramatically decreased ATP hydrolysis activity was found in our study, indicating it is 
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not directly involved in ATP binding.  Structural analysis showed that Arg120 is shifted 
further away from the ATP-binding site and its side chain is located outside the 
coordination sphere of the ATP binding site as predicated from HP0525-ATPγS 
structure.  The GER motif is conserved in VirB11 throughout type IV secretion systems.  
Similar motifs from human collagen type III and IV were shown to be responsible for 
protein-protein interaction, in which it bound to human integrin in a Mg 2+ -dependent 
manner (Raynal et al., 2006).  R113 of HP0525 was proposed to play dual roles in ATP 
binding and hydrolysis: to provide complementary electrostatic interaction with ATP γ-
phosphate and to interact with the catalytic Glu248, a conserved E box residue (Savvides 
et al.,  2003).  An equivalent mutant R101K of BaVirB11 was generated to test this 
hypothesis. The R101K mutant was found to display a similar ATP binding affinity as 
the wild-type enzyme and abolished ATP hydrolysis activity, indicating that direct 
interaction of Arg 101 with the catalytic Glu is crucial for ATP hydrolysis activity.  
Based on our finding, we further proposed that the GER motif and the linker region are 
not directly involved in ATP binding.  However, once an ATP binds, its negatively 
charged phosphate group interacts with the positively charged guanidine group of Arg in 
the wild-type enzyme.  This interaction brings the N-terminal domain to its closed 
conformation through the flexible linker.  The interactions are disrupted in the R120E 
and R101K mutants resulting in the N-terminal domains remain in their opened 
conformation. 
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  Table 8.  VirB11 mutants generated in this study 
 
 
Materials and Methods  
Enzymes, Chemicals, and Reagents 
Restriction endonucleases were purchased from Promega (Madison, Wis.) and New 
England Biolabs (Beverly, Mass.). Klenow fragment of Escherichia coli DNA 
polymerase I and T4 DNA ligase were purchased from New England Biolabs.  PCR 
QuickChange® site-directed mutagenesis kits were obtained from Strategene.  The 
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complementary pairs of oligonucleotide primers used for mutagenesis were synthesized 
by the Integrated DNA Technologies (IDT), Inc. (Woods Land, Texas).  A peptide 
which contains seven amino acid residues from BaVirB1 was synthesized by Sigma-
Aldrich Chemical Co. (St. Louis, Mo.). Isopropyl-β-D-thiogalactopyranoside, (IPTG), 
phenylmethylsulfonyl fluoride (PMSF), carbenicillin, kanamycin, Coomassie brilliant 
blue R250, malachite green, polyvinylacohol, 5-bromo-4-chloro-3-indolylphosphate, 
desthiobiotin, 2-[4-hydroxy-benzenazo]-benzoic acid, ammonium molybdate 
tetrahydrate, ATP-agarose beads, glutaraldehyde, and selenomethionine were purchased 
from Sigma-Aldrich Chemical Co. Other common chemicals were obtained from VWR. 
A Bradford protein assay kit was from Bio-Rad Laboratories (Hercules, Calif.).  Strep-
Tactin Sepharose was purchased from IBA BioTAGnology (Germany). A 
Superdex200TM gel filtration column was from Pharmacia Biotech (Piscataway, N.J.). 
 
Plasmids and Bacteria Strains 
 
The pT7-7StrepII-VirB11 plasmid for the production of Brucella abortus VirB11 protein 
was kindly provided by Dr. Renee Tsolis of University of California, Davis.  The 
construct contains a N-terminally tagged StrepII followed by a Factor Xa cleavage site 
and the full length VirB11 gene (Hoppner et al., 2005).  
The E. coli strain NovaBlue single® was used for plasmid transformation and 
manipulation and BL21(DE3) Novagen TM and B834(DE63) were used for protein 
overexpression.  
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Mutagenesis 
 
The site-directed mutations in BaVirB11 were generated following the PCR 
QuickChange® site-directed mutagenesis protocol of Strategene. The pT7-7strep-
VirB11 plasmid was used as the DNA template.  The complementary pairs of 
oligonucleotides listed in Table 9 were used for the PCR amplification. For each 50ul 
reaction, it contained 800uM of the four (d)NTP, 10pmol of each primer, 1mM MgCl2, 
1nmol of the template DNA and 1ul of Pfu (Pyrococcus furiosus) DNA polymerase from 
Stratagene.  The PCR products were digested with the Dpn I restriction enzyme to break 
down the methyleted parental template DNA before their transformation into Nova Blue 
competent cells (NovaGene). Five colonies from each mutant transformate were selected 
from LB plates supplemented with Carbenicillin (50ug/ml).  Plasmid DNA was purified 
using the mini-prep kit from Qiagen. Mutations were confirmed from sequence analysis 
using the T7 promoter primer.   
 
Bacteria Culture 
 
The bacteria were grown overnight at 37 °C on Luria-Bertani (LB) agar plates (1 % 
tryptone; 0·5 % yeast extract; 0·5 % NaCl; 1.5% agar) containing carbenicillin (100 
ug/ml). A single colony was picked to grow each 5ml culture in LB media containing 
100ug/ml carbenicillin at 37 °C in a shaker at 200 rpm. 2 liter cultures were inoculated 
with the same media under vigorous shaking at 37 °C. When the cell density reached 
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Table 9. PCR primers used to generate Brucella VirB11 mutants 
 
Primer name 
 
Sequence  
Mutant name 
K188Qf 
K188Qr 
CGAGACGGGATCAGGCCAGACCACACTGATG 
CATCAGTGTGGTCTGGCCTGATCCCGTCTCG 
K188Q 
Δ-GKT(187-189)f 
Δ-GKT(187-189)r 
GGCGAGACGGGATCAACACTGATGAAAGCG 
CGCTTTCATCAGTGTTGATCCCGTCTCGCC 
Δ-GKT(187-189) 
I281Tf 
I281Tr 
CATGGCGGCAGCCTCACCAGTTGC 
GCAACTGGTGAGGCTGCCGCCATG 
I281T 
H285Rf 
H285Rr 
ATCACCAGTTGCCGAGCCGGTTCGTGCG 
CGCACGAACCGGCTCGGCAACTGGTGAT 
H285R 
R120Ef 
R120Er 
TCACGATCGAGAAGCCGTCTTTCACCCG 
CGGGTGAAAGACGGCTTCTCGATCGTGA 
R120E 
Δ-IR(119-120)f 
Δ-IR(119-120)r 
ATCTCGGTTACGAAGCCGTCTTTCACCCG 
CGGGTGAAAGACGGCTTCGTAACCGAGAT 
Δ-IR(119-120) 
E209Kf 
E209Kr 
CGCCTGATCACCATCAAGGACGTACCGGA 
TCCGGTACGTCCTTGATGGTGATCAGGCG 
E209K 
R101Kf 
R101Kr 
CCTGCCGATGGGTGAGAAGATTCAGATTGTG 
CACAATCTGAATCTTCTCACCCATCGGCAGG 
R101K 
Δ-ER(109-101)f 
Δ-ER(109-101)r 
CCTGCCGATGGGTATTCAGATTGTGCGCCC 
GGGCGCACAATCTGAATACCCATCGGCAGG 
Δ-ER(109-101) 
 
 
 
OD595 = 0.7-0.9, the culture flasks were placed on ice for 20 min to bring the culture to 
18-20 °C.  Protein expression was induced by adding 0.5 mM isopropyl-b-D-
thiogalactoside (IPTG) to the culture and continued incubation at 18 °C under vigorous 
shaking for 12-16 hours.  For overexpression of the selenomethionine (SeMet) labeled 
VirB11 and the VirB11[R120E] mutant protein, a 5ml LB culture from a single colony 
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was grown overnight at 37 °C.  B834(DE63) cells were collected from the 5 ml  LB 
media and used for inoculation of 2 liter LB culture. The cells were centrifuged in 
sterilized centrifuge bottles when OD595 reached to 0.6-0.9 and then gently pelleted and 
washed with minimal media (M9). The cells were re-suspended in two of the 2 liter M9 
media supplemented with 50ug/ml Carbenicillin and 100ug/ml of 19 amino acid mix 
and 40 ug/ml SeMet and grown two more hours to let  OD595 reach to 0.6-0.9 before 
inducing with 1 mM IPTG. The induction was carried out at 18 °C for 12-16 hours. 
 
Protein Purifications 
 
 
For Strep-Tactin Sepharose chromatography, bacterial cells (from 4 liter culture) were 
suspended in 40 ml ice-cold StrepII binding buffer containing 100 mM Tris-HCl, pH8.0, 
150mM NaCl, 1 mM EDTA, plus 0.5 mM PMSF (phenylmethlsulphonylfluoride) and 
passed twice through a French pressure cell at 1000 p.s.i. The lysate was centrifuged 
(SS34 rotor, 60 min, 15 000 r.p.m. at 4 °C) to remove cell debris and unbroken cells. The 
N-terminal StrepII-fusion proteins were purified with a 4ml Strep-Tactin column 
following the instructions of the manufacturer (IBA) with some modifications. 
Specifically, the column was equilibrated with 5 bed volume of ice-cold StrepII binding 
buffer (100 mM Tris-HCl, pH8.0, 150mM NaCl, 1 mM EDTA).  Cell extract was 
applied to the pre-equilibrated column and washed with 10 bed volumes of washing 
buffer containing 100mM Tris-HCl, pH8.0, 1M NaCl, and 1mM EDTA and then 5 bed 
volumes of binding buffer before elution with 2.5mM desthiobiotin (Sigma). The 
column can be regenerated using 1mM 2-[4-hydroxy-benzenazo]-benzoic acid and re-
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equilibrated with 10 bed volumes of water. The fractions were collected and analyzed by 
SDS-polyacrylamide gel electrophoresis.  The samples were pooled, dialyzed and 
concentrated to 7-10m/ml in a buffer containing 25mM Tris/HCl, pH8.0, 1 mM EDTA 
and 1mM DTT.  Protein concentrations were determined using the Bradford dye binding 
assay (Bio-Rad) with bovine serum albumin as a reference. 
The sample generated by affinity chromatography was applied to a pre-equilibrated 
Superdex200TM gel filtration column (100/16 XK) operated by an HPLC system 
(Amersham Pharmacia Biotech) using a buffer containing 25 mM Tris-HCl, pH8.0, 
1mM EDTA, 1mM DTT.  Proteins were eluted at a follow rate of 0.3ml/min and 2-ml 
fractions were collected. The same buffer and follow rate was used to calibrate the gel 
filtration column for the calculation of the molecular weight of the protein.  The “gel 
filtration Calibration Kit” from Amersham Pharmacia Biotech was used for the 
molecular weight calibration. The molecular weight of proteins in the kit ranged from 
13.7 to 669 kDa. 
The pooled fractions were dialyzed for 4 hours or overnight against a buffer 
containing 25 mM Tris-HCl, pH8.0, 1mM EDTA, 1mM DTT.  The protein sample was 
concentrated using an Amicon Ultra-15 (Millipore) centrifugal filter with 30kDa 
minimal molecular weight cut off.  The freshly purified proteins were used for 
crystallization and ATP hydrolysis studies. 
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Colorimetric ATPase Activity Assay 
  
The malachite green based colorimetric assay was used to measure inorganic phosphate 
released by the ATPase activity of VirB11 (Cogan et al., 1999). The colorless 
phosphomolybdate complex is formed at a low pH and then converted to a colored 
complex in the presence of an enhancer, the basic pH indicator dye malachite green. The 
phosphomolybdate complex is quantified spectrophotometrically.  
The Malachite Green Reagent I was prepared by dissolving 50 mg malachite green 
(final concentration 0.76mM) and 0.17g polyvinylacohol (0.35% final concentration) in 
50ml of water and filtering through 0.45um filter. The Malachite Green Reagent II 
contains 28mM ammonium molybdate tetrahydrate in 2.1M H2SO4.  Equal volumes of 
the Malachite Green Reagent I and II were mixed right before the color development.  
To prepare phosphate standards, sodium dihydrogen orthophosphate monohydrate 
(NaH2PO4.H2O) was dried overnight in an oven at 110° to remove water prior to making 
up standard solutions.  A 1mM stock solution was prepared and a series dilution was 
obtained (500, 250, 150, 100, 50, 25, and 5uM stocks).  
10xATPase Assay Buffer containing 100mM Tris-HCl, 100mM NaCl, 20mM 
MgCl2, 10mM DTT at pH 7.5 and 1mM ATP stock solution was prepared prior to the 
assay.  The stop Buffer contained 0.5 M EDTA at pH 8.0.   VirB11 enzyme of 10nM 
concentration was pre-incubated in a 1xATPase assay buffer for 10 minutes before the 
reaction. 
The assay was performed in triplicate.  Each reaction mix consisted of 200ul of 10x 
ATPase assay buffer, 200ul of the enzyme, 200ul of 1mM ATP and 1.5ml of water. For 
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those samples incubated with an inhibitor or a stimulator, the water volumes were 
changed accordingly. The phosphate standards were prepared in triplicate from the seven 
5x stocks (described above) by addition of 400 ul of each 5x phosphate standard to tubes 
containing the complete assay buffer, bringing their final volume to 2ml.  The reaction 
mixtures were incubated at 30° for 5, 10, 20, 30, 60, 90 minutes.  At each time interval, 
200ul of each reaction mixture were transferred into 50 ul of stop buffer, including the 
phosphate standards.  The reaction was terminated by adding 100 ul of stop buffer at 5 
second intervals to all reactions, including the phosphate standards.  1.5ml of the 
Malachite Green Reagent was added to each reaction tube, mixed, and the color was 
allowed to develop for 5 min. The absorbance of the samples was read on a 
spectrophotometer at a wavelength of 610 nm. There are essential control conditions for 
the assay to eliminate contaminating background phosphate. Two control experiments 
were included in the ATP hydrolysis activity assays.  A sample with the complete assay 
buffer components (but no VirB11) is required to account for spontaneous ATP 
hydrolysis. This was used as the blank on the spectrophotometer.  The second control 
was to estimate the free phosphate contamination in the buffer system.  In this control, 
the VirB11 was included in the assay buffer and the ATP substrate was left out. 
 
ATP Binding Assay  
 
ATP binding assays were performed following the protocol of Sexton (Sexton et al., 
2004) with minor modification.  100ul of ATP-agarose beads (Sigma) were pre-washed 
with an ATP-binding buffer containing 25mM Tris-HCl, pH 8.0, 20mM NaCl, 1mM 
 126
EDTA, 1mM DTT, and 2mM MgCl2. 15ug of each protein sample was added to the 
ATP-agarose and incubated on ice for 30 minutes. The ATP-agarose beads were washed 
twice with an ATP-washing buffer containing 25mM Tris-HCl, pH 8.0, 0.5M NaCl, and 
2mM MgCl2.  The ATP-agarose-bound proteins were eluted by adding 100ul of 10mM 
ATP in an ATP-binding buffer and incubated for 30 minutes. The eluted proteins were 
boiled in a SDS-gel-loading buffer for 5 minutes. The samples were run on 12-15% 
SDS-PAGE and stained by Coomassie blue. 
 
Covalent Cross-linking of VirB11 subunits 
 
The covalent cross-linking experiments were carried out to determine the oligomer state 
of VirB11 mutants following the protocol of Krause (Krause et al., 2000).  15uM VirB11 
and its mutants were incubated with various concentrations (100; 300; 500uM) of 
glutaraldehyde at 25 oC for 90 minutes in the buffer containing 20mM sodium 
phosphate, pH 7.0, 1 mM DTT, 50mM NaCl, 50% glycerol, 10mM MgCl2, and 0.5mM 
ATP.  Reactions were stopped with 3.5M urea (final concentration).  Denatured samples 
were subjected to SDS-electrophoresis and the gels were stained with Serva Blue R.  
 
 
Crystallization and Data Collection 
 
Sitting-drop vapor diffusion crystallization screenings were performed by using HYDRA 
96 high-throughput robotic system (Robbins Scientific) with commercially available 
screens from Hampton Research (Crystal Screen 1&2, MembFac, and PEG/Ion crystal 
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screen kits).  Equal volumes (1 ul) of protein solution at 7mg/ml concentration were 
mixed with a reservoir solution containing ionic solvent with varied pH, precipitant, and 
additive. 
B. abortus VirB11 native crystals were obtained at 18 oC from a solution containing 
10% w/v PEG-4000, 0.1M HEPES, pH7.5, 0.1 M NaCl.  Small plate-like crystals 
formed in a few days.  Larger plate-like crystals grew in the well in which an additional 
10% protein was added two weeks after the initial crystal plate set-up.  The Se-Met 
derivative crystals were formed in the solution containing 10% w/v PEG-4000, 0.1M 
HEPES, pH7.5, 0.1M NaCl, 1mM MgCl2, 3% ethanol at the protein concentration of 9 
mg/mL.   
ATP analogous inhibitor bound crystals were also obtained with the same condition 
as used for Se-Met VirB11 in presence of 5mM Amp-PCP or 5mM ADPβS.   
The crystals were flash cooled to 120K after the progressive transfer to a series of 
cryoprotectant solutions containing 15 to 35% ethylene glycol in mother liquor.  Crystals 
of the native and the Se-Met derivative VirB11 belong to space group C2 with unit cell 
dimensions of a=123.1 Å, b=233.2 Å, c=107.3 Å, and b=123.6o.  The solvent content of 
the unit cell was estimated to be 52%, with six molecules per asymmetric unit.  A set of 
high resolution data was collected to 2.7 Å at Beamline 19ID, the Advanced Photon 
Source in Chicago. Initial molecular replacement methods failed to produce any solution 
using the homolog model, HP0520 as the search model. Later, MAD data were collected 
to a resolution of 2.9 Å at Beamline 23ID, Structural Biology Center at the Advanced 
Photon Source in Chicago. This single crystal was used for MAD data sets collection at 
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the wavelength of λ=0.936, 0.979, and 1.005 Å, respectively. Diffraction data were 
indexed and integrated using program HKL2000.  Attempts to use multiple wavelength 
data sets to solve the structure were not successful due to the weak diffraction nature of 
the BaVirB11 crystals. Data analysis shows the anomalous signal is only good to 5.3 Å 
between data sets collected at the peak and the inflection wavelength.  In addition, out of 
more than 100 crystals screened, only a few diffracted to resolution higher than 4 Å, and 
most of the diffracting crystals were highly mosaic with mosaicity range from 1.5 to 6 
degrees. The analysis of the Patterson function by XTRIAGE (Zwart et al., 2005) 
revealed a significant off-origin peak (21%), indicating possible pseudo translation 
symmetry.  
Hexagonal shaped crystals were obtained from a solution containing 18%PEG400, 
0.1M HEPES, pH7.5, and 0.1M MgCl2.  The native diffraction data used to solve the 
structure of BaVirB11 was collected on an R-AXIS image plate detector (Rigaku-MSC) 
at the wavelength 1.5418 Å. The crystal were formed in a solution containing 5mM 
BaVirB1 peptide that has been shown to interact with VirB11 (Hoppner et al., 2005). A 
total of 180 frames have been collected at 1 degree oscillation. Integration and scaling of 
the X-ray data was performed using the HKL2000. The hexagon crystal belongs to space 
group R3 with unit cell dimensions of a=110.58 Å, b=110.58 Å, c=347.29 Å, and α=90 
o, β=90 o, and γ=120o.  The solvent content of the unit cell was estimated to be 50.4%, 
with four molecules per asymmetric unit. 
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Structure Determination and Refinement 
 
The structure of BaVirB11 was solved using a local collected data set that resulted in 
space group (R3) to a maximum resolution of 3.6 Å.  An initial structural search model 
was constructed from HP0520 (PDB access code: 1OPX) by deleting the N-terminal 
domain and coveted those non-conserved C-terminal domain residues into alanine.  
Molecular replacement searches were carried out in PHASER (McCoy et al., 2005) 
using the mixed C-terminal domain as the search model.  Initial refinement was 
performed using Phenix-refine in Phenix packages (Adams et al., 2002). The refined 
map was used for auto-tracing to convert all residues into BaVirB11 sequence. The 
auto-tracing was carried out in program COOT (Emsley and Cowtan 2004). The 
resulting model was further refined using simulated annealing in Phenix.  An unbiased 
map obtained from SHAKE&WARP and a 2Fo-Fc map from REFMAC was used for 
model building using XTALVIEW.  The missing N-terminal domain was slowly built in 
and the refined model was used as a search model for molecular replacement searches 
using the high resolution data set (2.7 Å) collected from 23ID beam line at APS, 
Chicago.  The model building and refinements were carried out in Xtalview and 
REFMAC in CCP4.  
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Results and Discussion 
Protein Purification 
 
 
In order to carry out structural studies of VirB11, it is essential to produce large 
quantities of highly pure (>95%) protein.  The solubility and expression level of B. 
abortus VirB11 are low.  To overcome this problem, protein expression was induced 
with 0.5M IPTG at 16.0 o C for 12-16 hours.   
 
 
 
Figure 30.  One step Strep-tactin affinity purification of BaVirB11.  The collected 
fractions were analyzed by SDS-polyacrylamide gel electrophoresis and stained by 
Coomassie blue. 
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The N-terminal StrepII-fusion proteins were purified through a Strep-Tactin column 
(4ml).  The purification protocol was modified to improve the purity of the protein by 
increasing the washing stringency with a high salt buffer.  The Strep-Tactin column was 
washed again with a low salt buffer before eluted with 2.5mM desthiobiotin. The 
modified purification protocol allows us to obtain over 95% pure proteins from single 
step purification (Figure 30).  
The Strep-Tactin column purified VirB11 was also subjected to Superdex200TM gel 
filtration chromatography. VirB11 eluted from Superdex200 gel filtration appears to 
form hexamers as indicated by the molecular weight marker (Figure 31). The 
chromatography of the gel filtration purification is shown in figure 32 with the calibrated 
molecular weight marker indicated. However, the protein purified from a gel filtration 
column did not form crystals. 
The mutant proteins were over-expressed and purified by a one step Strep-Tactin 
purification protocol as used for the wild-type enzyme. However, three amino acid 
deletion mutants Δ-GKT(187-189)  and  Δ-IR(119-120)  showed little expression in E. coli and failed 
to be purified to large quantity for further studies. 
 
 132
      
Fractions 
 
Figure 31.  Chromatography of the gel filtration purification.  The arrows indicate the 
size of the elute based on the gel filtration calibration.  Vo represents the molecules 
eluted at void volume. 
 
 
Colorimetric ATPase Activities and ATP-agarose Binding Studies  
 
To gain insight into the domain requirement for BaVirB11 function, seven functional 
mutations of BaVirB11 were generated (Table 8), isolated and tested for their ATPase 
activities and ATP binding affinities.  Two of the double mutants Δ-GKT(187-189) and  Δ-IR(119-
120) produced little soluble proteins and were not included in the biochemical 
characterization. 
Ab280 
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ATPase activity was determined by measuring the release of phosphate ions that are 
the result of ATP hydrolysis. Formation of the green-colored phosphomolybdate-
Malachite green complex was detected by a spectrophotometer at OD610. A standard 
curve was performed using KHPO4 solutions of known concentrations and was used to 
determine the amount of phosphate released in the assay. The relative ATPase activity 
was calculated with the wild-type enzyme activity as 100%.  The relative ATP 
hydrolysis activities of the VirB11 and its mutants are shown in Figure 32.   
The mutant proteins of BaVirB11 were evaluated for their ATP binding activities by 
using ATP-agarose binding assay as described in the material and methods section. The 
samples were subsequently separated by SDS-PAGE and subjected to Coomassie blue 
staining.  The amount of ATP-agarose bound protein can be visualized and are shown in 
Figure 33. 
The most prominent feature in the amino acid sequences of the VirB11 is the 
presence of a conserved ATP binding motif, Walker A.  Studies have shown that 
mutations of invariant residues within the Walker A region in the VirB11 of 
Helicobacter pylori block the substrate transfer to recipient cells, and the purified mutant 
proteins show defect in ATP binding and hydrolysis (Berger and Christie 1994; Krause 
et al., 2000). Our Walker A mutant K188Q of BaVirB11 showed dramatically decreased 
ATP hydrolysis activity (5% active compared with the wild-type enzyme) (Figure 32).  
The ATP-agarose binding assay confirmed that the loss of ATP hydrolysis activity in the 
Walker A mutant resulted from the decreased ATP binding affinity to the enzyme 
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(Figure 33).   These results along with the wild-type enzyme control were used to 
validate the experimental methods.  
 
 
 
Figure 32.  ATPase activities of BaVirB11 and its mutants. All assays were performed 
with the enzyme at a final concentration of 1nM. Each reaction mixture was incubated 
for 10 minutes prior to the addition of ATP. Data were plotted as % label as Pi release 
with the wild-type enzyme as 100%. 
 
H285R is a His-box mutant. The equivalent mutation in A. tumefaciens was shown to 
affect T-pilus formation in vivo (Savvides et al., 2003).  The residues in His-box were 
shown to function catalytically ATP hydrolysis (Savvides et al., 2003).  The mutant 
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displayed a weaker ATP binding affinity (Figure 33) and decreased ATP hydrolysis 
activity (Figure 32), conforming the direct involvement of His285 in the nucleotide 
binding and hydrolysis.   
The I281T mutant has been regarded as an uncoupling mutant (I265T in A. 
tumefaciens VirB11) that shows no effect on substrate transfer but abolishes the 
formation of the T-pilus (Sagulenko et al., 2001).  However, the ATP binding affinity 
and ATPase activity of the mutant enzyme have not been shown before.  It is not clear 
why this mutant can translocate substrates efficiently while the pilus formation is 
disrupted. Sequence alignment reveals that I281 is located in between the two His-box 
residues H277 and H285 and is highly conserved among T4SS bacteria species (Figure 
29).  Mutation of I281T affected ATP-binding to the same degree as that of the H285R 
mutant (Figure 33), indicating I281T binds to ATP at a lower affinity than that of the 
wild-type enzyme.  In contrast to the H285R mutant, the I281T retains its ATP 
hydrolysis activity to about 70% active as that of the wild-type enzyme (Figure 32).  
This result explains the retained substrate transfer effect of the I281T mutant.  However, 
it is not known how this mutation affects the pilus formation in vivo.   
Mutations in the GER motif (R101Q) and the linker region (R120E) of VirB11 
completely abolish the ATP hydrolysis activity of the enzyme (Figure 32).   The 
interesting question is how the single site mutation in these regions could affect the 
enzymatic activity of the VirB11 so dramatically. It has been shown that a non-
hydrolysable ATP analog binds to HP0525 in between the interface of the N-terminal 
domain and the C-terminal domain, and the linker Arg is in close proximity to the ATP  
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Figure 33.  Comparisons of BaVirB11 and its mutants on ATP-agarose binding.   ATP 
binding assays were performed to determine the ATP binding affinity to the enzyme.   
ATP-agarose beads were pre-washed with an ATP-binding buffer and each protein 
sample was added to the ATP-agarose and incubated. The enzyme bound ATP-agarose 
beads were washed twice with an ATP-washing buffer before eluted with 10mM ATP.  
The eluted protein samples were run on 12-15% SDS-PAGE and stained by Coomassie 
blue.  The darker band indicates higher affinity of the enzyme to ATP and the lighter 
band implies the weaker binding. 
 
 
binding site in the ATPγS-HP0525 complex structure (Savvides et al., 2003). One 
possibility is that the single site mutation at the linker region might affect ATP binding 
due to the close proximity to the ATP binding site.  To our surprise, the binding 
affinities of the ATP-agarose to these two mutants are similar to that of the wild-type 
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enzyme (Figure 33), indicating that mutation in the GER motif or the linker region has 
no effect on ATP binding.  It would be possible that the N-terminal domain of BaVirB11 
organized differently than that of HP0525 so that the linker region is not in close contact 
to the ATP binding site. Crystal structure analysis may provide a clue to the 
conformation of the N-terminal domain and the flexibility of the linker region.  It has 
been shown that ATP binding to the Walker A motif is responsible for the 
conformational changes in the N-terminal domain, not the hydrolysis of ATP (Savvides 
et al., 2003).  A possible explanation for the decreased ATP hydrolysis activity in the 
linker mutation is that conformational changes at the N-terminal domain upon ATP 
binding are required for ATP hydrolysis activity.  It is likely that the R120E mutation 
disrupts the flexibly linker and locks the N-terminal domain in one conformation.  The 
binding of ATP to the mutant protein brings no change in the conformation of the linker 
region and the N-terminal domain, consequently, ATP hydrolysis is disrupted.  
VirB11 protein forms stable homohexameric rings capable of ATP binding and 
hydrolysis (Sexton et al., 2004).  To assess the ability of each BaVirB11 mutant protein 
to form stable homohexamer, the covalent cross-linking experiments were implemented 
as described in the Material and Method section. Purified wild-type enzyme was used as 
a positive control. The cross-linking experiments were repeated three times under 
various protein concentrations.  The proteins were completely dialyzed into a phosphate 
buffer at pH 7.0.  Some protein precipitated during the dialysis and concentration 
process.   Each of the single site mutants generated from this study were capable of 
forming a stable hexameric complex as indicated by the molecular weight on the SDS-
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PAGE (data are not shown), suggesting that the decreased ATP hydrolysis activity in 
mutant proteins was not a result from the disruption in the formation of the 
homohexamer.                                              
 
Structure Determination of BaVirB11  
  
B. abortus VirB11 native crystals were obtained at 18 oC from a solution containing 10% 
w/v PEG-4000, 0.1M HEPES, pH7.5, 0.1 M NaCl. Larger plate-like crystals (Figure 
34a) grew in the well in which an additional 10% protein was added two weeks after the 
initial crystal plate set-up.  Hexagonal shaped crystals were obtained from a solution 
containing 18%PEG400, 0.1M HEPES, pH7.5, and 0.1M MgCl2 (Figure 34b).  The 
native diffraction data used to solve the structure of BaVirB11 was collected on an R-
AXIS image plate detector (Rigaku-MSC) at the wavelength 1.5418 Å.  A total of 180 
frames have been collected at 1 degree oscillation. Integration and scaling of the X-ray 
data was performed using the HKL2000. The hexagon crystal belongs to space group R3 
with unit cell dimensions of a=110.58 Å, b=110.58 Å, c=347.29 Å, and α=90 o, β=90 o, 
and γ=120o.  The solvent content of the unit cell was estimated to be 50.4%, with four 
molecules per asymmetric unit. 
The structure of BaVirB11 was solved in space group R3 using the molecular 
replacement method discussed in the Materials and Methods section.  The asymmetric 
unit contains 4 monomers. The model has been refined to R/Rfree of 36.5%/39.7% to a 
resolution of 3.6 Å with N-terminal residues 1 to 98 missing.  This partial model was 
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used as a search model against a data set collected in the C2 space group to a higher 
resolution (2.7 Å). The asymmetric unit in this C2 space group contains 6 molecules. 
The model has been built and refined to contain residues18 - 348 in each monomer with 
R/Rfree of 35.6%/40.5% (Table 10). The six subunits in the asymmetric unit differ 
slightly from each other with a root-mean-square deviation (RMSD) of 0.63 Å for Cα 
atoms between subunit A and B, 0.72 Å between subunit B and C, 0.31 Å between B 
and D, 0.34 Å between B and E, and 0.42 Å between B and F.  Subunit B is the best 
refined subunit with the highest real space correlation among the six monomers. All of 
the descriptions of the VirB11 monomer in the following section are based on the 
refined subunit B. 
 
Structure of the Monomer  
 
 
The BaVirB11 monomer contains two domains, an N-terminal domain and a C-
terminal domain connected by a linker (Figures 29 and 35).  Both of the N- and C-
terminal domains of BaVirB11 align well with the corresponding domain in HP0525 
(Figures 29 and 36).  The topology of both structures, BaVirB11 and HP0525, is similar 
(Figure 37).  The N-terminal domain of BaVirB11 can be superimposed to the 
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 (a) BaVirB11 crystals --- plat-like crystals in C2 space group 
           
          (b) BaVirB11 crystals --- hexagonal crystals R3 space group 
 
 
Figure 34.  Crystals of the BaVirB11. 
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Table 10. Data collection and structure refinement statistics for BaVirB11  
 Possible 
Liganded 
Unliganded 
A. Data collection statistics   
    Wavelength 1.541 0.94 
    Unit cell parameters   
     a  110.6 123.1 
     b 110.6 233.2 
     c 347.3 107.3 
     Space group R3 C2 
     Resolution limits 3.6 2.7 
     Unique reflections 22656 63355 
     Completeness 88.2 (64.0)a  98.2 (89.0)a  
     Rsym b (%) 11.8 (23.8) 11.8 (23.8) 
     I/sigma 8.9 (1.1) 6.5 (1.5) 
B. Refinement statistics   
     Resolution range 30.0-3.6 30.0-2.7 
     Test set size 5% 5% 
     R cryst c (%) 36.5 35.6 
     R free d (%) 39.8 40.5 
     Protein-non-H atoms  11987 
     Number of water molecule 0 188 
     Rmsd of bond distances (A) 0.01 0.01 
     Rmsd of bond angles (deg) 1.79 1.69 
     Average B value 79.5 69.64 
  
a Numbers in parentheses represent values in the highest resolution shell. 
b Rsym Rsym = ∑h∑i⏐I(h,i) - <I(h) ⏐/ ∑h∑i I(h,i) where I(h,i) is the intensity value of I(h) for all i 
measurements. 
c Rcryst = ∑⏐⏐Fo - Fc ⏐⏐/  ∑ ⏐Fo⏐, where ⏐Fo⏐ and ⏐Fc ⏐ are the observed and calculated 
structure factor amplitudes respectively. 
dRfree  is the same as Rcryst but calculated with 5% subset of all reflections that was never used in 
any refinement. 
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Corresponding domain of HP0525 with an RMSD of 1.7 Å for Cα atoms over 69 
aligned residues.  Superimposing of the C-terminal domains from both structures results 
in an RMSD of 1.3 Å for 110 Cα atoms aligned indicating that the C-terminal domain is 
more conserved than the N-terminal domain.  
The N-terminal domain is comprised of residues 18 to 119.  Arg18 is the first residue 
for which interpretable electron density is visible.   The N-terminal domain is composed 
of a six-stranded antiparallel β sheet forming a polar surface that is involved in the 
protein-protein interaction between the subunits. This interaction is used extensively for 
the oligmerization of the protein (Savvides et al., 2003).  One helix-turn- helix motif 
(residue 20 to 34) and a longer α helix (residue 66 to 81) form a convex face against the 
one side of the β sheet on the N-terminal domain (Figure 35).  The β6 strand runs 
antiparallel in between β 5 and β 1 and extends to the linker region.  The linker could 
serve as a spring with a very well balanced N-terminal domain as a hammer head. The 
observed conformational variability and flexibility of the N-terminal domain in HP0525 
could be facilitated by the conserved topological fold of the protein (Savvides et al., 
2003).   
Two major differences in the N-terminal domain between BaVirB11 and HP0525 are 
found. First, the beginning part of the helix α1  that extends far out from the core of the 
protein in HP0525 is disordered in BaVirB11.  Second, unlike in HP0525, a short helix-
turn- helix motif is formed by residue 20 to 34 in the N-terminal domain of BaVirB11 
(Figure 35).  This helix-turn- helix motif, also called α - α Corner, is a common feature 
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of hydrophobic interactions.  Amino acid side chains at the interface between elements 
of secondary structure are shielded from water ( Nelson 2000).  Interestingly, this helix-
turn-helix motif is packed against the hydrophobic side of the N-terminal β sheet, 
creating a very hydrophobic environment.  
 
 
  
 
Figure 35.  Ribbon diagram of the structure of BaVirB11 monomer. Secondary structural 
elements are labeled from β1 to β13 for β sheets and α1 through α9 for α helices; a 
linker is indicated in dark blue. The figure is constructed using program SPOCK. 
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The C-terminal domain, made up of residue 140 to 346, exhibits a topology with a 
central β sheet composed of seven β−strands. Five β−strands run parallel in the middle 
section in the order of β 8−β 10−β11−β7−β12 (Figure 35).   Τwo outer strands 
β 9 and β 13  run anti-parallel to its adjacent strand β 8 and β 12,  respectively.  The 
central β sheet is surrounded by six α helices from both sides of the β sheet.  Helices α 4 
and α 5 are at one side of the central β sheet and flank the β 7 strand on both ends.  
Helices α 6 through α 9 are packed against the β sheet from the other side.  The C-
terminal domain contains all four characteristic sequence motifs identified in all 
members of the T2SS and T4SS superfamily (Planet et al., 2001): the Walker A (P loop), 
Walker B, His box and Glu box that involved in nucleotide binding (Figure 37).  
 
  
Figure 36. Superposition of HP0525 monomer model (dark blue) and the best refined 
BaVirB11 structure (brown).  The structures are shown in coil representation. 
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The two domains are linked by an extended loop between residues 120 and 139 between 
β 6 strand and α 4 helix (Figure 35).  The linker starts from the β6 strand in the N-
terminal domain cross the interface of the two domains to the outer rim of the C-terminal 
domain. Sequence alignments reveal that the linker is not conserved among the T4SS 
(Figure 29). It shows variable length in different bacterial species ranging from 10 to 20 
residues. Superimposing BaVirB11 and HP0525 shows that the linker in BaVirB11 
rotates about 10 degree away from the C-terminal domain resulting in the N-terminal 
domain shifting further away from the C-terminal domain (Figure 36).  
 
       
 
Figure 37. A magnified view of the NTD-CTD interface. The figure is constructed from 
the subunit B of the hexamer by using the program SPOCK.  The linker is colored in 
blue; Walker A in violet; E box in dark blue; H box in red, and Walker B in green. The 
side chains of Arg101 and Arg 120 are also high lighted.  
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Structure of the BaVirB11 Hexamer 
 
 BaVirB11 protein exists as a homohexamer in solution (Figure 31).  In the crystal 
structure, the hexamer is constructed from one of the two trimers in the asymmetric unit 
by the 2-fold crystallographic symmetry operation.  A ribbon diagram of the resulting 
ring structures are illustrated in Figure 38.  A surface diagram showing the electrostatic 
potential of the hexamers is presented in Figure 39.  The hexamer is formed by two 
layers of rings illustrated by coloring the N- and C-terminal domains differently (Figure 
38).  The C-terminal domains form a wheel-like ring with an inner hole about 10 Å in 
diameter and outer rim of ~100 Å in diameter (Figure 39a).  The N-terminal domains 
are positioned counter-clockwise in between two adjacent C-terminal domains forming 
an outer ring that lies on the top of the C-terminal ring (Figure 38).  The inner funnel of 
the N-terminal ring is ~40 Å in diameter and the outer rim is ~100 Å in diameter.  The 
chamber formed by these two layers of rings has a volume of ~ 70000 Å3. The outer 
surface of the N-terminal ring is flat and the C-terminal surface is more rugged (Figure 
39b). 
The N-terminal domain protrudes from the C-terminal domain, resulting in no direct 
contact between the two domains in the same subunit except in the linker interface 
(Figure 39b).  The subunit-subunit interface is extensive, mainly in between the adjacent 
C-terminal domains and in between an N-terminal domain and its adjacent C-terminal 
domain. The C-terminal domain to C-terminal domain interaction makes a major 
contribution to the oligmerization of the protein.  The buried interface of the adjacent C-
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terminal domains is 910 A2.  This interface is mainly made up by α 8 from one subunit 
and α 7 and α 9 from the adjacent subunit.  The NTD-CTD interaction is located in 
between α 6 and β 9 from one C-terminal domain and the loop that flanks the β 5 and β 
6 in the adjacent N-terminal domain. The interface in this region buries 716 A2 of 
surface area.  The ATP binding pocket is located at the interface of the N-terminal 
domain and the C-terminal domain (Figure 39b).    
 
      
  
    (a)      (b) 
 
 
Figure 38. Ribbon diagram of the BaVirB11 hexamer.  The N-terminal domain is 
colored in dark blue; the C-terminal domain is shown in magenta; the linker is presented 
in green.  (a). Ribbon diagram of the BaVirB11 hexamer viewed down from the ring 
formed by the N-terminal domains.  (b). Side view of the BaVirB11 hexamer.  The 
figure is obtained by rotating the BaVirB11 hexamer shown in (a) 90o up along the 
horizontal axis of (a).  
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      (a) 
    
      (b) 
 
Figure 39. Surface of the BaVirB11 was displayed using the program SPOCK.  Color 
coding to represent charge is that blue is for the positively charged region, red is for the 
negatively charged region, and white is for the hydrophobic region. (a). Surface of the 
BaVirB11 hexamer viewed down from the N-terminal side to show a large chamber and 
a small opening. The dimensions of the chamber are indicated.  (b). Surface view of 
subunit-subunit interface.  
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Structural analysis of the BaVirB11 mutants 
 
The BaVirB11 structure allows the loss of function associated mutations to be explained.   
Seven of such mutants were generated and five mutants containing a single-site mutation 
were analyzed for their functionality as reported in the previous section.  K118Q, a 
mutation in the Walker A motif, abolishes the ATP-binding and ATPase hydrolysis 
activity.   R101K, a mutation in the GER motif, was shown to retain the ATP-binding 
activity (Figure 33).  However, the ATPase hydrolysis activity was disrupted (Figure 
32).  Arg120 is a conserved residue located at the end of the β 6 strand in the N-terminal 
domain and at the beginning of the linker (Figures 29 and 36).  R120Q mutant was 
shown to have a normal ATP-binding affinity when compared with the wild-type 
enzyme (Figure 33).  The ATP hydrolysis activity of R120Q was found to be greatly 
reduced (Figure 32).  The I281T mutation was found to have reduced ATP-binding 
affinity but retained most of its ATP hydrolysis activity (Figures 32 and 33).  The 
H285R mutation was shown to be inefficient in ATP binding and hydrolysis (Figures 32 
and 33).   
Figure 40 shows an unbiased electron density at the linker region around the β5 
and β 6 sheets to confirm reliable structural analysis in the region.  Gln103 and Arg101 
from β5 and Ser116, Thr118, Arg120 and Arg123 from β6 form a charged surface on 
one side of the β sheet (Figure 41).  The other side of the β sheet is highly hydrophobic, 
made up of residues Ile125, Ile104, Ile115, Val117 and Ile119 (Figure 41).  The charged 
residues Arg101 and Arg120 are located at the interface of the N-terminal and C-
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terminal domains in close proximity to the ATP binding site, but are not directly 
involved in ATP binding (Figures 36 and 42).  Superimposition of HP0525-ATPγS 
complex structure to the BaVirB11 reveals that the nucleotide-binding environments of 
the two proteins are similar.  Five mutants generated in this study and their equivalent 
residues in the structure of HP0525-ATP γS complex are highlighted for comparison 
(Figure 42).  Lys184 of the HP0525 is a conserved residue in the P loop region.  The 
side chain of Lys 184 interacts directly with the γ-phosphate and plays an important role 
for ATP binding and hydrolysis (Savvides et al., 2003).  The equivalent residue Lys 188 
of BaVirB11 is found in a similar position and its side chain is within the coordination 
sphere of the ATP γ-phosphate. 
 
      
 
Figure 40. Selected section of the electron density map at the linker region.  The β5 
and β 6 sheets are presented to show very well refined Arg101 and Arg120 residues.  
Unbiased electron density was calculated using SHAK&WARP, the bias removal server 
(Reddy 2003). The map was contoured at one sigma and the figure was generated using 
Xtalview. 
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Figure 41. A model of the represented region defined in the figure.  Residues from β5 
sheet are labeled in black and the residues from β6 sheet and the linker region are 
labeled in purple.  Surface of the model is shown in a transparent mesh and displayed by 
colored surface potential.  Color coding to represent charge is that blue is for the 
positively charged region, red is for the negatively charged region, and white is for the 
hydrophobic region. 
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Replacing the positively charged Lys with a negatively charged Glu disrupts the 
favorable ionic interactions between the mutated residue and the γ-phosphate of ATP, 
blocking the ATP-binding and hydrolysis.  The imidazole ring of the His285 of the 
BaVirB11 flips 90o in respect to the equivalent residue (His273) of the HP0525- ATP γS 
(Figure 42).   The significance of this change is unknown.  It might be caused by a low 
quality of the structure refinements in the region.  The H285 brings more positive 
charges to the ATP-binding pocket.  Mutation of the His285 to an Arg showed a weaker 
binding affinity for ATP and decreased ATP hydrolysis activity.  Although the replaced 
Arg side chain could supply the positive charges to the ATP binding pocket, the role of 
the His285 in cleaving the γ-phosphate group and release of ADP as a product is not 
replaced by the Arg mutation.  R113 of HP0525 was proposed to play dual roles in ATP 
binding and hydrolysis: to provide complementary electrostatic interaction with ATP γ-
phosphate and to interact with the catalytic Glu248, a conserved E box residue (Savvides 
et al., 2003).  An equivalent mutant R101K of BaVirB11 displays a similar ATP binding 
affinity as the wild-type enzyme (Figure 33) and abolished ATP hydrolysis activity 
(Figure 32), indicating that direct interaction of Arg 101 with the catalytic Glu is crucial 
for ATP hydrolysis activity.  Arg101 may be involved in product release through 
interaction with the catalytic Glu residue.  Arg120 of BaVirB11 was found to have the 
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largest conformational change among the residues proposed with functional mutations 
(Figure 42).  This large conformational change is due to the movement of the flexible 
linker (Figures 39 and 42).  Arg120 is shifted further away from the ATP-binding site 
and its side chain is located outside the coordination sphere of the ATP binding site as 
predicated from HP0525-ATPγS structure (Figure 42).  R120E of BaVirB11 exhibits 
completely diminished ATP hydrolysis activity (Figure 32).  However, the mutant 
displays a similar ATP-binding affinity as the wild-type enzyme (Figure 33), indicating 
Arg120 is not directly involved in ATP binding.  It is possible that the negative charges 
introduced by Glu to replace the positively charged Arg side chain affect the flexibility 
of the linker.  In the wild-type enzyme, once an ATP molecule binds to the ATP-binding 
site, the positively charged guanidino group of Arg120 interacts with the negatively 
charged phosphate group of ATP to bring the N-terminal domains to the closed 
conformation through movement of the flexible linker. This movement is disrupted in 
the R120E mutant because the negative charges introduced by glutamic acid repel to the 
ATP phosphate groups.  This may result in the N-terminal domains remaining in their 
open conformation when ATP binds in the mutant enzyme.   
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Figure 42. Superimposition of HP0525 and BaVirB11 at the ATP binding site.  The 
active site architectures of the two proteins are shown.  Ribbon of the BaVirB11 is 
colored in cyan.  Ribbon of the HP0525 is in gold.  Five residues that had been mutated 
in this study are shown in default color in which white is for carbon atoms, red for 
oxygen and dark blue for nitrogen.  The corresponding residues of the HP0525 are in the 
same color as that of BaVirB11 except carbon atoms are colored yellow. The ATPγS 
molecule from HP0525 structure is indicated.   
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Summary 
 
VirB11, an ATPase, has been identified as an essential component of the T4SS that 
mediates the translocation of virulence factors of many pathogenic bacteria into 
eukaryotic cells (O’Callaghan et al., 1999; Schmiederer and Anderson 2000; Baron et 
al., 2002; Cascales and Christie 2004; Christie 2004; Remaut and Wakdman 2004; 
Sexton et al., 2004).  It presents an excellent drug target for the development of 
antimicrobial drugs, as inhibitors of VirB11 would essentially disarm the function of the 
T4SS.  In the thesis, a series of structural and functional studies have been initiated to 
elucidate the molecular features and structural determinants of the BaVirB11. Structure 
of BaVirB11 was found to exist as a homohexamer formed by two layers of rings, a 
wheel-like inner ring formed by the C-terminal domains and an outer ring constituted by 
the N-terminal domains. The two rings are connected through a linker that is in between 
the N-terminal domain and the C-terminal domain. A large conformational change was 
found in the linker region of BaVirB11 when compared with the structure of HP0525. 
In order to elucidate the functional role of each domain and relate its function to the 
structure, seven mutations of BaVirB11 were generated, isolated and tested for their 
ATPase activities and ATP binding affinities. The BaVirB11 structure allows the loss of 
function associated with mutations to be explained.  In the study, we found that the GER 
motif and the linker region are crucial for ATP hydrolysis activity of BaVirB11 to a 
similar degree as that of the Walker A and the His-box motif. Mutations in the GER 
motif (R101Q) and the linker region (R120E) of BaVirB11 completely abolish the ATP 
hydrolysis activity of the enzyme. However, the binding affinities of the two mutants to 
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the ATP are similar to that of the wild-type enzyme, indicating that mutation in the GER 
motif or the linker region has no effect on ATP binding, which is different from the 
Walker and the His-box motif. A possible explanation for the decreased ATP hydrolysis 
activity in the linker mutation is that the movement of the linker region rotates the N-
terminal domain of VirB11 and serves as the driving force for ATP hydrolysis. The 
R120E mutation disrupts the flexibly linker and locks the N-terminal domain in one 
conformation and, consequently, ATP hydrolysis is disrupted.  
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CHAPTER V 
SUMMARY AND FUTURE DIRECTIONS  
 
The challenge of fighting against tuberculosis is that there is wide spread drug resistant 
strains.  Primary resistance of M. tuberculosis is the resistance to INH, the first line 
antituberculosis drug.  In an effort to elucidate the molecular mechanism of INH 
activation and the relationship between drug resistance and the function of catalase-
peroxidase, we have solved the X-ray crystallographic structures of the wtKatG, S315T 
mutant, and INH co-crystallized wtKatG. The dimeric enzyme contains a heme cofactor 
of the iron protoporphyrin IX in each monomer. The heme iron of the wtKatG has six 
coordinates: the fifth coordinate is occupied by the side chain of His270 from the 
proximal side of the heme, and the sixth coordinate is from an ordered water molecule 
on the distal side of the heme.  Three catalytically important residues His270, Asp381, 
and Trp321 from the proximal side of the heme are conserved in the class I peroxidase 
family. On the distal side of the heme, three catalytically important residues Arg104, 
Trp107, and His108 are conserved as well.  An unusual adduct formed between side 
chains of Trp107, Tyr229 and Met255 is found to exist in the vicinity of the distal heme 
binding pocket.  Arg418 with double conformation side chains is located near the Trp-
Tyr-Met adduct.  In one conformation, the guanidino group of Arg418 forms a hydrogen 
bond with Oη of Tyr229, the central residue of the adduct. At the alternative 
conformation, the guanidino group points toward a large U-shaped solvent channel.  A 
molecular surface of the wtKatG reveals that two substrate access channels exist in each 
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dimer.  The major channel provides access to the deeply buried heme with the narrowest 
neck delimited by the carboxyl group of Asp137 and Ser315.  A large U-shaped channel 
connects to the molecular surface through two funnels.  Arg418 is located on the bottom 
of the channel.  In the conformation in which the side chain of Arg418 points to the 
molecular surface, the U-shaped channel is interrupted, indicating that the channel 
provides direct access to the adduct through the side chain of Arg418. 
Our results provide a detailed picture of how the S315T mutation affects the function 
of the enzyme by comparing the wtKatG structure to that of the mutant enzyme. The 
arrangement of the catalytically important residues from both the proximal side and the 
distal side is essentially the same as that of the wild-type enzyme, indicating the 
unaltered catalase and peroxidase activities of the mutant.  The heme iron in the S315T 
mutant has 5-coordinate instead of 6-coordinate in the wtKatG.  It has been shown that 
the oxyferrous wtKatG, either as Compound I or Compound II, is capable of oxidizing 
INH, while the  oxyferrous KatG[S315T] is incapable (Ghiladi 2004; Ghiladi et al., 
2005).  The most significant change in KatG[S315T] is the presence of the methyl group 
of the side chain of threonine, which effectively narrows the substrate access channel 
and hinders the continuous flow of the substrates.   
The structure of the wtKatG co-crystallized with INH was investigated to identify 
the substrate binding site in the enzyme.  The wild-type enzyme was treated with KCN, 
an inhibitor for a heme containing enzyme, before the co-crystallization with INH. The 
overall structure of the wtKatG-INH remained the same as that of the wtKatG.  An INH 
molecule was fitted and refined into a region of electron density located in close 
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proximity to the Pyrrole I of the distal heme.  The pyridine ring of INH is located 
parallel to the heme plane.  The carbonyl oxygen of INH forms hydrogen bond with Nε1 
of the indole ring of Trp107 and the pyridinyl nitrogen of INH forms hydrogen bond 
with the nitrogen atom of Tyr229.  Both Trp107 and Tyr229 are involved in the distal 
adduct formation. The nicotinamide-NH2 group of INH forms a hydrogen bond with the 
carboxyl group of Asp137, a key residue that has been proposed to play a role in the 
binding and activation of INH (Jakopitsch et al. 2003b).  Our data revealed an excellent 
position for INH binding and activation through interaction with Asp137 and the distal 
adduct.  Future work would be to determine structures of Compound I, Compound II and 
Compound III by using the KatG[Yy229F] mutant to elucidate the catalytic mechanism 
of the enzyme. 
 VirB11, an ATPase, has been identified as an essential component of the T4SS that 
mediates the translocation of virulence factors of many pathogenic bacteria into 
eukaryotic cells (O’Callaghan et al., 1999; Schmiederer and Anderson 2000; Baron 
2002; Cascales and Christie 2004; Christie 2004; Remaut 2004; Sexton 2004).  It 
presents an excellent drug target for the development of antimicrobial drugs, as 
inhibitors of VirB11 would essentially disarm the function of the T4SS.  In the thesis, a 
series of structural and functional studies have been initiated to elucidate the molecular 
features and structural determinants of the BaVirB11. Structure of BaVirB11 was found 
to exist as a homohexamer formed by two layers of rings, a wheel-like inner ring formed 
by the C-terminal domains and an outer ring constituted by the N-terminal domains. The 
two rings are connected through a linker that is in between the N-terminal domain and 
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the C-terminal domain. A large conformational change was found in the linker region of 
BaVirB11 when compared with the structure of HP0525. 
In order to elucidate the functional role of each domain and relate its function to the 
structure, seven mutations of BaVirB11 were generated, isolated and tested for their 
ATPase activities and ATP binding affinities. The BaVirB11 structure allows the loss of 
function associated with mutations to be explained.  In the study, we found that the GER 
motif and the linker region are crucial for ATP hydrolysis activity of BaVirB11 to a 
similar degree as that of the Walker A and the His-box motif. Mutations in the GER 
motif (R101Q) and the linker region (R120E) of BaVirB11 completely abolish the ATP 
hydrolysis activity of the enzyme. However, the binding affinities of the two mutants to 
the ATP are similar to that of the wild-type enzyme, indicating that mutation in the GER 
motif or the linker region has no effect on ATP binding, which is different from the 
Walker and the His-box motif. A possible explanation for the decreased ATP hydrolysis 
activity in the linker mutation is that the movement of the linker region rotates the N-
terminal domain of VirB11 and serves as the driving force for ATP hydrolysis. The 
R120E mutation disrupts the flexibly linker and locks the N-terminal domain in one 
conformation and, consequently, ATP hydrolysis is disrupted.  
The work on the I281T mutant reveals that the mutant binds ATP weakly; however, 
it retains its ATPase activity.  Interestingly, the I281T mutant was found to show no 
effect on substrate transfer but abolishes the formation of the T-pilus (Sagulenko et al., 
2001).  Structural analysis reveals that I281 is located in between the two His-box 
residues H277 and H285 and is not in direct contact to the ATP-binding site. This may 
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explain the efficient substrate transfer in the I281T mutant because of the retained ATP 
hydrolysis activity of the mutant enzyme.  However, it is not known how this mutation 
affects the pilus formation in vivo. 
In order to further investigate the functional role of each domain, more structural 
studies are needed. The primary study shows that each mutant forms crystals in different 
shapes, which even resulted in different space groups under different crystallization 
conditions. Structures of the linker mutant, the GER motif mutant and the I281T mutant 
may help us understand the mechanism of the BaVirB11 better, especially when the 
structures of the substrate bound mutants are available.  To further study the roles of the 
linker region and the GER motif in substrate transfer and the pilus biogenesis of the 
T4SS, each mutant gene can be transformed into the wild-type A. tumefaciens strain 
(A348) or the ∆VirB11 gene deletion strain and the virulence assays can be performed 
and compared using T-pilus isolation and conjugation assay.  Nucleotide-dependent 
conformational changes in the linker mutant and the GER mutant can be compared by 
the analytical sedimentation studies. We also may be able to monitor the conformational 
change during ATP binding and hydrolysis by using the MINT-ATP, which releases 
fluorescence upon the ATP binding. 
VirB11 was shown to interact with other VirB protein components such as VirB1, 
VirB4 and VirB10, to coordinate substrate transfer across the inner membrane.  The 
structures of the protein-protein complexes are more likely to give us insight about the 
functionality of the VirB11 protein as well as the T4SS.  
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The ultimate goal of the structural studies is to design drugs that can be used to treat 
the T4SS dependent pathogens.  Such drugs would disarm but not kill the pathogens and 
therefore not be subject to resistance selection as other classical antibiotics.  
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